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Zusammenfassung 
Die vorliegende Arbeit hatte es zum Ziel zu untersuchen inwiefern die 
intermittierende Theta Burst Stimulation (iTBS) eine wirksame 
Therapiemöglichkeit in der Behandkung von Angststörungen darstellen könnte. 
Der theoretische Hintergrund dieser Fragestellung basierte dabei auf der 
Annahme eines in der Literatur häufig berichteten Ungleichgewichts des 
Angstnetzwerks, welches sich durch präfrontale Hypoaktivität sowie Hyperaktivität 
subkortikaler Strukturen wie beispielsweise der Amygdala auszeichnet. 
Darüberhinaus wurde die Fähigkeit der repetitiven transkraniellen 
Magnetstimulation (rTMS), wie in diese Falle der iTBS, umschriebene kortikale 
Aktivierungsmuster auf eine nicht-invasive Art und Weise zu modulieren in 
mehreren Studien sowie klinischen Fallberichten gezeigt. Aus diesen Befunden 
abgeleitet wurden zwei Studien konzipiert, wobei beide eine jeweils 
unterschiedliche potenzielle Anwendung der iTBS zur Behandlung von 
Angststörungen untersuchen sollte. Folglich beschäftigte sich die erste Studie mit 
der Wirkung einer wiederholten (plazebo-kontrollierten) iTBS Applikation als 
zusätzliche Unterstützung während dem Verlauf einer manualbasierten kognitiven 
Verhaltenstherapie (15 Sitzungen während der ersten drei Wochen) in einer 
Gruppe von Patienten mit Panikstörung mit und ohne Agoraphobie. Die zweite 
Studie wiederum konzentrierte sich auf den Einfluss einer einmaligen iTBS 
Anwendung vor einer angstauslösenden Situation auf die Symptome in einer 
Gruppe von Spinnenphobikern (subjektiv wahrgenommene Angst sowie 
Verhaltens- und psychophysiologische Korrelate). In beiden Studien wurde die 
präfrontale Aktivität sowohl vor als auch nach der iTBS Behandlung mit Hilfe der 
Nahinfrarotspektroskopie aufgezeichnet und schließlich mit den 
Aktivierungsmustern einer gesunden Kontrollstichprobe verglichen.  
Grundsätzlich konnten beide Studien Veränderungen im Angstnetzwerk 
hinsichtlich abweichender präfrontaler Aktivierungsmuster im Vergleich zur 
gesunden Kontrollgruppe replizieren. Weiterhin konnte gezeigt werden, dass 
diese Veränderungen sich nach iTBS Applikation teilweise normalisieren liesen. 
Eine klinische Verbesserung bezüglich einer subjektiv stärker ausgeprägte 
Symptomreduktion nach iTBS Anwendung konnte jedoch in keiner der beiden 
  
Studien nachgewiesen werden. Mögliche Gründe und Schlussfolgerungen für 
zukünftige Studien zur klinischen Anwendung von iTBS werden diskutiert.  
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“They tell us that the only thing we have to fear is fear itself, but I don't believe 
that." he said.  
 
Then, a moment later, he added: "Oh, the fear is there, all right. It comes to us 
in many different forms, at different times, and overwhelms us. But the most 
frightening thing we can do at such times is to turn our backs on it, to close our 
eyes. For then we take the most precious thing inside us and surrender it to 
something else.” 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                      
 
 
 
 
 
                                                                                                Haruki Murakami,               
                                                                                              Kafka on the shore
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1. General Introduction 
1.1 Outline of the present work 
The overall goal of this dissertation was to further clarify the neuro-physiological 
characteristics of pathological anxiety and related cognitive and emotional biases in 
order to assess the potential of repetitive transcranial magnetic stimulation (rTMS) as 
a supportive tool in its treatment. To do so, two studies were conducted, whereby 
the first one addressed the question by exploring the prefrontal activation patterns of 
patients with panic disorder with and without agoraphobia prior to as well as after 15 
(sham-controlled) rTMS applications over the left dorsolateral prefrontal cortex 
(DLPFC). In doing so, the rTMS treatment was performed as an add-on to cognitive 
behavioural therapy (CBT) which was conducted in a manual-based group setting. 
The outcome of this study resulted in two manuscripts, whereby the first one 
(section 2.1) focused on neurobiological alterations and their modulation via rTMS 
during a cognitive task in this group of patients. Respectively, the second one 
(section 2.2) further explored neuronal alterations during the processing of emotional 
stimuli as well as the overall improvement of clinical symptoms during the time 
course of CBT.  
The second study was subsequently designed to examine the impact of prefrontal 
rTMS on emotional processing and emotion regulation in a more exclusive manner by 
specifically looking at a single (sham-controlled) rTMS session which was combined 
with a virtual reality (VR) challenge as a fear-inducing situation in a group of spider 
phobic participants.  Again, two manuscripts emerged from this study. The first one 
(section 3.1) described the effects of the elicited fear during VR immersion on an 
electrophysiological level (heart rate, heart rate variability and skin conductance) as 
well as on a subjective level (anxiety and disgust ratings) in more detail. The second 
one (section 3.2) once again focused on prefrontal activation patterns before and 
after the rTMS-VR combination but this time with a special emphasis on the 
functional connectivity between different cortical areas. Moreover, changes in 
perceived valence and arousal ratings of the presented stimuli were reported. 
Preceding these manuscripts, the following section shall give a concise overview of 
the fundamental background in anxiety research which was taken as a basis for the 
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scientific deduction of the study designs. Hereby, the neurobiological findings which 
have been related to pathological anxiety as well as its state of the art treatment 
options as the foundation for further research are considered.  
 
 
1.2  Pathological anxiety – global overview 
In general, as a basic emotion, fear clearly has a functional adaptive value (Ekman, 
1999). In this regard it initiates the well-known “fight or flight response” (Cannon, 
1915) by activating the sympathetic nervous system, thereby enabling organisms to 
quickly react towards environmental stimuli which may threaten survival (Bracha, 
2004). In this context it may also be argued that it further has a social function as 
the fear reaction of one individual can serve others as a warning sign of potential 
danger (Marsh, Ambady, & Kleck, 2005).  Usually, the degree of danger should 
determine the intensity of the fear reaction thereby also modulating the behavioural 
response. However, depending on the individual’s predisposition as well as 
experiences the responsiveness of the “fear circuit” (for a more detailed explanation 
please refer to the next section) may be increased, leading to hypervigilance as well 
as exaggerated cognitive and behavioural reactions to environmental stimuli (Rosen 
& Schulkin, 1998). Pathological anxiety can hence be defined as an oversensitive fear 
network which leads to an overestimation of the actual danger and manifests itself in 
situationally inadequate thoughts and actions. The negative thinking thereby typically 
includes all cognitive modalities such as attention, memory and judgement (Beck, 
Emery, & Greenberg, 2005). Behavioural reactions associated with pathological 
anxiety are mostly escape from or avoidance of the feared state or stimulus (Woody 
& Teachman, 2000).  
 In principle, reactions to threat can be described as an interplay between bottom-up 
and top-down processes (Kim et al., 2011). In this regard, bottom-up processing is 
necessary in order to respond fast and automatically to survival relevant stimuli while 
top-down processes are needed to include further knowledge or contextual 
information in order to regulate the emotion so the behaviour can be adapted.  
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Accordingly, pathological anxiety can be conceptualised as an impaired interaction of 
bottom-up and top-town processing. In this context, a specific phobia as for example 
spider phobia can be seen as a model for the development of anxiety disorders 
where the interplay of bottom-up and top-down processing is out of balance. In this 
case, the spider as the initially threatening stimulus activates a fear reaction via 
bottom-up processing. Whereas individuals without spider phobia are able to 
integrate further information about the spider (like that it is not harmful) and hence 
down regulate their emotion, a spider phobic is flooded by his initial fear. This may 
either be caused by a hyper vigilant bottom-up system or because the top-down 
regulatory system is not efficient enough, whereby, of course, both systems affect 
each other.  
 
 
1.3 Neurobiological aspects of the fear response 
1.3.1 The fear network: the influence of cognitive control on fear-inducing 
stimuli 
The neurobiological correlates of the fear response have been addressed in a large 
number of studies and review articles (for example, Dresler et al., 2013; Gorman, 
Kent, Sullivan, & Coplan, 2000; Öhman & Mineka, 2001). In this regard, there is 
consensus that the amygdala may be seen as a core structure of fear processing 
which automatically gets activated by environmental as well as visceral stimuli. Via 
different nuclei it thereby receives input from a huge number of different brain areas, 
especially from primary sensory cortices as well as directly via the sensory thalamus. 
Contextual information is included through projections from the hippocampus. In 
turn, the central nucleus of the amygdala activates targets in the brainstem (as the 
locus ceruleus or the periaqueductal gray region) and hypothalamus which initiate 
the fear response by activation of the sympathetic nervous system as well as 
hypothalamic–pituitary–adrenocortical (HPA) axis and associated neurochemical  
reactions (Deppermann, Storchak, Fallgatter, & Ehlis, 2014). However, as already 
stated, an emotional reaction is not solely determined by the stimulus per se, but 
rather the integration of the stimulus within its context by including top-down 
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information. On a neurobiological basis, this is thought to be accomplished via 
reciprocal connections of the amygdala and the prefrontal cortex (PFC). In this 
regard, the medial PFC (MPFC) (Kim et al., 2011), which is again interconnected with 
other prefrontal areas such as the DLPFC as well as the anterior cingulate cortex 
(ACC), plays a crucial role in effective emotion regulation.  
When speaking about emotion regulation, neuroimaging studies generally 
differentiate between two major strategies to influence the emotional response: 
attentional control and cognitive change (Ochsner & Gross, 2005). Hereby attentional 
control can be described as selectively focusing on either perceptual or emotional 
features of a stimulus or simply distracting yourself by thinking of something else 
thereby suppressing the emotional response. Cognitive change on the other hand 
includes anticipatory processes in terms of expectancies for pleasant or aversive 
experiences. Furthermore, cognitive change also comprises cognitive reappraisal as a 
strategy to actively influence the perception of a given stimulus by changing the 
interpretation of its meaning. Additionally to the medial and lateral PFC as well as the 
ACC, the insular and the orbitofrontal cortex (OFC) have been shown to be activated 
during these processes (Ochsner & Gross, 2005). Furthermore, a number of studies 
have shown that the inferior frontal gyrus (IFG), comprising parts of Broca´s area in 
the left hemisphere, is not only involved in language processing (Friederici, 2011) but 
also attentional processes (Hampshire, Chamberlain, Monti, Duncan, & Owen, 2010), 
emotion regulation (Goldin, McRae, Ramel, & Gross, 2008) and behavioural control 
(Swick, Ashley, & Turken, 2008). 
All in all, it is important to note that prefrontal areas are not only involved in 
controlling or diminishing the emotional response, but also in generating or 
amplifying it (Wager, Davidson, Hughes, Lindquist, & Ochsner, 2008), and they are 
also influenced by the input they receive from the amygdala (Gorman et al., 2000). 
In effect, the already described imbalance between bottom-up and top-down 
processing as a model for the expression of pathological anxiety could also 
repeatedly be shown on a neurobiological level whereby reciprocal inhibitory 
connections between PFC and amygdala may lead to hyperactivity of the amygdala 
on the one hand and prefrontal hypoactivation on the other hand (De Carvalho et al., 
2010; Engel, Bandelow, Gruber, & Wedekind, 2009; Kent & Rauch, 2003; Nishimura 
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et al., 2007; Ohta et al., 2008). However, even though the common neurobiological 
model for pathological anxiety includes hypoactivation of prefrontal areas, it is 
important to note that there are also diverging findings. An example for this 
discrepancy in results may be given by the frequently applied Emotional Stroop 
paradigm which is generally assumed to assess emotional regulation by means of 
attentional processes (for example Todd, Cunningham, Anderson, & Thompson, 
2012). The general idea behind this task is that reading is a rather automated 
process in adults, thus the meaning of a presented word will capture attention no 
matter whether it is relevant for the ongoing task thereby imparing behavioural 
performance. Further, negative compared to neutral word valence should lead to an 
even more distracting effect. This way, presenting disorder-specific stimuli should 
have a bigger impact within a particular group of patients when being compared to 
healty controls (Williams, Mathews, & MacLeod, 1996). However, when applying such 
a task, on the one hand, prefrontal hypoactivation due to inhibitory effects of a 
hyperactive amydgala in anxiety disorders may be expected. On the other hand 
however, it can also be assumed that a more negative valence of the presented 
words will capure more attention which will in turn lead to an increase in PFC 
activation in patients with anxiety disorders. In fact, both, prefrontal hypoactivation 
as well as prefrontal hyperactivation in response to fear-relevant words has been 
reported before (Chechko et al., 2013; Dresler et al., 2012; Puetz et al., 2016; 
Schienle, Schäfer, Walter, Stark, & Vaitl, 2005; Straube, Mentzel, Glauer, & Miltner, 
2004; Tupak, Reif, et al., 2013). Thus, it is important to not look at behavioural and 
activational results separately but rather try and integrate both findings. Surely, 
further explanations for the discrepancy regarding the findings in terms of prefrontal 
hypoactivation versus prefrontal hyperactivation in anxiety disorders might simply be 
given by general differences of the applied tasks but possibly also by the use of the 
particular emotion regulation strategy.  As a final remark in this context, it needs to 
be mentioned that, in line with the diverging findings on prefrontal activation, a very 
recent meta-analysis (Sobanski & Wagner, 2017) on the functional neuroanatomy of 
panic disorder also found that the presumed amygdala hyperactivation in anxiety 
disorders strongly depends on a number of factors including the presented stimuli or 
the experimental design but also the particular study population. Thus, this finding 
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again underlines the importance of not just considering the mere activatinal patterns 
but also the contextual circumstances of their appearance.  
 
 
1.3.2 The valence hypothesis 
For a long time, models of emotion processing have proposed that there is a 
hemispheric lateralisation regarding the valence of emotional stimuli. In this regard, 
positive or approach-related emotions are supposed to rather be processed in the left 
hemisphere while negative or withdrawal-related emotions are rather processed in 
the right hemisphere (Reuter-Lorenz & Davidson, 1981; Wedding & Stalans, 1985). 
In 1998, this hypothesis could for the first time also be validated by a neuroimaging 
study (Canli, Desmond, Zhao, Glover, & Gabrieli, 1998). Since then, a number of 
studies have replicated these findings (for example, Balconi & Mazza, 2010; Schutter, 
de Weijer, Meuwese, Morgan, & van Honk, 2008). As a consequence, one could 
hypothesise that individuals suffering from a psychological disorder which is 
associated with an increase in negative affect, such as major depression or anxiety 
disorders, should probably be characterised by a hemispheric disparity in terms of 
left lateralised hypoactivation and right lateralised hyperactivation. Current research 
could show that there is indeed evidence for this assumption. In this respect, studies 
with depressed patients repeatedly found left frontal hypoactivation or right 
prefrontal hyperactivation (Davidson, 2002; Henriques & Davidson, 1991, 2000). So 
far, findings are less clear for anxiety disorders, but there are hints that a similar 
hemispheric imbalance exists (Davidson, 2002; Wiedemann et al., 1999)) which 
would be in line with the idea of an altered network in pathological anxiety that is 
characterised by diminished prefrontal activation as described above. Within the 
framework of this idea, it may be assumed that the alterations of the fear network 
cannot only be detected when a fear-inducing stimulus is present, but can more 
generally be found across situations, e.g. also during the completion of cognitively 
demanding tasks which require the recruitment of prefrontal control (Ohta et al., 
2008).  
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In fact, from animal as well as epidemiological and twin studies in humans, it may be 
assumed that the proness to experience increased state anxiety across different 
situations is associated with a generally increased sensitivity towards potentially fear-
inducing stimuli. Thus, independent of a manisfest anxiety disorder, there seem to be 
certain relatively stable personality traits as for example harm avoidance which may 
in turn also be partly associated with the described alterations within the fear 
network (Kampman, Viikki, & Leinonen, 2017). Altogether, these changes within the 
fear network can presumably be accounted for by neurochemical processes. In this 
regard, a number of studies mainly found alterations in the gamma-aminobutyric 
acidergic (GABA) and serotoninergic neurotransmitter system (Dresler et al., 2012). 
Moreover, it is also likely that the endocannabinoid system indirectly plays a crucial 
role in modulating the neural activation during a fear response by disinhibiting 
prefrontal output neurons as well as influencing GABA release in the hippocampus 
(Deppermann et al., 2014). 
 
 
1.3.3 Influence on heart rate and electrodermal activity 
As the fear response includes the activation of the sympathetic nervous system, this 
leads to a number of homeostatic changes in the body which prepare the organism 
for action. In doing so, the preganglionic nerve fibres that innervate the adrenal 
medulla release acetycholine which in turn triggers the release of adrenaline as well 
as noradrenalin that finally acts on the cardiovascular system by increasing the heart 
rate (HR) and dilating the bronchi (Deppermann et al., 2014). Moreover, the blood 
pressure changes due to vasoconstriction, which supports the blood supply to those 
organs that are most important for the “fight or flight” reaction. At last, the 
sympathetic nervous systems also controls the activation of the sweat glands in the 
body whereby the sweat production increases during acute fear in order to cool the 
body down during the expected action (Drummond & Lance, 1987).  This increase in 
sweat production is further associated with an increase in skin conductance which 
can be used to measure the electrodermal activity (EDA). Since especially HR and 
EDA are relatively easy to assess, a number of studies have been conducted which 
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showed that the mere presentation of pictures of potentially fear-relevant stimuli can 
cause changes in HR and EDA (Flykt, 2005). Going beyond the presentation of just 
two-dimensional visual stimuli, VR scenarios use specialised computer displays or 
headsets (head mounted displays, HMD) which simulate three-dimensional virtual 
rooms in which the user is able to interact with the virtual world. By implication, VR 
scenarios also provoke physiological changes in terms of EDA and HR even though 
the results on HR were not as distinct (Diemer, Mühlberger, Pauli, & Zwanzger, 
2014). Interestingly, they cannot only be used to trigger an initial response of the 
sympathetic nervous system but also to study habituation effects while the 
participant stays in the virtual environment (Mühlberger, Herrmann, Wiedemann, 
Ellgring, & Pauli, 2001). When speaking of habituation effects, the parasympathetic 
nervous system also needs to be mentioned: In simplified terms it can be regarded 
as the antagonist of the sympathetic nervous system. In this regard, it contributes to 
the reestablishment of homeostasis after a stress response by also using cholinergic 
neurotransmission in interplay with muscarine as well as nicotine receptors which 
causes the initiation of autonomous changes such as bronchoconstriction, 
vasodilation and the down-regulation of the HR (McCorry, 2007). 
A possibility of directly assessing parasympathetic activity is measuring heart rate 
variability (HRV). HRV includes a number of different parameters which can be 
analysed in order to gain knowledge about different aspects of an individual´s 
autonomous nervous system response. In this context, after transforming the HRV 
from the time to the frequency domain it is especially interesting to differentiate 
between the low (LF) and the high frequency (HF) components as the LF is generally 
mediated by the sympathetic as well as the parasympathetic nervous system while 
the HF is solely mediated by the parasympathetic nervous system. Thus, the ratio of 
these two sub-measures of HRV can give a good estimation of the interplay of 
sympathetic and parasympathetic activation (Berntson et al., 1997) and can 
consequently also be used to describe habituation effects.  
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1.3.4 Situationally bound and situationally predisposed anxiety 
So far, the neuronal network that gets activated at the moment of confrontation with 
fear-inducing stimuli as well as the associated psychophysiological reactions have 
been delineated. While there are some situations or stimuli which automatically lead 
to this response of the “fear network”, there are others which just increase the 
probability of such a reaction. Hence, it is important to differentiate between 
situationally bound and situationally predisposed anxiety. A classical example of 
situationally bound fear is a specific phobia where the affected person gets triggered 
whenever they are confronted with the phobic object and hence tries to avoid the 
situation in the future or else only handles the confrontation under great emotional 
distress (American Psychiatric Association, 2013). Hereby, the fear acquisition is 
thought to operate via classical conditionining (Pavlov, 1927) or observational 
learning  (Olsson, Nearing, & Phelps, 2007; Rosen & Schulkin, 1998) whereby 
genetic predisposition in terms of a higher susceptibility of some individuals to 
develop pathological fear (see section 1.3.2)  of especially evolutionary relevant 
stimuli (for example a spider or a snake) certainly also plays a role (Hettema, Neale, 
& Kendler, 2001). In this context, it is not important whether the person explicitly 
remembers an aversive event with the phobic object, e.g. being bitten by a dog or 
watching somebody else being bitten by a dog (Eysenck, 2014). It is, however, 
essential that the contingency relationship between the stimulus and the fear 
response is stable and occurs automatically without deliberate influence by the 
person during the first moment of confrontation (American Psychiatric Association, 
2013).  
For situationally predisposed anxiety, on the other hand, the contingency relationship 
between stimulus and response is not a linear one. In this regard, panic disorder can 
be seen as a typical example of situationally predisposed anxiety. By definition, panic 
disorder is characterised through reoccurring panic attacks which are accompanied 
by a number of physiological reactions such as tachycardia, hyperventilation, 
sweating or nausea. Usually, the first of these panic attacks happens “out of the 
blue” in an unexpected situation. This way, the person is lacking a logical explanation 
for the attack and hence may start worrying about possible reasons thereby implicitly 
attributing a certain danger to the situation where it first occurred (American 
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Psychiatric Association, 2013). As a consequence, they will probably worry and thus 
be on higher alert as soon as they get into a similar situation the next time and pay 
more attention to potential physical signs for another panic attack. This increased 
vigilance and attention to somatic sensations, on the other hand, does in fact 
increase the chance to actually experience another panic attack in the situation. 
Nevertheless, the attack can still not clearly be ascribed to the situation per se, 
hence more and more similar situations become predisposed for the occurrence of 
panic attacks (for instance, somebody could have the first panic attack on a bus ride 
and then transfer this experience to train rides and later to all types of public 
transportation as the general features of the situation are similar) (Yoris et al., 
2015). As situationally predisposed anxiety only means there is an increased chance 
to actually have a fear response, the reinforcement of the learning experience only 
takes place intermittently and is therefore also harder to extinguish (Wittchen & 
Hoyer, 2011) which has relevant implications for its therapy (see section 1.4.2).  
Thus, to conclude it needs to be noted that specific phobia and to an even greater 
extent panic disorder, do not only include the situational fear reaction but also 
comprise anticipatory anxiety which involves the internal representation of possible 
(aversive) future events which is mainly associated with prefrontal activation (Holtz, 
Pané-Farré, Wendt, Lotze, & Hamm, 2012). In fact, regarding the pathogenesis as 
well as maintaining conditions of anxiety disorders, anticipatory anxiety plays a core 
role as it usually leads to avoidance of the feared object or situation thereby 
preventing the affected person from making new learning experiences, e.g. noticing 
that not all dogs bite or that it is in fact not dangerous to take a train despite having 
gone through a panic attack there before. Especially in the case of situationally 
predisposed anxiety it may also happen that instead of complete avoidance a person 
still frequents the situation but then escapes as soon as they notice any signs (such 
as increased heart beat)  of a fear reaction which may also be described as “fear of 
fear itself”. Analogical to avoidance, escape prevents the person from learning that 
neither the situation nor the experience of a panic attack in it is life threatening. This 
interplay of an acute fear reaction, anticipatory anxiety as well as escape and 
avoidance as maladaptive coping mechanisms finally lead to something which is 
commonly called “the viscous cycle of anxiety” (Armfield, 2013; Westbrook, 
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Kennerley, & Kirk, 2011) whereby most contemporary treatment options try to find a 
way to interrupt it (see next section). 
 
 
1.4 Contemporary treatment options 
1.4.1 Current guidelines 
According to the current guidelines for the treatment of anxiety disorders (Bandelow 
et al., 2014), a number of effective therapy options exist. Regarding panic disorder, 
psychotherapy as well as pharmacotherapy is recommended whereby, so far, 
randomised controlled studies showed an effective treatment effect only for CBT 
rather than psychodynamic therapy. Especially in the case of agoraphobic avoidance 
behaviour, the therapy should include therapist-guided exposure where the patient 
confronts his fears with instruction by the therapist. Until now, there is lacking 
evidence that individual therapy is most beneficial for the patient, so the therapy 
may also be conducted in a group setting. Referring to pharmacotherapy, especially 
the administration of selective serotonine re-uptake inhibitors (SSRIs) such as 
Citalopram, Escitalopram, Paroxetin or Setralin as well as serotonin noradrenalin re-
uptake inhibitors (SNRIs) such as Venlafaxin is advised. Even though 
benzodiazepines effectively reduce acute fear reactions, they should only be 
administered under special circumstances (for example a severe comorbid 
cardiovascular condition, otherwise self-endangering behaviour like suicidality) as 
they are known for their dependence potential. Moreover, they can be seen as a kind 
of avoidance or escape strategy as they limit or reduce the fear response and impede 
the acquisition of new information (Vidailhet et al., 1994). 
As significant a improvement during the combined treatment of CBT and 
psychotropic medication in terms of SSRIs and SNRIs as compared to monotherapy 
could be shown in otherwise treatment-resistant patients with panic disorder (Freire, 
Zugliani, Garcia, & Nardi, 2016), a combined approach is recommended in such 
cases. Interestingly, a recent study by Liebscher et al. (2016) compared the effects 
of CBT with therapist-guided or non-guided exposure with the administration of 
SSRIs and SNRIs and found that both, psychotherapy as well as pharmacotherapy 
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lead to a significant reduction of depressiveness and general anxiety symptoms like 
the number of panic attacks, restlessness or worrying compared to a waiting control 
group. However, patients that received CBT and particularly therapist-guided 
exposure training further showed a significantly greater reduction of anticipatory fear 
and agoraphobic avoidance behaviour which may imply that actually being 
confronted with a panic-associated situation has a more specific effect on anxiety 
compared to pharmacotherapy and reduces not only the number of experienced 
panic attacks per se but also the fear of possibly experiencing one. Thus, this finding 
may be an explanation for the add-on effect of CBT to sole pharmacological 
treatment. Apart from these rather “traditional” treatment options, regular endurance 
sport may also be helpful to fight panic symptoms according to expert opinion and 
has, therefore, been included into the current guidelines.  
Regarding the treatment of specific phobia, the state of the art treatment focuses on 
exposure therapy whereby the exposure should be conducted in-vivo if possible. 
Whether it is accomplished in a graduated manner or via “flooding” where the 
patient is confronted with his or her worst fear from the beginning is not further 
specified and can therefore be decided depending on the phobic object and the 
individual patient. If in-vivo exposure is not feasible, the confrontation with the 
phobic object should be achieved via VR. Even though different studies exist that 
tried to combine exposure therapy with the administration of pharmacotherapy there 
is little evidence for a significant add-on effect until now (Abramowitz, Deacon, & 
Whiteside, 2012).   
To conclude, the current guidelines for the treatment of anxiety disorders offer a 
great number of treatment approaches which have been evaluated with respect to 
their efficacy. However, up to a third of all patients does not benefit sufficiently 
(Diemer, Vennewald, Domschke, & Zwanzger, 2010; Freire et al., 2016; Taylor, 
Abramowitz, & McKay, 2012). For this reason, further research is conducted in order 
to still improve the standard of knowledge and shall be discussed in the next chapter.  
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1.4.2 Recent advances in the understanding and treatment of anxiety 
1.4.2.1 Investigation of markers predicting therapy response 
Regarding the research on the mechanisms of action of therapeutic interventions, an 
important domain is the knowledge of predictive neurobiological markers which may 
yield information on the efficacy of a particular treatment and the according clinical 
decision. Thus, Lueken et al. (2016) performed a systematic review and found that 
genetic as well as neuroimaging and psychophysiological markers may serve as valid 
predictive clues on pharmacological but also psychotherapeutical treatment outcome. 
In more detail, the authors found a possible association between the 5-
HTTLPR/rs25531 variant, which influences serotonergic neurotransmission, and 
treatment response. Intriguingly, the direction of the relationship was determined by 
the received treatment: while the more active allele was associated with a better 
response to pharmacotherapy, the less active allele was associated with a better 
response to psychotherapy which may be explained by the assumption that the latter 
allele is also linked to increased environmental sensitivity whereby psychotherapy can 
be considered as a relevant environmental factor.   
With respect to markers based on neuroimaging, the most consistent results were 
found for the ACC as well as for temporal lobe activation. Regarding the ACC, the 
direction of the relationship between baseline activation and treatment outcome did 
not only depend on the location within the ACC  and the type of treatment but also 
on the task the patients had to perform, so further research needs to be done to get 
a better specification. The results for the temporal lobe are also relatively 
heterogeneous depending on the exact location but it may be assumed that 
especially visual object processing and recognition might be of predictive value for 
therapy response.  
Psychophysiological measures put the HR as well as HRV and blood pressure in the 
focus of attention even though, so far, study results are still ambiguous. Comparable 
to the above mentioned finding, a differentiation between therapy option and the 
direction of the effect could be detected whereby high HR, high blood pressure and 
low HRV were associated with a better response to psychotherapy and a low HR, low 
blood pressure and high HRV were associated with a better response to 
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pharmacotherapy. As low heart rate variability is thought to be linked to lower 
environmental adaptability, this could be a reason why psychotherapy, which is 
supposed to increase cognitive flexibility, is especially effective in this group of 
patients.  
Even though these studies represent first interesting approaches to find predictive 
markers of therapy response, further research is needed to develop a 
methodologically sound background in order to eventually use these biomarkers to 
inform individual clinical decisions. Apart from the research regarding the prediction 
of therapy response, there is a whole field which deals with the extension or 
variation of CBT elements as well as the development of alternative (add-on) 
treatment options. A general overview shall be given during the next sections.  
 
 
1.4.2.2 The third generation of behavioural therapy 
The third generation or “third wave” of behavioural therapy generally describes a 
movement away from the cognitive focus of the second generation behavioural 
therapy to a build-up of new experiences within the therapeutic context (Kahl, 
Winter, & Schweiger, 2012). In this regard, it is generally less focused 
on straightforward psychological symptom reduction even though this is of course a 
desired “side effect”. The spectrum of evolving treatment options is very 
heterogeneous and comprises disorder specific techniques as well as treatment 
options which can be administered independent of the diagnosis. One of the most 
investigated approaches in this context is probably acceptance and commitment 
therapy (ACT) which has originally been developed by Steven Hayes who suffered 
from “treatment-resistant” panic disorder himself. In this section, it shall therefore be 
described in more detail as an example of a “third wave” approach in the treatment 
of anxiety disorders as it further comprises a number of “typical” third wave methods 
like acceptance-based strategies as well as possibilities on how to pursue a value 
oriented life depite persisting difficulties.  
Being a psychologist himself, when Hayes noticed he did not profit sufficiently from 
his treatment of panic symptoms, he tried to find alternatives for dealing with them 
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which included meditation and mindfulness. This way, he learnt to detach his 
thoughts from his self and hence witness his thinking from the perspective of an 
observer and to learn how to accept that he was not able to control his panic 
symptoms permanently (Cloud, 2006). During the following years, Hayes 
investigated his personal observation of what was helpful in a more scientific 
framework and developed relational frame theory which may be seen as the basis for 
ACT. Relational frame theory thereby principally assumes that human language and 
cognition are relational entities implying that the relationship between stimuli is not 
just based on the physical properties of the stimuli but also on contextual 
information. The number of built relations is thereby arbitrary and depends on the 
social context. Eventually, this signifies that the use of language influences the 
predications humans make about their environment thereby manipulating thoughts, 
emotion and finally behaviour (Cullinan & Vitale, 2009). Getting back from relational 
frame theory to psychotherapy it can be assumed that automated, inflexible relations 
may lead to psychopathology (Tonneau, 2004). Hence, the general goal of ACT is to 
increase psychological flexibility by increasing awareness of personal relations in 
terms of thoughts or experiences without attachment to them. To do so, it uses 
strategies like mindfulness exercises, cognitive defusion techniques and metaphors. 
Furthermore, it includes commitment and behaviour change processes whereby the 
goal is not so much symptom reduction itself but rather accepting the negative 
experiences one might have while at the same time building a value-based life 
(Hayes, 2006). Regarding the treatment of anxiety disorders, ACT seems to be 
equivalently effective as standard CBT. However, the mechanisms of action appear to 
differ whereby compared to standard CBT, therapy outcome was rather associated 
with “acting with awareness”, “acceptance” as well as the reduction of “experimental 
avoidance” in ACT treated patients only (Forman, Herbert, Moitra, Yeomans, & 
Geller, 2007). Thus, it may be generally concluded that ACT is not superior to 
standard CBT but that there are specific elements which may help patients that 
would otherwise not benefit. Of course, depending on the patient’s individual needs, 
these elements can be included separately into any psychotherapy. In fact, one 
might argue that a lot of these interventions have already been used before without 
being given a specific name and should therefore not be considered “new wave”. To 
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take it further, it may even be reasoned that the “third wave” is actually a step back 
to the “first wave” as it is generally based on building new relations to the 
experienced environment by behavioural and emotional activation within the 
therapeutical context. However, no matter whether the third wave should really be 
called a new generation or rather “old wine in a new bottle”, it includes a diversity of 
different intervention techniques which – when used deliberately – open up different 
possibilities for patients which might otherwise not benefit enough. However, further 
research is needed to achieve a better empirical support (Kahl et al., 2012). 
 
 
1.4.2.3 New approaches to exposure therapy 
As stated above, therapy-guided exposure is one of the first-line treatment options 
for anxiety disorders, yet clinically significant improvement is only described in 50-
65% of all patients (Gloster et al., 2011). Furthermore, it is a common finding that 
exposure-based methods are applied relatively rarely by therapists despite the 
recommendation in the guidelines (Levita, Duhne, Girling, & Waller, 2016). Thus, 
there is still a need of research in order to improve its efficacy, but also reduce the 
barriers that keep therapists from using it. In this regard, a recent study by Harned, 
Dimeff, Woodcock & Contreras (2013) tried to predict the adoption of exposure 
therapy and found that its proficient use was related to the anxiety sensitivity, 
attitude and expertise of the therapists as well as organisational (e.g., work context, 
availability of supervision) and patient related factors (like comorbid disorders, 
resistance or the severity of the symptoms).  Interestingly, however, the study could 
show that most of these factors were moderated by the training the therapists had 
received whereby a more intensive training could compensate for the originally 
limiting factors. Even though this result seems rather intuitive, it also implies that the 
practical training therapists obtain needs to be improved and research in exposure 
therapy also includes the investigation of the factors that make the training most 
effective so that it will be actively adopted. Naturally, research in the field of 
exposure therapy does not only comprise treatment delivery factors but also its 
mode of action per se. For example, there are studies (for example, Craske et al., 
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2008) that suppose that not fear reduction during the exposure situation but rather 
fear tolerance, meaning the absence of experimental avoidance (e.g., dysfunctional 
emotion regulation strategies like suppression), predict long-term success of 
exposure therapy. In this regard, patients might actually benefit more if they can 
leave the feared situation and end the exposure therapy before anxiety has 
decreased (provided they resume exposure at a later time) rather than enduring the 
aversive event until the end. On a similar account, the use of safety signals still 
needs to be investigated further as, on the one hand, one may deduce that as long 
as safety signals are present the missing occurrence of a feared event (such as 
fainting or losing control) can always be attributed to the presence of the safety 
signal, hence new learning that the situation per se is not dangerous does not seem 
possible. On the other hand, however, one may argue that it is rather the (cognitive) 
occupation with the safety signal that inhibits new learning when it is used as some 
kind of avoidance strategy and as long as that is prevented safety signals may also 
help the patient to tolerate the fear at the beginning of exposure therapy.  Even 
though, as mentioned in section 1.4.1, studies on the combination of exposure 
therapy and pharmacotherapy to improve extinction learning (extinction not meaning 
“unlearning” but rather the active aquistion of new knowledge which finally prevents 
or at least temporarily diminishes the response to a conditioned stimulus (Phelps, 
Delgado, Nearing, & LeDoux, 2004)) do exist, so far there does not seem to be a 
significant add-on effect. However, apart from classical pharmaceutical 
administration, recent research deals with the combination of exposure and different 
new agents also referred to as “neuroenhancers”. The underlying presumption of 
combining neuroenhancers and exposure therapy is that these agents facilitate the 
forming of new memories by, for example, targeting NMDA receptors and therefore 
boostering habituation processes and extinction learning. In a recent review 
(Hofmann, Mundy, & Curtiss, 2015), the authors compared the effect of a number of 
commonly studied substances such as d-cycloserine, yohimbine, cortisol, 
catecholamines, oxytocin, modafinil as well as some nutrients like caffeine and amino 
fatty acids and found that d-cycloserine showed the most promising result. 
Nevertheless, they argue that further studies are needed to investigate the optimal 
timing and dosage as well as the long-term effects of its usage. Moreover, as the 
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endocannabinoid system is thought to play an important role in the modulation of 
PFC activity (see section 1.3.2), there are also approaches to administer substances 
which make the non-psychotominetic component cannabidiol of cannabis available 
within the brain which, besides its anxiolytic effects, also presumably facilitates 
extinction learning (Das et al., 2013; Singewald, Schmuckermair, Whittle, Holmes, & 
Ressler, 2015). 
Another factor, which deserves some consideration when planning exposure therapy, 
is the level of control over the environment as well as the related costs. For instance, 
even though it has been known for a long time that exposure therapy is a very 
effective treatment option for flight phobia (Haug et al., 1987), it is rather expensive 
to conduct repeated exposure sessions on a plane. Moreover, the conditions (for 
example bad weather) during the flight cannot be manipulated according to the 
patients’ needs by the therapist. In this regard, a lot of current studies focus on the 
effectiveness of VR exposure therapy (Powers & Emmelkamp, 2008). Besides the 
visual input the patient receives over the HMD or a special computer monitor, further 
sensory input such as acoustic, haptic or olfactory stimulation may also be included 
to simulate the presence in the virtual environment and to allow interaction with it 
(Mühlberger et al., 2001). Meanwhile, the effectiveness of VR exposure has been 
established by independent meta-analyses (Morina, Ijntema, Meyerbröker, & 
Emmelkamp, 2015; Opriş et al., 2012), but still larger controlled studies as well as 
further research regarding factors like the specifics in terms of the treated type of 
phobia, the combination of VR and real world elements (Baus & Bouchard, 2014) or 
the influence of the sense of presence during VR immersion (Morina et al., 2015) are 
needed to further establish VR as an efficacious treatment tool. Interestingly, 
regarding the latter point, there seems to be a positive correlation between the 
sense of presence and perceived anxiety, at least when using VR in the treatment of 
animal phobia, while for social phobia such a relation has not been shown until now 
(Morina et al., 2015).  
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1.4.2.4 Neurostimulation and neurofeedback – a neurophysiologically 
based treatment perspective  
Both neurostimulation as well as neurofeedback take the existing findings on anxiety 
disorders regarding alterations within the fear network as the basis for their 
approach. The underlying idea of neurofeedback is that patients learn to consciously 
control their brain activation patterns by basically receiving a real-time visual 
feedback of their ongoing brain activation over a display and having to find a way to 
self-regulate it in a particular way according to a given instruction (Gevensleben et 
al., 2014). 
For instance, regarding the found prefrontal hypoactivation which is related to 
pathological fear reactions, it might be an option to instruct the patient to regulate 
specific parameters which are associated with the brain’s activational state whenever 
a  certain (possibly fear-inducing) stimulus is presented. To do so, a number of 
different feedback methodologies including electroencephalography (EEG), functional 
magnetic resonance imaging (fMRI) or functional near-infrared spectroscopy (fNIRS) 
are possible (Mayer, Wyckoff, Fallgatter, Ehlis, & Strehl, 2015). Especially regarding 
the treatment of attention deficit hyperactivity disorder (ADHD) multiple studies 
already exist which could show an improvement of clinical symptoms (Gevensleben 
et al., 2014) but also significant alterations with regard to the underlying neural 
activation patterns (Lévesque, Beauregard, & Mensour, 2006) which suggests that 
the neurodfeedback approach might generally also be suited for other psychiatric 
disorders. In this context, a recent controlled study (Zilverstand, Sorger, Sarkheil, & 
Goebel, 2015) which investigated fMRI-based neurofeedback training over the left 
DLPFC and right insula in a group of spider phobics could show a reduction of 
subjectively perceived anxiety as well as changes in insula activation in the 
neurofeedback training group. Hence, from this perspective it seems promising to 
further investigate neurofeedback training as a therapeutic tool in anxiety disorders.  
Another way to purposefully influence brain activation in distinct areas is 
neurostimulation. In this context, two common methods comprise rTMS as well as 
transcranial direct current stimulation (tDSC). Both methods can be considered non-
invasive in the sense that the neurostimulation is achieved from outside through the 
skull without the necessity of implanting micro-electrodes into the brain. To do so, 
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rTMS uses a specific coil placed on the skull above the chosen area which produces 
electric pulses in order to cause the depolarisation of the underlying neurons and 
hence the discharging of action potentials via electromagnetic induction. Depending 
on the frequency of the electric and resulting magnetic pulses a facilitory or inhibiting 
effect may be achieved (Vennewald, Diemer, & Zwanzger, 2013). 
Theta burst stimulation (TBS) is a refined form of rTMS which again may be applied 
in an activating (intermittent, iTBS) or inhibitory (continuous, cTBS) fashion. In 
comparison to traditional rTMS, its advantages include that a longer lasting 
stimulation effect may be achieved after a shorter stimulation time (Huang, Edwards, 
Rounis, Bhatia, & Rothwell, 2005). Accordingly, studies could demonstrate acute TBS 
effects on cortical activation of the underlying areas which lasted about one hour 
after one-time application (Grossheinrich et al., 2009). Having said this, it must 
however be kept in mind that TBS, or more generally rTMS application over one 
specified area, may also affect other brain regions (Ilmoniemi et al., 1997). Indeed, 
some studies exist which showed that rTMS can cause the opposite effect on the 
contralateral hemisphere (Di Lazzaro et al., 2008). TDCS, on the other hand, uses 
two electrodes which are attached on the scalp in order to create a constant low 
current in-between which increases (anodal stimulation) or decreases (cathodal 
stimulation) the threshold for action potentials in the underlying neuronal 
organisations (Nitsche & Paulus, 2001). While the advantage of rTMS is a better 
spatial resolution (Antal, Nitsche, & Paulus, 2006), tDCS is more user-friendly as the 
stimulation is hardly noticeable and can hence be accomplished while the patient is 
involved in other activities (e.g. simultaneous application during therapy session 
(Bajbouj & Padberg, 2014). Recent studies could even show a beneficial effect of the 
combination of the two methods which surely also presents a further field of future 
research. Generally, especially in repeated applications, rTMS as well as tDCS are 
supposed to initiate long-lasting changes in cortical excitability which are thought to 
be achieved via the associated neurotransmitter release and thus neuroplastic 
processes (Gersner, Kravetz, Feil, Pell, & Zangen, 2011). Regarding their clinical 
application in the treatment of anxiety disorders, so far only a few randomised 
controlled studies exist for either of these methods. However, a systematic review 
(Kekic, Boysen, Campbell, & Schmidt, 2016) which evaluated the use of tDCS in 
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psychiatric disorders found an exponential increase over the last ten years whereby 
the study outcome suggested a beneficial effect of repeated tDCS application on 
symptom severity. However, the main research focus seemed to be on depressive 
disorders (Shiozawa, Fregni, et al., 2014). For anxiety disorders, only very few 
studies or case reports exist (Kar & Sarkar, 2016; Shiozawa, Leiva, et al., 2014) 
which nevertheless showed some encouraging effects. Further, one study (van't 
Wout et al., 2016) could demonstrate a favourable add-on effect of tDCS during 
exposure-based extinction learning. Even though more studies examining the impact 
of rTMS on anxiety symptoms exist, again there is a lack of randomised controlled 
studies and results are inconsistent as has been demonstrated in a systematic review 
by Zwanzger, Fallgatter, Zavorotny & Padberg (2009) or even more recently by 
Vennewald et al. (2013). In this respect, in line with the above quoted valence 
hypothesis most studies or rather case reports and clinical trials used either facilitory 
stimulation on the left hemisphere (Dresler et al., 2009; Guaiana, Mortimer, & 
Robertson, 2005) or inhibitory stimulation on the right hemisphere (Mantovani, Aly, 
Dagan, Allart, & Lisanby, 2013; Schutter, van Honk, d'Alfonso, Postma, & de Haan, 
2001) in panic disorder and found an improvement of clinical symptoms. However, 
sample sizes are often small and the results are inconclusive for example Prasko et 
al. (2007) and Vennewald et al. (2016) found no difference on fear processing 
between sham and active inhibitory rTMS over the right PFC). Further, there is a lack 
of studies which examined a possible add-on effect of rTMS to (exposure-based) 
psychotherapy. In fact, when considering that it does not only influence the brain’s 
current activational state but also fosters neuroplastic processes by means of 
neurotransmitter release (Gersner et al., 2011), it may, comparable to 
neuorenhancers, serve as a tool to increase the effects of new learning experiences 
during psychotherapy. The assumption that it might be promising to further pursue 
this idea of employing rTMS not as a stand-alone therapeutic tool but rather an add-
on to (exposure-based) psychotherapy is supported by a preliminary report by 
(Osuch et al., 2009) who showed that active compared to sham rTMS improved the 
effects of imaginal exposure therapy and reduced physiological hyperarousal in a 
sample of patients suffering from chronic post-traumatic stress disorder (PTSD).  
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1.5  Rationale for the current work 
The previous sections have given an update on the theoretical background regarding 
pathological fear and associated neurobiological findings on the one hand, and its 
current treatment recommendations and their development on the other hand. 
Accordingly, the present work intended to combine the knowledge of both domains 
in order to investigate the possibility to directly influence the underlying neural 
activity related to anxiety disorders in order to alleviate clinical symptoms. To do so, 
two different studies were conducted where we examined the effects of a 
neuromodulation technology on emotional as well as cognitive aspects of anxiety in 
more detail.  
Regarding the first study, in line with the valence hypothesis, we chose to apply a 
sham-controlled activating rTMS protocol over the left PFC in a group of patients 
suffering from panic disorder with or without agoraphobia during a time course of 
three weeks as an add-on to manual-based CBT which took place in a group setting. 
Before the start as well as after the completion of the rTMS administration, a 
measurement of functional brain activation by means of fNIRS was conducted while 
the patients completed an emotional (Emotional Stroop task) as well as a cognitive 
(Verbal fluency task) paradigm. In order to validate the valence hypothesis as well as 
the effect of rTMS on prefrontal functioning, we also investigated a group of healthy 
controls with the same two paradigms. As the studies on neurostimulation described 
in the sections above found some promising results with respect to its effects on 
anxiety, we attempted to not only quantify its impact per se but rather aimed at 
investigating whether it might accelerate or reinforce the effects of CBT. In more 
detail, we addressed the following research hypotheses:  
(1) In line with the currents findings on alterations within the fear network, patients 
suffering from panic disorder with or without agoraphobia significantely differ relative 
to healthy controls regarding their prefrontal activation during the completion of an 
emotional paradigm. 
(2) These differences in activation patterns are not only present during emotional 
tasks but, more generally, may rather be a characteristic in this group of patients 
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and therefore also be detectable during cognitive tasks in terms of prefrontal 
hypoactivation as predicted by the valence hypothesis.  
(3) RTMS has the ability to specifically enhance these prefrontal activation patterns.  
(4) An increase in activation should be correlated with clinical symptom reduction 
and thus treatment efficacy of CBT.  
During the second study, we decided to again apply a sham-controlled activating 
rTMS protocol at the same stimulation site. However, this time we aimed at 
eliminating as many confounding effects as possible (e.g. simultaneous 
psychotherapy) and therefore investigated a group of spider phobic subjects that did 
not suffer from any comorbid psychological disorders whereby they received their 
treatment just prior to a phobia-related VR challenge which served as the fear-
inducing situation. Before as well as right after rTMS application in combination with 
the VR challenge their prefrontal brain activation was again recorded by means of 
fNIRS during an emotional Stroop paradigm.  As in the first study, the effects within 
the phobic group were compared to the effects of a healthy control group. The 
postulated research hypotheses were framed as the following questions:  
(1) Being confronted with virtual spiders will provoke anxiety as well as disgust which 
is associated with the activation of the sympathetic nervous system (increase in HR 
and EDA as well as alterations in HRV) in people suffering from spider phobia.  
(2) These reactions are less prominent in healthy control subjects.  
(3) Prefrontal activation patterns of spider phobics should differ from the ones of 
healthy control subjects when responding to phobia-related stimuli. 
(4) Accordingly, in comparison to the healthy control group, the performance of the 
spider phobics should be reduced (increased reaction times, higher error rates).  
(5) Active rTMS over the prefrontal cortex should lead to improved cognitive control 
and therefore attenuate the increase of anxiety and disgust. This effect should be 
detectable for all associated measures (activation of the sympathetic nervous 
system, brain activation, behavioural performance, perceived valence and arousal of 
the presented stimuli). 
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(6) Nevertheless, participants with spider phobia should still experience a more 
pronounced feeling of presence during the VR challenge due to their residual fear.  
(7) Finally, to get a better understanding of the emotional control processes on a 
neuronal level, we conducted a functional connectivity analysis within the prefrontal 
cortex in addition to the standard fNIRS analysis. 
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2. Study 1: Clinical and neurobiological effects of NIRS-controlled 
transcranial magnetic stimulation (rTMS) in patients with panic disorder 
during CBT treatment 
2.1 Manuscript 1: Does rTMS alter neurocognitive functioning in patients 
with panic disorder/agoraphobia? – An fNIRS-based investigation of 
prefrontal activation during a cognitive task and its modulation via sham-
controlled rTMS 
 
The contents of this chapter are published in:  
Deppermann, S*., Vennewald, N*., Diemer, J., Sickinger, S., Haeussinger, F. B., 
Notzon, S., Laeger, I., Arolt V., Ehlis A.-C., Zwanzger, P. & Fallgatter, A. J. (2014). 
Does rTMS alter neurocognitive functioning in patients with panic 
disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a 
cognitive task and its modulation via sham-controlled rTMS. BioMed research 
international. 
 
 
 
 
 
 
 
 
 
 
 
 
* Both authors contributed equally to this work 
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2.1.1 Abstract 
Objectives. Neurobiologically, panic disorder (PD) is supposed to be characterised by 
cerebral hypofrontality. Via functional near-infrared spectroscopy (fNIRS), we 
investigated whether prefrontal hypoactivity during cognitive tasks in PD-patients 
compared to healthy controls (HC) could be replicated. As intermittent theta burst 
stimulation (iTBS) modulates cortical activity, we furthermore investigated its ability 
to normalise prefrontal activation. Methods. Forty-four PD-patients, randomised to 
sham or verum group, received 15 iTBS-sessions above the left dorsolateral 
prefrontal cortex (DLPFC) in addition to psychoeducation. Before first and after last 
iTBS-treatment, cortical activity during a verbal fluency task was assessed via fNIRS 
and compared to the results of 23 HC. Results. At baseline, PD-patients showed 
hypofrontality including the DLPFC, which differed significantly from activation 
patterns of HC. However, verum iTBS did not augment prefrontal fNIRS activation. 
Solely after sham iTBS, a significant increase of measured fNIRS activation in the left 
inferior frontal gyrus (IFG) during the phonological task was found. Conclusion. Our 
results support findings that PD is characterised by prefrontal hypoactivation during 
cognitive performance. However, verum iTBS as an “add-on” to psychoeducation did 
not augment prefrontal activity. Instead we only found increased fNIRS activation in 
the left IFG after sham iTBS application. Possible reasons including task-related 
psychophysiological arousal are discussed. 
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2.1.2 Introduction 
According to DSM-IV, panic disorder (PD) is characterised by the sudden onset of 
unexpected panic attacks resulting in constant worries about possible reasons and 
negative consequences of the attacks. Moreover, in the case of comorbid 
agoraphobia, this eventually leads to behavioural avoidance of situations from which 
escape might be difficult in case of an attack (American Psychiatric Association, 
2000). On a neurobiological level, functional imaging studies of PD-patients with and 
without agoraphobia have found hypoactivity of the prefrontal cortex (PFC), paired 
with hyperactivity of fear relevant brain structures such as the amygdala, suggesting 
an inadequate inhibition by the PFC in response to anxiety-related stimuli (Dresler et 
al., 2013; Gorman et al., 2000; Gorman, Liebowitz, Fyer, & Stein, 1989). In fact, 
hypofrontality of PD-patients has not just been observed in response to emotional 
stimuli (Dresler et al., 2012), but also during cognitive tasks without any emotional 
content. For example, in a near-infrared spectroscopy study, Nishimura et al. 
(Nishimura et al., 2007) reported hypoactivation of the left PFC in particular while 
Otha et al. (2008) found that PD-patients as well as patients with a depressive 
disorder showed lower bilateral prefrontal activation than healthy controls during a 
verbal fluency task. Moreover, Nishimura et al. (2009) investigated a potential 
relation between the frequency of panic attacks/agoraphobic avoidance and PFC 
activation during a cognitive task, indeed finding an association between altered 
activation patterns in the left inferior prefrontal cortex and panic attacks as well as 
between the anterior part of the right PFC and the severity of agoraphobic 
avoidance. 
Cortical activation patterns can be selectively modified by means of repetitive 
transcranial magnetic stimulation (rTMS) via electromagnetic induction (Wassermann 
& Zimmermann, 2012). This way, rTMS has been shown to modulate 
neurotransmitter release (Pogarell et al., 2007) and—depending on its stimulation 
frequency—normalise prefrontal hypoactivity (Speer et al., 2000). In fact, even 
though results are still inconsistent (Herwig et al., 2007), rTMS has been shown to 
have a moderate antidepressant effect (Rumi et al., 2005; Schutter, 2009). Within 
this framework it is of special interest that the method does not just seem to alter 
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affective states but also cognitive functioning (Cho, Yoon, Lee, & Kim, 2012; 
Yamanaka, Yamagata, Tomioka, Kawasaki, & Mimura, 2010). 
Functional near-infrared spectroscopy (fNIRS) is an imaging method which allows for 
a less complicated and faster application compared to other imaging methods such 
as functional magnetic resonance imaging (fMRI) or positron emission tomography 
(PET) (Ernst, Schneider, Ehlis, & Falgatter, 2012). Especially psychiatric patients with 
claustrophobic fears benefit from the fact that they merely need to sit in a chair 
while optodes that emit and receive near-infrared light are attached to their heads 
(Irani, Platek, Bunce, Ruocco, & Chute, 2007). This way, task-related changes in 
oxygenated and deoxygenated haemoglobin concentrations can be examined. Even 
though disadvantages such as a relatively low spatial resolution (approximately 
3 cm), a limited penetration depth (approximately 2 to 3 cm) (Cui, Bray, Bryant, 
Glover, & Reiss, 2011; Haeussinger et al., 2011), and influences of extracranial 
signals do exist (for a review see (Ferrari & Quaresima, 2012), fNIRS has proven to 
be a useful tool in psychiatric research (Ehlis, Schneider, Dresler, & Fallgatter, 2014). 
Based on these findings and considerations, the goal of the current study was to (1) 
clarify whether the findings of Otha et al. (2008) concerning prefrontal hypoactivity 
in PD-patients compared to healthy controls during a cognitive paradigm (verbal 
fluency task) could be replicated via fNIRS in a larger sample. Also, a sham-
controlled rTMS protocol was applied over the time course of three weeks above the 
left DLPFC to (2) examine whether excitatory rTMS can serve as an adequate tool in 
order to improve cognitive dysfunction in terms of prefrontal hypoactivation in PD-
patients. In this regard, the patients' behavioural performance during the verbal 
fluency task was also taken into account. 
 
 
2.1.3 Materials and methods 
2.1.3.1 Participants 
Patients were recruited via the outpatient departments of the two study centres, 
advertisement in newspapers, as well as the internet and information material sent 
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to local physicians. Exclusion criteria for all participants were age under 18 and over 
65 years, pregnancy, and severe somatic disorders (e.g., cardiovascular disease, 
epilepsy, and neurological disorders). Also, patients fulfilling rTMS contraindications 
such as ferromagnetic implants or significant abnormalities in routine EEG were 
excluded. All patients were diagnosed with PD with or without agoraphobia according 
to DSM-IV-TR criteria (American Psychiatric Association, 2000). Nonprominent 
comorbid psychiatric disorders (except for bipolar or psychotic disorder, borderline 
personality disorder, acute substance abuse disorders, and acute suicidality) were no 
exclusion criteria. Psychopharmacological treatment was permitted if the dosage had 
been stable for at least three weeks prior to baseline assessment (t1). 
Benzodiazepines, tricyclic antidepressants (except for Opipramol), and antipsychotics 
(expect for Quetiapine with maximal dosage of 50 mg) were excluded. Healthy 
controls who suffered from any axis-I psychiatric disorder (except for specific phobia) 
or had a family history of psychiatric disorders were excluded. A total of 23 controls 
and 44 PD-patients, of which 22 were randomised to the sham and 22 to the verum 
rTMS group, were selected for the study. Groups did not differ with respect to 
gender, age, years of education, and handedness (Table 1). After a comprehensive 
study description, written informed consent was obtained. The study was approved 
by the Ethics Committees of the Universities of Muenster and Tuebingen and all 
procedures were in accordance with the latest version of the Declaration of Helsinki. 
 
Table 1: Sociodemographic sample characteristics. 
 
 
Group 
Age 
mean (range) 
Gender Handed- 
ness 
First language Years of 
education 
Mean (SD) 
Duration of 
Illness in 
months 
Mean 
(range) 
Controls 33.4 (19-64) 14 females 
9 males 
20 right 
3 left 
22  German 
1 bilingual 
12.5 ( 1.1) 
 
- 
 
Sham 36.3 (22-56) 
 
14 females 
8 males 
21 right 
1 left 
20 German  
1 bilingual  
1 other  
12.4 (2.0) 
 
84 (1-336)  
Verum 37.6 (19-63) 
 
13 females 
9 males 
20 right 
2 left 
19 German 
1 bilingual 
2 other 
12.1 (1.7) 
 
92 (1-372) 
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Comparisons         
Controls vs. 
Sham 
t43=-0.921 
p=0.362 
χ²1=0.037  
p=0.848 
χ²1=1.003
,  
p=0.317 
χ²2=1.531 
p=0.465 
t33=-0.234 
p=0.816 
-  
Controls vs. 
Verum 
t43=-1.148 
p=0.257 
χ²1=0.015 
p=0.903 
χ²1=0.178 
p=0.673 
χ²2=2.198 
p=0.333 
t37=-0.913 
p=0.367 
-  
Sham vs. Verum t42=-0.399 
p=0.692 
χ²1=0.096 
p=0.757 
χ²1=0.358 
p=0.550 
χ²2=0.667 
p=0.717 
t42=0.490 
p=0.626 
t42=-0.290 
p=0.773 
SD: standard deviation. 
 
2.1.3.2 Design 
PD-patients received a total of 15 rTMS applications during three weeks at one of the 
study centres (Muenster or Tuebingen). Before the first and after the last rTMS-
session brain activation was assessed with fNIRS while patients were performing a 
cognitive task. Between the first and the second fNIRS assessment, all patients 
received three group sessions of psychoeducation concerning PD. Healthy control 
subjects attended the two fNIRS measurements but received no rTMS in-between. 
Enrolment took place between January 2011 and July 2013. Patients and therapists 
were blinded to rTMS group assignment. This investigation was conducted within the 
framework of a larger study which included 9 weeks of cognitive behavioral therapy 
for patients with panic disorder/agoraphobia and additional fNIRS investigations 
described elsewhere (Deppermann et al., submitted, see section 2.2). 
 
 
2.1.3.3 Psychoeducation 
Psychoeducation sessions were held in groups of up to 6 participants and were 
conducted by trained psychologists, who were supervised regularly by clinical 
psychotherapists. A state-of-the-art, standardised treatment manual was used 
(Margraf & Schneider, 1998, 2013). The content of the sessions included information 
about the pathogenesis of PD and agoraphobia, the vicious cycle of anxiety, somatic 
components of anxiety, and the sharing of personal experiences among the patients. 
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2.1.3.4 Verbal fluency task (VFT) 
All subjects were assessed twice within a three-week interval between the first (t1) 
and the second (t2) measuring time.  
During the measurements participants sat in a comfortable chair and were advised to 
keep their eyes closed and relax in order to avoid head or body movements. The VFT 
consisted of a phonological, a semantical and a control task. During the phonological 
task, subjects were instructed to produce as many nouns as possible beginning with 
a certain letter, whereas during the semantical task they had to name as many 
nouns as possible belonging to a certain category while repetitions and proper nouns 
were supposed to be avoided. During the control task the participants were 
instructed to repeat the weekdays in a speed that approximately matched the 
number of recited days to the number of mentioned nouns. The VFT started with a 
resting state phase of 10 seconds followed by the different tasks and more resting 
state periods, which lasted 30 seconds each. The sequence of the three tasks and 
resting phases were repeated three times, each time with a different letter or 
category. The letters and categories were chosen from the “Regensburger 
Wortflüssigkeitstest” (Aschenbrenner, Tucha, & Lange, 2000). Different 
letters/categories were used at t1 and t2 and counterbalanced between subjects. 
During the resting phase, participants were told to relax. 
 
 
2.1.3.5 rTMS 
Starting after the first fNIRS measurement, intermittent theta burst stimulation (iTBS, 
Huang et al., 2005) was applied in the patient group during 15 daily sessions on 
workdays during three weeks with a figure-of-eight coil (MCF-B65, 2 × 75 mm 
diameter, n = 34, MAGSTIM 9925-00, 2 × 70 mm, n = 9) by means of a 
MagOption/MagPro X100 stimulator (MagVenture, Denmark, n = 34) and a MAGSTIM 
RAPID2 T/N 3567-23-02 stimulator (n = 9), respectively. ITBS was used in order to 
achieve a facilitating effect on cortex excitability, as this could be demonstrated for 
the motor cortex, but also for more frontal cortex areas in previous studies (Huang et 
al., 2005; Restle, Murakami, & Ziemann, 2012). The iTBS protocol consisted of a 
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total of 600 pulses applied in intermittent biphasic bursts at a frequency of 15 pulses 
per second via 2 second trains, starting every 10 seconds as described by Huang et 
al. (2005). The time of day for iTBS application did not vary for more than 2 hours 
from one day to the next. As the circadian rhythm is known to influence cortical 
excitability (Sale, Ridding, & Nordstrom, 2007) the participants' individual resting 
motor threshold was determined prior to each iTBS session on the left motor cortex 
and stimulation intensity was set to 80% of this threshold. Stimulation site was F3 
(left DLPFC) according to the international 10–20 system for electrode placement 
(Herwig, Satrapi, & Schönfeldt-Lecuona, 2003). In order to ensure that the site of 
stimulation stayed constant over all sessions, F3 was drawn onto an individual textile 
cap for each participant prior to the first session. Additionally, other orientation 
points as the nasion, the inion, and the auricles were sketched on. While the coil was 
held tangentially to the scalp forming a 45° angle to the mid-sagittal line of the head 
(handling pointing in a posterior direction) for verum stimulation, it was flipped away 
from the scalp in a 90° angle for the sham stimulation. The post-fNIRS measurement 
(t2) was set to be conducted no earlier than 12 hours after the last rTMS-session to 
avoid the measurement of acute rTMS effects. 
 
 
2.1.3.6 fNIRS 
Relative temporal changes in oxygenated (O2Hb) and deoxygenated haemoglobin 
(HHb) were measured from a 10-second baseline using the ETG-4000 optical 
topography system (Hitachi Medical Co., Japan). For this purpose, the ETG-4000 
uses laser diodes which emit light of two wavelengths (695 ± 20 nm and 830 ± 
20 nm) and photodetectors which receive the scattered light intensity. Since the main 
light absorbers in this setup are the two types of haemoglobin, changes in measured 
light intensity between the emitter-detector pairs can be related to haemodynamic 
changes—which are coupled to neural activation—using a modified Beer-Lambert 
equation (Obrig & Villringer, 2003). Altogether the probe set consisted of 16 
photodetectors and 17 light emitters arranged in a 3 × 11 fashion with an 
interoptode distance of 3 cm resulting in 52 distinctive channels with a penetration 
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depth of approximately 2 to 3 cm (Cui et al., 2011; Haeussinger et al., 2011). The 
probe set was attached over the participants' prefrontal cortex having the central 
optode of the lowest row on FPz stretching out towards T3 and T4, respectively, 
according to the 10–20 international EEG system (Jasper, 1958b). The sampling 
frequency was 10 Hz. The unit used to quantify haemoglobin concentration changes 
was mmol × mm. Subsequently, the recorded data were averaged over the 
corresponding blocks and exported into Matlab R2012b (The Math Works Inc., 
Natick, USA) where they were first corrected for changes in the NIRS signal that 
were not directly due to functional changes in haemoglobin concentration related to 
the attended tasks. To this end, frequencies that exceeded 0.05 Hz were removed 
using a low pass filter and clear technical artefacts (e.g., due to an optode losing 
contact to the scalp during measurement) were corrected by means of interpolation 
by replacing the values of the corresponding channels with the values of the 
circumjacent channels in a Gaussian manner (closer channels were taken more into 
account). In order to further remove artefacts, due to head movements, a 
correlation-based signal improvement (CBSI) procedure according to Cui, Bray & 
Reiss (2010) was applied, adjusting the values for each channel by the equation 
 [CBSI]  =  0.5∗([O2Hb]−std[O2Hb]std  [HHb]∗[HHb]).  
According to this approach, cortical activation should result in a negative correlation 
between O2Hb and HHb concentrations so in case of positive correlations the O2Hb 
signal is adjusted. Even though exceptions regarding a strictly negative correlation 
during brain activation exist (Yamamoto & Kato, 2002), Brigadoi et al. (2014) 
showed promising results for this procedure. Finally, the CBSI adjusted signal was 
once more interpolated in a Gaussian manner by using an inner-subject variance 
threshold of 4 as an interpolation criterion, assuming that exceeding values were 
most likely the result of further artefacts. Altogether a total of 5% of all channels 
were replaced. 
After preprocessing, the data were averaged for all three groups within a time frame 
of 0–45 seconds after the onset of each task. The amplitude integrals in CBSI 
concentration between 5 and 40 seconds were taken as the basis for statistical 
analysis as a delay of the haemodynamic response after task onset can be assumed. 
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2.1.3.7 Regions of interest (ROI) 
Based on prior studies investigating verbal fluency (Nishimura et al., 2007; Nishimura 
et al., 2009; Ohta et al., 2008; Schecklmann et al., 2008; Tupak et al., 2012), 
different a priori ROIs were defined. Accordingly, in addition to temporal areas 
(middle and superior temporal gyrus (MSTG)) and the inferior frontal gyrus (IFG) 
comprising Broca's area, the DLPFC is also supposed to be critically involved when 
performing a VFT. Corresponding channels were chosen using a virtual registration 
procedure as described by Lancaster et al. (2000), Rorden & Brett (2000) and 
Tsuzuki et al. (2007) (cf. Figure 1). 
 
Figure 1 
Probe set arrangement with numbers indicating channels. DLPFC: dorsolateral prefrontal cortex, IFG: 
inferior frontal gyrus, MSTG: middle superior temporal gyrus, color-coded channels were used for 
analyses. 
 
 
2.1.3.8 Clinical assessment 
PD with or without agoraphobia was diagnosed by experienced clinical psychologists 
with the German version of the Structured Clinical Interview for DSM-IV, Axis I 
Disorders (SCID-I First, Spitzer, Gibbon, & Williams, 1995; Wittchen, Wunderlich, 
Gruschwitz, & Zaudig, 1997). Anxiety was measured with the following 
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questionnaires: Panic and Agoraphobia Scale (PAS; Bandelow, 1999), Hamilton 
Anxiety Rating Scale (HAM-A; Hamilton, 1996), and Cardiac Anxiety Questionnaire 
(CAQ; Eifert et al., 2000; Hoyer, Helbig, & Margraf, 2005). All questionnaires were 
completed at t1 and t2. For all scales, higher scores indicate more severe symptoms. 
In case of missing questionnaire items, a last observation carried forward analysis 
(LOCF) was conducted. If less than 10% of all items were left out, missing values 
were substituted by the participant's mean on the relevant scale. 
 
 
2.1.3.9 Statistical analyses 
All analyses were conducted with IBM SPSS Statistics 20 and 21, respectively. The 
sample characteristics were assessed by means of χ2 tests (gender, handedness, and 
first language) or t-tests (age, years of education, duration of illness for patients, and 
questionnaire data for t1 and t2), directly comparing the experimental groups (active 
versus sham, sham versus controls, and active versus controls). If numbers for the 
corresponding categories were below 5, Fisher's exact test was considered instead of 
asymptotic significance. The effects of patients' blinding regarding rTMS treatment 
condition were evaluated using binomial tests (test proportion: 0.5) for the 
subjectively perceived rTMS condition in each patient group, separately. The optimal 
sample size was determined based on previous studies investigating the effect of 
high-frequency rTMS on symptom severity in depression (e.g., Berman et al., 2000). 
The effect size of such a treatment protocol was estimated to approximate 0.5, while 
power was defined as 80%. The α-level was set to 5%. Since the effect of rTMS 
protocols in patients suffering from anxiety disorders is still difficult to quantify 
(Pallanti & Bernardi, 2009), it was decided to follow a more conservative assessment 
resulting in a target sample size of n = 40 patients. 
For baseline assessment, fNIRS-data for all ROIs were analysed by means of 
analyses of variance (ANOVA) with the between-subject factor group (patients versus 
controls). The corresponding behavioural performance was analysed accordingly. In 
order to verify that changes in CBSI concentration were task-related, effects of 
hemispheric lateralisation were further analysed using a 2 × 3 repeated 
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measurement ANOVA (RM-ANOVA) with the within-subject factors hemisphere (left 
versus right) and task (semantical versus phonological versus control task). As the 
factor time was of no relevance within this context, the corresponding data were 
averaged across the two measurement times. Accordingly, the phonological and 
semantical task should elicit a left lateralisation in the language relevant ROIs (IFG & 
MSTG) (Tupak et al., 2012). 
To evaluate the effects of rTMS on prefrontal activity, 2 × 3 RM-ANOVAs for each 
ROI and cognitive task were conducted (within-subject factor time (t1 versus t2), 
between-subject factor group (verum versus sham versus controls)). 
The total number of produced nouns for the phonological and semantical task was 
investigated according to the collected fNIRS-data via a 2 × 3 RM-ANOVA with the 
within-subject factors time (t1 versus t2) and the between-subject factor group 
(verum versus sham versus controls). The number of weekdays was not considered 
in the analysis as it was matched to fit the number of nouns in the other tasks. 
In case of violations of the sphericity assumption, the degrees of freedom in the 
ANOVAs were corrected using the Greenhouse-Geisser or Huynh-Feldt procedure 
depending on ε (ε > 0.75 Huynh-Feldt, ε < 0.75 Greenhouse-Geisser; (see Quintana 
& Maxwell, 1994). To avoid α-error accumulation due to multiple testing, the 
significance level of α = 0.05 was adjusted using a Bonferroni-Holm (BH) (Holm, 
1979) correction procedure for the ROIs in each hemisphere, separately. Post hoc 
analysis was conducted by means of two-tailed t-tests for paired and independent 
samples. 
In order to assess the relationship between cortical activation and behavioural 
performance, correlations between the number of recited words and CBSI-
concentration were calculated at t1 and t2 for each group and task separately by 
means of Spearman's rho. To further directly consider changes over time, 
correlations between the differences (t2−t1) in CBSI concentrations and number of 
recited words were calculated. For post hoc t-tests and correlations, one-tailed P-
values were considered in case of directed hypotheses. 
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2.1.4 Result 
2.1.4.1 Sample characteristics 
Tables Tables1 and 2 give an overview of the sociodemographic sample 
characteristics at baseline and clinical questionnaire data for t1 and t2. 
Sociodemographic data did not differ between groups. For the clinical questionnaire 
data, no significant differences emerged between the sham- and verum-stimulated 
group for t1. Verum group versus controls and sham group versus controls, 
respectively, revealed significant differences on all scales in the expected directions 
(data shown for HAM-A, self-rated PAS, and CAQ, Table 2). 
 
Over the course of treatment, the degree of assessed symptoms on HAM-A, self-rated PAS and CAQ declined significantly in the 
verum and sham stimulated group. However, no significant differences after treatment between these two groups occurred. a p 
< 0.001 compared with sham rTMS (t1); b p < 0.001 compared with verum rTMS (t1); c p < 0.001 compared with sham rTMS 
(t2); d p < 0.001 compared with verum rTMS (t2); e p < 0.01 t-test for paired samples; f p < 0.001 t-test for paired samples; 
CAQ: Cardiac Anxiety Questionnaire; HAM-A: Hamilton Anxiety Rating Scale; PAS: Panic and Agoraphobia Scale; rTMS: 
repetitive transcanial magnetic stimulation; SD: standard deviation; t1: measuring time 1; t2: measuring time 2. 
 
When patients were asked to guess whether they had received active or sham rTMS, 
16 patients in the sham group thought that they had been sham stimulated while 5 
thought that it had been the active protocol. Fourteen patients in the verum group 
thought they had obtained the active protocol and 4 said that they received a 
placebo treatment. Additionally, 5 patients (1 sham, 4 verum) did not reply to the 
question. For each patient group, these guesses differed significantly from chance 
(binomial test, sham group: P = 0.027 and verum group: P = 0.031). 
 
Table 2: Clinical characteristics of all groups, before and after rTMS treatment. 
Group t1 HAM-A 
Mean (SD) 
t2 HAM-A 
Mean (SD) 
t1 Self-rated 
PAS 
Mean (SD) 
t2 Self-rated 
PAS 
Mean (SD) 
t1 CAQ 
Mean (SD) 
t2 CAQ 
Mean (SD) 
Controls 3.83  (3.20) a, b 2.74 (3.57) c, d 0.22 (1.04) a, b 0.13 (0.34) c, d 0.33 (0.20) a, b 0.33 (0.22) c, d 
Sham 20.3 (7.10) 15.20 (8.81) e 20.52 (8.10) 15.34 (8.30) e 1.36 (0.51) 1.06 (0.65) f 
Verum 22.41 (8.97) 18.37 (10.05) e 20.76 (7.76) 14.91 (6.90) f 1.63 (0.71) 1.20 (0.71) f 
   
38 
 
2.1.4.2 Behavioural performance 
Table 3 contains means and standard deviations for the number of produced nouns 
for the phonological as well as the semantical task for each group and each 
measuring time. 
 
Table 3: Number of produced nouns for phonological and semantical task for t1 and t2. 
 Controls Sham Verum 
        
Time 
Phonological 
Mean (SD) 
 
Semantical  
Mean (SD) 
 
Phonological 
Mean (SD) 
 
Semantical  
Mean (SD) 
 
Phonological 
Mean (SD) 
 
Semantical  
Mean (SD) 
 
t1 20 (7.6) 37.2 (7.2) 18.4 (7.2) 33.2 (7.4) 16.9 (6.4) 34.3 (7.8) 
t2 19.7 (7.0) 38.2 (10.1) 19.2 (7.2) 32.5 (7.4) 19.4 (7.8) 35.5 (8.8) 
SD: standard deviation; t1: measuring time 1; t2: measuring time 2 after 3 weeks. 
 
With respect to behavioural data, no significant baseline differences could be found 
between patients and controls. Further the 2 × 3 RM-ANOVA revealed no significant 
changes for either the phonological or the semantical task. 
 
 
2.1.4.3 Prefrontal activitiy at baseline 
Because one patient missed t2, the fNIRS-data of this subject were excluded from all 
analyses. Concerning the remaining subjects, significant results were found for all 
ROIs on both hemispheres for the phonological task (Figure 2) whereby the healthy 
controls displayed more activation than the patients (left DLPFC: F1,65 = 9.304, P = 
0.003, left MSTG: F1,65 = 8.795, P = 0.004, left IFG: F1,65 = 5.279, P = 0.025, 
right DLPFC: F1,65 = 11.649, P = 0.001, right MSTG: F1,65 = 5.158, P = 0.026, 
right IFG: F1,65 = 8.130, P = 0.006, all P BH-corrected). For the semantical task 
significant differences in terms of higher activation in the healthy controls were found 
only for the DLPFC bilaterally (left DLPFC: F1,65 = 6.189, P = 0.015, right DLPFC: 
F1,65 = 11.176, P = 0.001, all P BH-corrected). For the control task no significant 
differences were found (Figure 3). 
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Figure 2                                                             Figure 3 
 
a) 
                                                           
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Contrast maps phonological task. Differential CBSI concentration levels contrasted between 
groups ((a) controls versus PD-patients and (b) verum versus sham) for the phonological task at 
baseline. Differences in CBSI levels between groups are depicted by means of t -values for each 
channel, whereby only t ≤ 1.7 values for are shown. 
Figure 3: Haemodynamic response function of the left dorsolateral prefrontal cortex at the baseline 
measurement, averaged over all subjects for each task, separately. 
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2.1.4.4 Effects of hemispheric lateralisation 
Regarding hemispheric lateralisation effects, the 2 × 3 RM-ANOVA showed a 
significant main effect for the two language related ROIs IFG (F1,65 = 15.030, P < 
0.001 (<0.0167, BH-corrected)) and MSTG (F1,65 = 8.317, P = 0.005 (<0.025, BH-
corrected)) where activation—as indicated by CBSI concentration—was higher for the 
left hemisphere. A significant main effect of task was identified for all ROIs (DLPFC: 
F2,100 = 24.275P < 0.001 (<0.0167, BH-corrected), MSTG: F2,100 = 55.974P < 
0.001 (<0.025, BH-corrected), and IFG: F2,100 = 61,718P < 0.001 (<0.05, BH-
corrected)). The interaction hemisphere∗task was significant for the IFG (F2,130 = 
8.151, P < 0.001 (<0.0167, BH-corrected) and the MSTG (F2,114 = 3.478, P = 
0.040 (<0.05, BH-corrected)). Post hoc analyses showed that this was due to a left 
lateralisation concerning the phonological (IFG, right versus left: t65 = −3.734, P < 
0.001 and MSTG, right versus left: t65 = −2.983, P = 0.002) and partly the 
semantical (IFG, right versus left: t65 = −4.034, P < 0.001) task while there was no 
significant difference for the control task. Regarding the DLPFC, no significant main 
effect of hemisphere was found, whereas the interaction hemisphere∗task was 
significant (F2,130 = 11.040, P < 0.001 (<0.025, BH-corrected)). For the DLPFC, 
results were in contrast to the above-mentioned findings with a significant 
lateralisation effect in terms of increased activation in the right hemisphere for the 
control task (t65 = 5.072, P < 0.001) but no significant difference for the two active 
verbal fluency tasks. Differences between tasks were significant for all comparisons 
for the IFG (right hemisphere: t65 ≥ 2.7, P ≤ 0.005 and left hemisphere: t65 ≥ 3.37, 
P < 0.001) and left MSTG (t65 ≥ 3.322, P < 0.001) with activation during the 
phonological task > activation during the semantical task > the control task. For the 
right hemisphere of the DLPFC, activation during the phonological task was also 
higher than for the semantical task (t65 = 6.083, P < 0.001). For the left DLPFC, 
participants showed similar activation patterns as for the IFG and left MSTG with 
respect to the three test tasks (phonological > semantical > control, for all: t65 ≥ 
3.114, P ≤ 0.0015). 
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2.1.4.5 Effects of rTMS on prefrontal activity 
For the left DLPFC, the analyses of the phonological task showed a significant main 
effect of group (F2, 63 = 5.32, P = 0.007 (<0.0167, BH-corrected)). Post hoc 
analyses revealed that this was due to significantly lower cortical activation of 
patients in the sham (t42 = −2.13, P = 0.02) and verum group (t43 = −2.74, P = 
0.005) compared to healthy controls. No significant interaction effect of time and 
group or main effect of time was found. For the right DLPFC, a significant main effect 
of group (F2,63 = 5.34, P = 0.007 (<0.0167, BH-corrected)) was found. No 
significant effect of time or significant interaction effect of time and group existed 
with respect to the phonological task. Post hoc t-tests displayed similar results as for 
the left DLPFC. Verum- and sham-stimulated patients showed a reduced activation 
compared to healthy controls (for both: t32 ≤ −2.348, P ≤ 0.013). 
For the semantical task, a significant main effect of group was found for the left and 
the right DLPFC (for both: F2,63 ≥ 5.30, P ≤ 0.007 (<0.0167, BH-corrected)). For 
both areas, actively stimulated patients showed a significantly reduced cortical 
activation compared to healthy controls (left DLPFC: t35 = −2.78, P = 0.005 and 
right DLPFC: t43 = −2.60, P = 0.007). Also, sham-stimulated patients showed 
significant hypoactivation compared to healthy participants with respect to the right 
(t38 = −3.19, P = 0.002) and left DLPFC (t34 = −2.316, P = 0.014). No significant 
main effects of time or significant interactions of time and group were discerned for 
the left and right DLPFC, respectively. No significant differences between sham- and 
verum-stimulated patients existed with regard to the left or right DLPFC for the 
phonological and semantical task, respectively. 
The analyses of the control task for the left and right DLPFC revealed neither 
significant main effects of group nor significant main effects of time. Also, no 
significant interaction effects of time and group were found. 
For reasons of clarity, solely significant results for the IFG with respect to the three 
test tasks are depicted in Table 4. For the MSTG, no significant outcomes were 
found. 
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Table 4: Significant results for the cognitive tasks with respect to the IFG.  
 
 
 
 
df  
(df error) 
F p 
Verum vs. 
Sham  
Verum vs. 
Controls 
Sham vs. 
Controls 
Paired t-tests 
ROI        
 
Left IFG – 
phonological task 
 
       
Time x Group 2 (63) 5.23 0.008           
(< 0.0167, BH-
corrected) 
t1: ns. 
t2: ns. 
t1: ns. 
t2: ns. 
t1: S < 
HC** 
t2: ns. 
S: t1 < t2* 
V: ns. 
HC: ns. 
    *significant at a significance level of ≤0.05, **significant at a significance level of ≤0.01, BH-corrected: Bonferroni-Holm-   
    corrected, HC: healthy controls, IFG: inferior frontal gyrus, S: sham group, and V: verum group. 
 
 
2.1.4.6 Correlations between fNIRS data and behavioural performance  
At baseline, no significant correlations between CBSI concentration and the number 
of recited words were found for either PD-patients or for the healthy controls. At the 
second measurement time, a relationship was merely found for the healthy controls 
in terms of negative correlations for all ROIs, except for the right DLPFC with the 
number of recited words during the phonological task (left DLPFC: r = −0.416, P = 
0.024, left MSTG: r = −0.431, P = 0.020, left IFG: r = −0.452, P = 0.015, right 
MSTG: r = −0.534, P = 0.004, right IFG: r = −0.558, P = 0.003, all P BH-corrected). 
Regarding changes over time, significant results existed only during the phonological 
task in the two patients' groups. In this context, an increase in the number of recited 
words was significantly associated with a decrease in CBSI concentration (resp., vice 
versa) for the DLPFC (sham, left DLPFC: r = −0.498, P = 0.011, verum, left DLPFC: r 
= −0.485, P = 0.011, verum, right DLPFC: r = −0.607, P = 0.001, all P BH-
corrected). As all correlations were negative, they were only considered explorative, 
as positive correlations were hypothesized and one-sided tests were conducted. 
 
 
2.1.5 Discussion 
The present study aimed to confirm the finding that PD-patients are characterised by 
prefrontal hypoactivation during cognitive tasks as compared to healthy controls 
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(Ohta et al., 2008). Moreover, it additionally addressed the question whether a 
potential hypoactivation of the PFC can be normalised by means of repeated iTBS. 
Patients with PD were investigated via fNIRS while performing a VFT prior to and 
after receiving daily prefrontal iTBS application over a time course of three weeks in 
addition to weekly group sessions of psychoeducation. The VFT-results were 
compared with those of healthy control subjects. 
Regarding our first hypothesis, our results are in line with the above-mentioned 
findings concerning hypofrontality during cognitive tasks in PD-patients. With respect 
to our second hypothesis, unexpectedly, an increase in activation over time could 
only be found for the left IFG in sham-stimulated patients. 
In more detail, before the start of rTMS treatment, differences in cortical activation 
(as indicated by CBSI data) between patients and controls were observed for specific 
task conditions of the VFT. In fact, as predicted by our hypothesis, patients did not 
differ from controls during the control task but displayed decreased prefrontal 
activation in all ROIs during the phonological task and partly also during the 
semantical task. The missing differences during the control task indicate that the 
differences in CBSI concentration between healthy controls and patients during the 
two active tasks were indeed due to altered cognitive processing and not to more 
general effects elicited by the measurement situation. Still, it cannot be excluded that 
our fNIRS signal may have been affected by components that are not directly related 
to cognitive processing but still lead to a (task-related) change in blood flow and 
hence a change of the measured signal. Regarding more general effects that might 
influence the fNIRS signal, a recent study by Takahashi et al. (2011) showed that the 
verbal fluency task is particularly affected by confounding effects due to stress 
induced skin blood flow, especially for NIRS channels located over the forehead. In 
order to verify that we still mainly measured cortical activation, we presumed that 
lateralisation effects in terms of increased left hemispheric activation should be found 
for language related areas such as the MSTG and IFG but not for the DLPFC. Further, 
increases in these two ROIs should only exist for the semantical and phonological but 
not for the control task. In line with previous studies (Tupak et al., 2012) we could 
confirm these assumptions and accordingly ascribe our finding mainly to differences 
in cortical activation. 
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Contrary to our second hypothesis, no significant changes in prefrontal activation 
after rTMS treatment could be found in the verum group. In fact, the only significant 
change was found for the sham group which showed an increase in CBSI 
concentration in the left IFG during the phonological task. As at first glance these 
findings are hard to interpret and we further analysed the prefrontal activation 
patterns in relation to the behavioural performance of healthy controls and the two 
patients groups. 
When regarding only the behavioural data, descriptively, healthy controls could name 
more nouns than both patients groups; however, this difference was not significant. 
Further, when associating CBSI concentrations in the different ROIs with the number 
of recited nouns at baseline, no significant correlations could be revealed for either 
group. Interestingly, however, at the second measurement time, negative 
correlations between the behavioural performance and activation patterns in nearly 
all ROIs existed for the healthy controls. Even though we originally applied one-sided 
testing (assuming a positive relationship between behavioural performance and 
cortical activation), we still think that it is worthwhile to give these negative 
correlations some considerations as they might be helpful for a better understanding 
of our results. 
Similar to the finding in healthy controls, negative associations between changes in 
the number of recited nouns from t1 to t2 and changes in DLPFC activation bilaterally 
during the phonological task could be found for both patients groups. In order to 
interpret these results in a meaningful way, it has to be considered that multiple 
distinct mechanisms might have an influence on the fNIRS signal. Firstly, according 
to our hypothesis, it can be assumed that a demanding cognitive task leads to an 
increase in cortical activation which then triggers a certain performance at the 
behavioural level. In this context, higher cortical activation should lead to a better 
behavioural performance as it implies that more cognitive resources can be recruited 
to fulfil the task as well as possible. From another perspective, one could also 
assume that in subjects with a highly efficient cortical processing (i.e., in case of a 
subjectively nonchallenging task situation) fewer cognitive resources are needed to 
achieve good results. In this case, low cortical activation should be associated with 
high behavioural performance. However, it needs to be kept in mind that the fNIRS 
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signal might not just contain components which are due to cortical activation but 
might also be influenced by extracranial signal components that relate to peripheral 
processes such as psychophysiological arousal induced changes in blood flow. In 
particular, in frontopolar regions, these components have been shown to also trigger 
an increase in the fNIRS signal due to stress induced vasodilation during a verbal 
fluency task (Haeussinger et al., 2014). In this context, higher CBSI concentrations 
might then also be associated with a decrease in behavioural performance as it can 
be presumed that too much psychophysiological arousal should have a negative 
effect on cognitive functioning. Even though we tried to control for such arousal 
effects by performing a control task and considering lateralisation effects, we cannot 
exclude the fact that it still had an effect on our results. 
Accordingly, we conclude that we could not find any significant correlations at the 
baseline measurement time as psychophysiological arousal was probably very high 
for all participants, hence having confounding effects on the fNIRS signal 
components due to cortical activation. At the second measurement time, cortical 
activation should have been the same for the healthy controls while arousal may 
have decreased for some participants as the situation was more familiar, leading to a 
reduction in signal intensity and negative correlations with behavioural performance 
due to improved cognitive function (with reduced arousal). While it cannot be 
excluded that these negative correlations also imply that the task was not 
challenging enough for some of the healthy subjects, the study by Takahashi et al. 
(2011) points more in favour of an interpretation in terms of a decrease in 
psychophysiological arousal. In fact, the authors could show that already a repetition 
of the verbal fluency task within one measurement could lead to a significant 
repetition effect by means of a decrease in psychophysiological arousal and 
associated fNIRS signal intensity. 
Concerning the PD-patients, psychophysiological arousal should have also decreased 
but possibly not as much as in the healthy controls as the measurement situation still 
represented a typical panic-relevant situation (patients had to sit in a small room 
with the fNIRS probe set attached to their heads so a sudden escape was not 
possible). At the same time it can be expected that arousal effects, which are 
prominent in the frontopolar area of the PFC, also have an effect especially on the 
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DLPFC which cannot be neglected (Haeussinger et al., 2014). A possible explanation 
especially for the influence of DLPFC activation through the frontopolar region is 
given by Kirilina et al. (2012) who found that the vein responsible for arousal effects 
in the forehead also stretches out to dorsolateral regions. Consequently, apparent 
effects of a slight decrease in arousal would most likely be expected in the DLPFC, 
hence explaining the negative correlations between changes in behavioural 
performance and changes in CBSI concentrations for the patients. Even though 
correlations between CBSI concentrations and behavioural performance during the 
semantical task were not significant, it is noteworthy to mention that the direction of 
the correlations was generally the same, supporting our prior assumptions. 
We therefore conclude that healthy controls as well as patients in both groups were 
generally less affected by psychophysiological arousal during the second 
measurement time. In this regard, the increase in activation from the first to the 
second measurement time for the left IFG in the sham group might not be related to 
an increase in cognitive functioning but might merely represents a more general 
possibly also arousal related effect. A further reason which might have contributed to 
the increase in CBSI concentrations after sham iTBS might be given by simple 
regression towards the mean. In this regard it needs to be considered that sham- 
and verum-stimulated patients did not differ significantly in their activation patterns 
after rTMS application. Instead, sham-stimulated patients showed a significantly 
decreased baseline CBSI concentration in the left IFG compared to healthy controls. 
All in all, our findings confirm our first hypothesis that PD-patients show a prefrontal 
dysfunction that is at least partly independent of panic-related tasks. However, an 
increase in cortical activation after verum iTBS was not found. Instead, we could 
accentuate the need to consider task-related arousal induced effects especially when 
investigating patients with anxiety disorders. 
To our knowledge, this is the first controlled study investigating effects of add-on 
theta burst stimulation (TBS) on prefrontal activation and cognitive functioning in 
patients with PD/agoraphobia. So far, only a few open studies investigated the 
effects of TBS on psychiatric symptoms (e.g., Chistyakov, Rubicsek, Kaplan, Zaaroor, 
& Klein, 2010; Holzer & Padberg, 2010). 
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However, limitations of this study have to be mentioned. The stimulation condition 
(verum versus sham) was correctly identified by the majority of patients, so one 
could argue that placebo effects might have affected our results. Possibly, patients 
exchanged their perceptions about rTMS during the psychotherapy group sessions, 
as they became acquainted with each other over the course of psychoeducation. For 
further investigations, we therefore emphasise the need for specialised sham coils 
which produce a superficial electrical current on the skull, as demonstrated by Rossi 
et al. (2007). Although in our study sufficient blinding could not be reached, 
promising results of rTMS in controlled studies with electromagnetic placebo coils 
could demonstrate specific effects of verum stimulation on psychiatric symptoms 
(e.g., for PTSD and comorbid depression by Boggio et al. (2010). Referring to the 
choice of the rTMS-frequency, we used a protocol which is assumed to facilitate 
motor cortex excitability (Huang et al., 2005). Also, a facilitation of frontal activity 
could be demonstrated. For example, speech repetition accuracy was promoted by 
intermittent theta burst stimulation of the left posterior inferior frontal gyrus (Restle 
et al., 2012). Nevertheless, rTMS effects seem to be influenced by a wide range of 
factors, for example, genetic variables or the way of application. Cheeran et al.  
(2008) could demonstrate a significant influence of the brain-derived neurotrophic 
factor gene (BDNF) on the TBS-efficacy for the primary motor cortex. Also, TBS 
after-effects seem to hinge on the NMDA-receptor (Huang, Chen, Rothwell, & Wen, 
2007). Further, a study of Gamboa, Antal, Moliadze, & Paulus (2010) demonstrated 
reversed iTBS-effects after a prolonged, single application of 1200 instead of 600 
stimuli. Taken together, it could be questionable if iTBS consistently facilitates the 
excitability of stimulated neurons. Moreover, in our study, rTMS was generally 
applied after psychoeducation sessions. However, an application prior to 
psychoeducation could have led to a different processing of the afterwards presented 
information. We therefore suggest that future studies should systematically assess 
temporal effects of rTMS applications in relation to additional intervention methods. 
Regarding methodology, we have already discussed the problems that arise from the 
confounding skin blood flow signal component in the fNIRS data. A possible solution 
to this—which allows for an even more precise interpretation of the result—might be 
to measure the skin components selectively by additionally placing optodes with 
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shorter interoptode distances on the probe set (Takahashi et al., 2011). Finally, 
concerning the diagnostic process, PD/agoraphobia was diagnosed prior to t1 with 
the help of structured clinical interviews. However, the time lag between these 
interviews and t1 was not standardized in our study. 
 
 
2.1.6 Conclusion 
This pilot study investigated cortical activation patterns of patients with 
PD/agoraphobia compared to healthy controls. Further, effects of add-on iTBS on 
cortical activation and cognitive performance in PD/agoraphobia were analysed. 
Findings of a baseline cortical hypoactivation could be replicated. However, an 
increase in cortical activation after verum iTBS could not be supported. Instead we 
only found increased CBSI concentrations for the left IFG after sham iTBS 
application. By integrating behavioural performance into our analysis we could 
attribute this finding to more general effects such as task-related psychophysiological 
arousal and regression towards the mean. Taken together, our results confirm that 
PD is characterised by prefrontal hypoactivation. As we could not verify an increase 
in cortical activation after verum iTBS, further studies that should control for task-
related psychophysiological arousal are needed in order to evaluate under which 
circumstances iTBS might serve as a therapeutic tool in the treatment of PD. 
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2.2 Manuscript 2: Neurobiological and clinical effects of fNIRS-controlled 
rTMS in patients with panic disorder/agoraphobia during cognitive-
behavioural therapy 
 
The contents of this chapter are published in:  
Deppermann, S.*, Vennewald, N.*, Diemer, J., Sickinger, S., Haeussinger, F.B., 
Dresler, T.,  Notzon,S., Laeger,I., Arolt,V., Ehlis, A.-C., Fallgatter, A.J., Zwanzger, P. 
(2017). Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with 
panic disorder/agoraphobia during cognitive-behavioural therapy.  
NeuroImage: Clinical, 16:668, 2017. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Both authors contributed equally to this work 
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2.2.1 Abstract 
Background 
A relevant proportion of patients with panic disorder (PD) does not improve even 
though they receive state of the art treatment for anxiety disorders such as 
cognitive-behavioural therapy (CBT). At the same time, it is known, that from a 
neurobiological point of view, PD patients are often characterised by prefrontal 
hypoactivation. Intermittent Theta Burst Stimulation (iTBS) is a non-invasive type of 
neurostimulation which can modulate cortical activity and thus has the potential to 
normalise prefrontal hypoactivity found in PD. We therefore aimed at investigating 
the effects of iTBS as an innovative add-on to CBT in the treatment for PD. 
Methods 
In this double-blind, bicentric study, 44 PD patients, randomised to sham or verum 
stimulation, received 15 sessions of iTBS over the left prefrontal cortex (PFC) in 
addition to 9 weeks of group CBT. Cortical activity during a cognitive as well as an 
emotional  (Emotional Stroop) paradigm was assessed both at baseline and post-
iTBS treatment using functional near-infrared spectroscopy (fNIRS) and compared to 
healthy controls.   
Results 
In this manuscript we only report the results of the emotional paradigm; for the 
results of the cognitive paradigm please refer to Deppermann et al. (2014). 
During the Emotional Stroop test, PD patients showed significantly reduced activation 
to panic-related compared to neutral stimuli for the left PFC at baseline. Bilateral 
prefrontal activation for panic-related stimuli significantly increased after verum iTBS 
only. Clinical ratings significantly improved during CBT and remained stable at follow-
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up. However, no clinical differences between the verum- and sham-stimulated group 
were identified, except for a more stable reduction of agoraphobic avoidance during 
follow-up in the verum iTBS group.  
Limitations 
Limitations include insufficient blinding, the missing control for possible state-
dependent iTBS effects, and the timing of iTBS application during CBT.  
Conclusion 
Prefrontal hypoactivity in PD patients was normalised by add-on iTBS. Clinical 
improvement of anxiety symptoms was not affected by iTBS. 
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2.2.2 Introduction 
With a 12-month prevalence of 2–3% (Kessler et al., 2006; Wittchen et al., 2011), 
panic disorder (PD) and comorbid agoraphobia represent a massively impairing 
anxiety disorder (Barlow, 2002) posing a substantial economic burden (Zaubler and 
Katon, 1998), and high comorbidity and/or chronicity are frequently observed in this 
group of patients (Roy-Byrne et al., 2006). Fortunately, effective treatment options 
exist, as cognitive-behavioural therapy (CBT) has been proven effective in numerous 
randomised controlled studies (Bandelow et al., 2007; Hofmann and Smits, 2008; 
Schmidt and Keough, 2010). Moreover, pharmacotherapy has been confirmed to be 
beneficial in the treatment of PD with/without agoraphobia (Bandelow et al., 2008). 
However, up to one third of patients do not respond sufficiently to either approach 
(Diemer et al., 2010; Taylor et al., 2012). Several factors contributing to this 
phenomenon have been observed, e.g. disorder duration (Scheibe and Albus, 1996; 
Slaap and den Boer, 2001). Thus, despite a wide range of treatments available, 
improved therapeutic strategies for PD and agoraphobia are still needed. 
From a neurobiological point of view of PD, alterations of the “fear network” in terms 
of hyperactivity of subcortical structures such as the amygdala have been 
consistently observed (cf. de Carvalho et al., 2010). Concurrently, a number of 
imaging studies have shown hypoactivation of the lateral prefrontal cortex, which is 
indirectly linked to the amygdala and is known to be critically involved in voluntary 
emotion regulation and cognitive control (Urry et al., 2006; Kent and Rauch, 2003; 
but see Dresler et al., 2013 for a comprehensive review). Since CBT works by 
changing problematic cognitions and prompting inhibitory learning (Craske et al., 
2014), hypothetically, on a neurobiological basis, these effects of CBT should be 
associated with increased prefrontal activation which has in fact been shown in a 
number of studies (for a review see Clark and Beck, 2010). By implication, one could 
further conclude that directly enhancing prefrontal activation patterns in addition to 
CBT might enhance CBT outcome. 
Based on the principle of electro-magnetic induction, repetitive Transcranial Magnetic 
Stimulation (rTMS) is capable of modulating cortical activity locally and non-invasively 
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(Wassermann and Zimmermann, 2012). RTMS applied to the prefrontal cortex has 
been shown to exert antidepressant effects in several sham-controlled trials 
(Schutter, 2009; Berlim et al., 2013), however, inconsistent findings exist (Herwig et 
al., 2007). As a potential treatment option for anxiety disorders, the technique has so 
far been less investigated (Paes et al., 2011; Zwanzger et al., 2009). Although 
promising results have been demonstrated in small controlled trials, open studies and 
case reports (Mantovani et al., 2007; Paes et al., 2011; Zwanzger et al., 2009; 
Zwanzger et al., 2002; Dresler et al., 2009), again so far the findings are not 
conclusive and further controlled studies are needed to determine the optimal 
stimulation characteristics (Prasko et al., 2007) To increase cortical activity, the rTMS 
protocol intermittent Theta Burst Stimulation (iTBS) is recommended (Huang et al., 
2005). 
To evaluate cortical effects of neurobiological interventions, functional near-infrared 
spectroscopy (fNIRS) provides a non-invasive optical imaging technique that applies 
near-infrared light to measure task-related alterations of oxygenated and 
deoxygenated haemoglobin concentrations (Ferrari and Quaresima, 2012; Ehlis et 
al., 2014). Advantages compared to fMRI-investigations are considerable: fNIRS 
devices are mobile and allow for a more comfortable investigation without a 
potentially anxiety-inducing scanner environment, which might be particularly 
favourable for patients with claustrophobic difficulties (cf. Ohta et al., 2008). 
In the present pilot study, we aimed at investigating, whether iTBS, applied 
concurrently to group CBT for PD, normalises prefrontal hypoactivity in terms of a 
“trans-situal characteristic” in this group of patients but also during specific fear-
relevant situations. Do to so, we applied a cognitive task as well as an emotional 
task. Whereas the results of the cognitive task and the corresponding clinical data 
collected during the first three weeks of iTBS treatment have been published in 
Deppermann et al. (2014), this manuscript focuses on the results of the emotional 
paradigm (Emotional Stroop task) and the clinical data which was collected over the 
whole time course of CBT. More specifically, the following hypotheses were tested: 
(1) PD/agoraphobia patients are characterised by prefrontal hypoactivation, as 
assessed by fNIRS, during a task that requires emotion regulation and cognitive 
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control (Emotional Stroop task) compared to controls. (2) CBT and add-on iTBS 
normalises these activation patterns and (3) improves clinical symptoms. (4) 
Changes in fNIRS patterns are correlated with treatment efficacy. 
 
 
2.2.3 Materials and methods 
Inclusion criteria, implementation of fNIRS and iTBS application were identical to the 
procedures described in Deppermann et al. (2014) but, for more clarity, will be 
delineated again in the following sections. 
 
2.2.3.1 Participants 
The study included 44 patients, aged 18–65 years and diagnosed with PD 
with/without agoraphobia according to the DSM-IV-TR (American Psychiatric 
Association, 2000). PD with/without agoraphobia was diagnosed by experienced 
clinical psychologists with the Structured Clinical Interview for DSM-IV, Axis I 
Disorders (SCID-I; First et al., 1996; Wittchen et al., 1997). In the PD group, 
comorbid psychiatric disorders (except for bipolar or psychotic disorder, borderline 
personality disorder, acute substance abuse disorders and acute suicidality) were no 
exclusion criteria and the intake of psychopharmacological medication like selective 
serotonin (noradrenaline) reuptake inhibitors was permitted if the dosage had been 
kept stable for at least three weeks prior to baseline assessment. 
23 healthy controls with no family history of mental disorders and no current or past 
mental, somatic or organic brain disorder were included. Groups did not differ with 
respect to gender, age, years of education, handedness, comorbid depression or 
duration of illness (Table 1). After a comprehensive study description, written 
informed consent was obtained. A clinical trial registration did not take place but the 
study was approved by the Ethics Committees of the Universities of Muenster and 
Tuebingen. All procedures were in accordance with the Declaration of Helsinki in its 
latest version. 
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Table 1. Baseline sample characteristics. 
 Verum  Sham Controls Statistics Post-hoc 
Number in sample 22 (14) 22 (12) 23 (19)   
Mean age in years  
(range) 
37.6 (19-63) 
(38.4 (21-63)) 
36.3 (22-56) 
(39.1 (24-56) 
33.4  (19-64) 
(34.7 (22-64)) 
F2,66 = 0.807, p = 0.45 
 (F2,44 = 0.74, p = 0.48) 
 
% women 59 (50) 
 
64 (75) 
 
61 (63) X² = 0.097, p = 0.95 
(z = 1.70, p = 0.43) 
 
Handedness (number of 
right-handed subjects) 
20 (13) 21 (12) 20 (16) z = 1.037, p = 0.87 
(z = 1.89, p = 0.45) 
 
First Language 19 (13) german 
1 (0) bilingual 
2 (1) other 
19 (11) german  
2 (1) bilingual  
1 (0) other 
22 (18) german 
1(1) bilingual 
- 
z = 2.74, p = 0.64 
(z = 5.73, p = 0.50) 
 
 
Mean years of education 
(SD) 
12.1 (1.7) 
(12.2 (1.8)) 
12.4 (2.0) 
(12.3 (2.4)) 
12.5 (1.1) 
(12.4 (1.2)) 
F2,66 = 0.33, p = 0.72 
(F2,44 = 0.033,  p= 0.97) 
 
Mean duration of illness in 
months (range) 
92 (1-372) 
(109.8 (18.372)) 
84 (1-336) 
(111.2 (5-336)) 
- F1,43 = 0.084, p = 0.77 
(F1,25 = 0.001, p = 0.97) 
 
Comorbid depression 8 (4) currently 
9 (7) in past 
5 (3) never 
6 (2) currently 
11 (8) in past 
5 (2) never 
- z = 0.56, p = 0.92 
(z = 0.86, p = 0.76) 
 
 
Mean HAM-A – total  (SD) 22.41 (8.97) 
(21.14 (8.01)) 
20.3 (7.1) 
(20.25 (8.66)) 
3.90 (3.35) 
(0.26 (1.15)) 
F2,66 = 50.49, p < 0.001 
(F2,44 = 33.45, p < 0.001) 
V = S > HC 
(V=S > HC) 
Mean self-rated PAS 
total (SD) 
20.76 (7.76) 
(18.02 (7.92)) 
20.52 (8.10)  
(18.83 (9.43)) 
0.22 (1.04) 
(4.37 (3.24)) 
F2,66 = 75.64, p < 0.001 
(F2,44 = 41.75, p < 0.001) 
V = S > HC 
(V=S > HC) 
Mean CAQ – total (SD) 1.63 (0.71) 
(1.52 (0.67))  
1.36 (0.51) 
(1.36 (0.54)) 
0.33 (0.20) 
(0.32 (0.22)) 
F2,66 = 39.95, p < 0.001 
(F2,44 = 29.49, p < 0.001) 
V = S > HC 
(V=S > HC) 
CAQ: Cardiac anxiety questionnaire; HAM-A: Hamilton Anxiety Rating Scale; HC: healthy controls; PAS: Panic and Agoraphobia Scale;. S: sham group; SD: standard deviation; V: verum group; values 
in parentheses indicate results for the subgroup used for analyses of the behavioural data during the emotional Stroop task. For all questionnaires, higher scores indicate higher severity of symptoms. 
For PAS, the median for PD-patients is reported to be 23  [Bandelow, 1997]. 
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2.2.3.2 Design 
This multicentre study combined a 9-week CBT group intervention with a sham-
controlled iTBS augmentation within the first 3 weeks of CBT. Patients diagnosed 
with PD with/without agoraphobia were randomised to either sham or verum iTBS. 
Enrolment took place between 01/2011 and 07/2013. Patients and therapists were 
blinded to iTBS group assignment (Fig. 1). 
 
Figure 1 
 
Study design. 
Abbreviations: CAQ, Cardiac anxiety questionnaire; CBT, Cognitive Behavioural Therapy; fNIRS, 
functional near-infrared spectroscopy; HAM-A, Hamilton Anxiety Rating Scale; iTBS, intermittent Theta 
Burst Stimulation; PAS, Panic and Agoraphobia Scale; S1-S9, therapy sessions 1 to 9. 
 
2.2.3.3 CBT 
CBT (based on Margraf and Schneider (1990) and Schneider and Margraf (1998)) 
was conducted as a standardised treatment by trained clinical psychologists, who 
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were continually supervised by experienced clinical psychotherapists. It was 
administered in a 9-week group setting (except for session 6) with a maximum of 6 
patients/group. Two booster sessions took place after 3 and 6 months, respectively. 
Sessions lasted 1 ½ hours each, respectively (Fig. 1). 
 
2.2.3.4 iTBS 
After randomisation, a (sham) iTBS protocol (Huang et al., 2005) was applied over 
the left PFC in 15 daily sessions which always took place at the same time during the 
day for each individual patient but could vary between patients depending on their 
available free time during the first three weeks of CBT. We used a figure-of-eight coil 
(MCF-B65, 2 × 75 mm diameter, n = 34, MAGSTIM 9925-00, 2 × 70 mm, n = 9) 
using a MagOption/MagPro × 100 stimulator (MagVenture, Denmark, n = 35), and a 
MAGSTIM RAPID2 T/N 3567-23-02 stimulator (n = 9), respectively. The rTMS coil 
was placed over electrode position F3 (left dorsolateral PFC) of the international 10–
20 EEG system (Herwig et al., 2003). In order to adjust the stimulation intensity to 
the individual cortical excitability, the participants` resting motor threshold was 
defined prior to each iTBS application and stimulation intensity was set to 80% of it. 
As a manipulation check, after all 15 iTBS sessions were completed, the participants 
were asked which stimulation (verum or sham) they believed they had received. 
 
2.2.3.5 Outcome measures 
2.2.3.5.1 Emotional Stroop task 
The Emotional Stroop task consisted of 15 panic-related and 15 neutral words 
presented in red, green, yellow and blue. The words belonging to the two conditions 
did not differ significantly with regard to the number of letters, syllables and 
frequency in spoken/written language. Furthermore, they had already been used in 
prior studies (e.g., Dresler et al., 2012). Participants had to indicate the word colour 
independent of its meaning via button press. It is assumed that emotional, in 
contrast to neutral, words bind more attention due to emotional interference, 
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thereby increasing reaction times (RTs) and error rates (ERs) for emotional words. 
For panic-related words, this effect should be more pronounced in PD patients 
(Dresler et al., 2012). 
All 120 trials were presented in randomised order on a black LCD screen. A fixation 
cross (500 ms) preceded each stimulus (1500 ms), while the inter-trial intervals 
(4000–8000 ms) were randomly jittered. 
We assessed RTs and ERs as indices of emotional interference. 
 
2.2.3.5.2 fNIRS measures 
FNIRS measurements were conducted using the ETG-4000 Optical Topography 
System (Hitachi Medical Co., Japan). The probe set consisted of 52 channels 
arranged in a 3 × 11 optode array (16 photo-detectors and 17 light emitters). It was 
placed with its central optode of the lowest row on FPz stretching out towards T3 
and T4, respectively, according to the 10–20 international EEG system (Jasper, 
1958). 
We recorded changes of the concentration of O2Hb and HHb relative to the 
individual resting baseline during the Emotional Stroop task for the two conditions 
neutral words and panic-related words, respectively. The sampling frequency was set 
to 10 Hz. Measurements took place at baseline just before the beginning of the 
treatment period (within a range of 48 h before the first iTBS session) as well as 
after the completion of all 15 iTBS sessions. In order to avoid the measurement of 
acute iTBS effects, the post measurement was set to be performed after at least 
12 h past the last iTBS session (please also refer to Fig. 1). 
 
2.2.3.5.3 Clinical outcome measures  
Quantitative psychometric assessment was administered at baseline, day 7 (iTBS-7), 
day 14 (iTBS-14), day 21 (post-iTBS), the end of CBT (post-CBT, week 9), and at 3-
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month and 6-month follow-up after CBT (Fig. 1). The following questionnaires were 
used: 
The Panic and Agoraphobia Scale (PAS; Bandelow, 1997) consists of an observer-
rated and a self-rated questionnaire assessing symptoms of PD with or without 
agoraphobia with reasonable reliability and validity (Bandelow, 1997). Each item 
scores from 0 to 4, with higher scores indicating higher symptom severity. We 
assessed the total score indicating global severity on both the observer-rated and the 
self-rated questionnaires, as well as 5 subscores per questionnaire: a) panic attacks, 
b) agoraphobic avoidance, c) anticipatory anxiety, d) disability and e) worries about 
health (Bandelow, 1997). 
The Hamilton Anxiety Rating Scale (HAM-A; Hamilton, 1996) is an observer-based, 
clinical interview assessing a comprehensive range of anxiety symptoms. Beside a 
total score, the subscales “somatic anxiety” and “psychic anxiety” can be calculated. 
Higher scores indicate a stronger severity. 
The Cardiac Anxiety Questionnaire (CAQ; Eifert et al., 2000; Hoyer et al., 2005) is a 
self-report questionnaire with good reliability and validity, designed to assess heart 
focused anxiety (Eifert et al., 2000; Hoyer et al., 2005). Each item scores from 0 to 4 
with higher scores indicating stronger symptoms. Beside a total score, 3 subscales 
(fear, avoidance, attention) can be calculated. 
 
2.2.3.6 Data preparation  
Matlab was used to correct for fNIRS signal changes that were not directly due to 
functional changes in haemoglobin concentration related to the attended tasks and 
included the following steps: the data was filtered with a high pass of 0.03 and a low 
pass of 0.5 Hz, manual interpolation of channels which clearly displayed technical 
artefacts according to a Gaussian distribution (circumjacent channels were taken 
more into account), a correlation-based signal improvement (CBSI) procedure 
according to Cui et al. (2010), automatic Gaussian interpolation for channels where 
the within-subject variance exceeded four. Due to technical problems, complete data 
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sets were only available from n = 20 verum-stimulated patients, n = 21 sham-
stimulated patients, and n = 21 healthy controls. The data of the remaining 
participants were segmented channel-wise in an event-related manner. A time frame 
of 0–16 s after stimulus onset was extracted and adjusted for linear drifts and 
baseline. The resulting averaged amplitude integrals (4–10 s after stimulus onset) 
were taken as the basis for statistical analyses. 
For the data of the clinical assessment (HAM-A, PAS, CAQ), a last observation carried 
forward analysis (LOCF) was applied, if drop-outs or complete omissions of 
questionnaires between any times of measurement occurred. If there were 
questionnaire items missing, missing values (if < 10%) were substituted by the 
mean value of the subject on the relevant scale. 
 
2.2.3.7 Regions of interest (ROI) 
To assess the effects of the stimulus-related oxygenation changes as well as iTBS 
treatment, regions of interest (ROIs) were defined a priori. This was done in 
agreement with current findings on Emotional Stroop paradigms which are known to 
activate prefrontal areas (such as our site of iTBS application) as the major neural 
correlate of cognitive control (Tupak et al., 2013; Zhang et al., 2011; Dresler et al., 
2012). The channels, including the left and right PFC ROIs, were chosen with respect 
to a virtual registration procedure described by Tsuzuki et al. (2007), Singh et al. 
(2005), Rorden and Brett (2000) and Lancaster et al. (2000) (Fig. 2). In order to 
additionally verify that the expected activation changes were unique to the 
predefined ROIs, a control “non-ROI” comprising all temporal channels was defined. 
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Figure 2 
 
  
Probe set arrangement with numbers indicating channels.  
PFC: prefrontal cortex; colour-coded channels were used for analyses. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web version of this article.) 
 
2.2.3.8 Statistical analyses 
Baseline sample characteristics were tested with one-way ANOVAs, χ2- or t-tests, 
depending on the variable in question. Fisher's exact test was used for analysing 
baseline sample characteristics if there were fewer than five cases per category. 
To evaluate the effectiveness of patient blinding regarding the iTBS treatment 
condition, we conducted binomial tests of the subjectively perceived iTBS condition 
(test proportion: 0.5) for each group. 
Regarding fNIRS data, for both ROIs, 2 × 2 × 3 repeated measurement analyses of 
variance (RM-ANOVAs) were conducted with the within-subject factors condition 
(panic-related vs. neutral words) and time (pre vs. post iTBS treatment) and the 
between-subject factor group (verum vs. sham vs. controls). An RM-ANOVA was 
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Behavioural data (RTs and ERs) were analysed by means of RM-ANOVAs. 
For the clinical data, 2 × 3 RM-ANOVAs were conducted with the within-subject 
factor time (baseline vs. post-iTBS) and the between-subject factor group (verum vs. 
sham vs. controls) considering differences between the three groups on the total 
scores (CAQ, HAM-A, PAS self-rated). The content of the subscales of all 
questionnaires was grouped according to the topics (as outlined in the 
Supplementary material) and Bonferroni-Holm-correction (Holm, 1979) was applied 
within each topic. 
To analyse the course of iTBS effects on clinical data over time, RM-ANOVAs (7 × 2-
design) were calculated with the within-subject factor time (from baseline to follow-
up 2) and the between-subject factor group (verum vs. sham). The following post-
hoc comparisons were conducted: baseline vs. post-iTBS, baseline vs. post-CBT, 
baseline vs. follow up 1, baseline vs. follow-up 2, follow-up 1 vs. follow-up 2, post-
iTBS vs. post-CBT, post-iTBS vs. follow-up 1, and post-iTBS vs. follow-up 2 Two-
tailed t-tests for matched samples were employed for post-hoc analyses. 
Correlations (Spearman's rho) between the CBSI concentrations and the 
questionnaire subscales were calculated for the sham and verum group at baseline 
and post-iTBS. To do so, the difference between activation elicited by panic-related 
and neutral words was calculated. Changes in these CBSI concentrations (CBSIpost-
iTBS - CBSIbaseline) were correlated with changes in the questionnaire scores (post-
iTBS - baseline). 
Behavioural data (RTs and ERs) were available from n = 46 participants (20 controls, 
14 verum, 12 sham patients). Due to technical problems, button presses were not 
recorded properly for the remaining participants and one control subject had to be 
excluded due a too high ER (> 2 standard deviations). Again, it was verified that 
groups did not differ significantly concerning baseline characteristics (Table 1). 
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2.2.4 Results 
2.2 4.1 Sample Characteristics 
Table 1 shows the sample characteristics for the verum and sham groups as well as 
the healthy controls. No significant group differences for sociodemographic variables 
were found for the complete sample or the sub-sample (values in brackets) used for 
the analysis of the behavioural data. For clinical ratings, no significant differences 
existed between verum and sham group. Compared to the control group, clinical 
ratings were significantly higher for both patient groups (Table 1). 
 
2.2.4.2 Manipulation check 
2.2.4.2.1 iTBS blinding check 
One patient in the sham group and three patients in the verum group did not 
respond when asked about perceived group allocation. In the verum group, 14/19 
patients guessed their treatment condition correctly, as did 16/21 in the sham group. 
The proportion of correct guesses differed significantly from chance (0.5) in both 
groups (p = 0.027 for sham group, p = 0.031 for verum group). 
 
2.2.4.2.2 Emotional Stroop task - behavioural data  
For the behavioural data, there was a significant main effect of the factor time in 
terms of a decrease of performance from baseline to post-iTBS regarding RTs 
(F1,42 = 4.622, p = 0.037) as well as ERs (F1,42 = 5.6, p = 0.007). Furthermore, a 
significant main effect for the factor condition (F1 42 = 180, 109, p < 0.001) and the 
factor group (F2,42 = 2.42, p = 0.04) was detected for ERs only. As can be seen in 
Table 2, all subjects committed more errors for panic-related words then for neutral 
words but the sham-stimulated patients generally committed the fewest errors 
(verum vs. sham: t24 = 2.098, p = 0.047; controls vs. sham: t29 = 2.958, 
p = 0.006). There were no significant interactions. Mean RTs and ERs are for all 
groups, times and conditions are shown in Table 2. 
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Table 2. Mean and Standard Deviation of reaction times (RT) and error rates (ER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ms, milliseconds; iTBS, intermittent theta burst stimulation 
 
 
 
2.2.4.3 fNIRS Data - baseline differences and treatment effects 
 
The 2 × 2 × 3 RM-ANOVAs of CBSI concentrations revealed no significant main 
effects, but a significant three- way interaction of condition ∗ time ∗ group for both 
the left (F2,59 = 4.017, p = 0.023) and right PFC (F2,59 = 3.836, p = 0.027). 
For the left ROI, separate post-hoc analyses for each time point displayed a 
significant difference in prefrontal activation for panic vs. neutral words for the two 
PD patients groups at baseline whereby the patients showed less prefrontal 
activation in response to panic than to neutral words (sham (panic vs. neutral): 
t20 = − 2.643, p = 0.016; verum (panic vs. neutral): t19 = − 2.126, p = 0.047), but 
not at post-iTBS. No difference was found for the control group (Fig. 3a) at either 
time point. 
Further post-hoc analyses of the changes of CBSI concentration over time (baseline 
vs. post-iTBS) in each group separately revealed a significant effect for the left PFC 
only in the verum group with a decrease in activation for neutral words (t19 = 2.220, 
p = 0.039) and an increase for panic-related words from baseline to post-iTBS 
(t19 = − 2.454, p = 0.024) (Fig. 3b). 
 
 
 Sham             Verum Controls  
RTs/ 
ERs 
 
 
   
Panic-related 
 
 
 
 
Baseline  772 (122)         800 (80)   
3.8 (0.8)           4.0 (1.0) 
 
808 (110)         812 (90) 
4.1 (1.4)           4.6 (1.7) 
 
765 (116) 
4.2 (1.5) 
 
800 (102) 
5.4 (1.6) 
 
Post-iTBS 
 
 neutral 
 
    
Baseline  771 (111)        799 (80) 
0.5 (0.8)          2.0 (1.6) 
 
769 (117) 
1.8 (1.4) 
Post-iTBS  802 (124)        813 (96) 
1.4 (1.0)          1.7 (1.5) 
790 (106) 
1.9 (1.7) 
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Comparing the three groups (verum, sham, controls) directly with each other, we 
further found a differentiation between the verum and the sham group for neutral 
words, whereby CBSI concentration was higher in the sham group (t39 = 2.208, 
p = 0.033). Concerning the right PFC, pairwise comparisons of activation for panic 
vs. neutral words showed no significant differences for any group at any 
measurement time. Similar to the results of the left PFC, there was a significant 
change from baseline to post-iTBS in the verum group, where the direction of 
change was the same as for the left PFC (increased activation for panic-related 
words: t19 = − 3.062, p = 0.006, decreased activation for neutral words: 
t19 = 2.204, p = 0.040) (Fig. 3b). 
Pairwise group comparisons showed significant differences in activation patterns only 
for post-iTBS with less activation for panic-related words (t39 = − 2.052, p = 0.047) 
and more activation for neutral words (t39 = 2.528, p = 0.016) in the control group 
compared to the verum group. The same pattern emerged when contrasting the 
sham and verum group: verum-stimulated patients showed more activation for 
panic-related words (t39 = − 2.054, p = 0.047) and less activation for neutral words 
(t39 = 2.420, p = 0.020). There were no significant differences in CBSI 
concentration levels between sham and control group for either panic-related or 
neutral words at any measuring time. 
Regarding the RM-ANOVA for the temporal control region, no significant effects were 
observed. 
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Figure 3 
 
Figure 3a: Contrast maps panic-related words vs. neutral words for each group.  
Figure 3a depicts differential CBSI concentration levels contrasted between the two conditions (panic-
related words vs. neutral words) by means of t-values for each channel. (Intended for colour 
reproduction) 
Fig. 3b: Contrast maps iTBS-related activation changes.  
Figure 3b illustrates the changes in CBSI concentration levels from baseline to post-iTBSin the two 
patients groups by means of t-values for each channel, whereby positive values indicate an increase 
and negative a decrease in activation.   
 
2.2.4.4 Clinical data  
For the total scores (PAS-total, HAM-A total, CAQ-total), 2 × 3 RM-ANOVAs revealed 
significant main effects for the factors time and group, as well as a significant 
time × group interaction (all p ≤ 0.001). For both time points (baseline and post-
iTBS), patients (verum and sham group) scored significantly higher on the clinical 
ratings than healthy controls. Post-hoc analyses further showed that patients' scores 
(verum and sham) on HAM-A-total, observer- and self-rated PAS-total and CAQ-total 
decreased significantly from baseline to post-iTBS. However, no significant 
differences between the verum and sham group were found (please refer to 
Deppermann et al., 2014). 
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For the entire group of patients (verum and sham), scores of all subscales decreased 
significantly from baseline to follow-up 2 after 6 months, as shown in a significant 
main effect of the factor time (all p < 0.05, for further details please refer to the 
supplementary material). However, there were no significant differences between the 
sham and verum group. Additionally, a significant interaction of time and iTBS group 
was found for self-rated agoraphobic avoidance (Table 3). Post-hoc analyses 
revealed, under sham iTBS, a significant decrease from baseline to post-CBT, follow-
up 1 and follow-up 2, but a significant increase of agoraphobic symptoms from 
follow-up 1 to follow-up 2. Verum iTBS resulted in significantly reduced self-rated 
avoidance behaviour for the comparisons baseline vs. post-CBT, vs. follow-up 1 and 
vs. follow-up 2. Also, agoraphobic symptoms declined significantly from post-iTBS to 
follow-up 1 and follow-up 2 (Table 3). 
For the remaining subscales, no significant interactions of time and iTBS group were 
found.
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Table 3. Clinical course of agoraphobic avoidance behaviour from baseline to follow-up 2. 
  
 
 
 
Measuremen
t time 
Verum  
(n= 22) 
Sham 
(n=22) 
Fdf, p Post hoc 
tests 
 
 
 
  
Mean (SD) Mean (SD) time 
 
time x group 
 
 patient group - total verum group sham group 
   
PAS (OR) 
Agoraphobic     
avoidance  
Baseline 1.91 (1.22) 1.39 (1.19) F6,252 = 7.91, < 0.001 
 
ns. 
 Baseline    >   post- iTBS * 
                       post-CBT***,  
                       follow-up1*** 
                       follow-up2*** 
 
post- iTBS >   post-CBT* 
                        follow-up 1*** 
                        follow-up 2** 
 
follow-up 1  =  follow–up 2 
 
 
 
 
 
 
 
 
 
iTBS-7 1.35 (1.14) 0.96 (1.04) 
iTBS-14 1.14 (1.23) 1.00 (1.03) 
post-iTBS 1.20 (1.08) 1.20 (1.24) 
post-CBT 0.85 (1.04) 0.82 (0.99) 
Follow- up 1 0.50 (0.77) 0.88 (0.93) 
Follow-up 2 0.77 (0.92) 0.80 (1.10) 
   
PAS (SR) 
Agoraphobic     
avoidance 
Baseline 2.03 (1.02) 1.80 (1.10) F4, 179 = 9.6, < 0.001 
 
F4,179 = 3.39, = 0.009 
  Baseline    >    post-CBT* 
                        follow-
up1*** 
                        follow-up2** 
 
post- iTBS =    post CBT 
post- iTBS >   follow-up 1** 
                        follow-up 2* 
follow-up 1  =  follow–up 2 
 
Baseline    >    post-CBT** 
                        follow-
up1*** 
                        follow-up2* 
 
post- iTBS =   post-CBT 
                        follow-up 1 
                        follow-up 2 
follow-up 1  <   follow–up 2* 
 
iTBS -7 2.22 (1.01) 1.21 (0.91) 
iTBS -14 1.97 (0.87) 1.58 (1.04) 
post- iTBS 1.74 (0.70) 1.50 (1.14) 
post-CBT 1.54 (0.82) 1.11 (0.98) 
Follow- up 1 1.18 (0.91) 1.08 (0.86) 
Follow-up 2 1.29 (0.89) 1.35 (0.80) 
*, significant at a significance level of p ≤ 0.05; **, significant at a significance level of p ≤ 0.01; ***, significant at a significance level of p ≤ 0.001; CBT, cognitive behavioural therapy; df, degrees of 
freedom;  F, F-value; ns.; iTBS, intermittent Theta Burst Stimulation; not significant; OR, observer-rated; p, p-value; PAS, Panic and Agoraphobia Scale; SD, standard deviation; SR, self-rated; Only 
significant ANOVA-results are depicted. P-values of ANOVA are Bonferroni-Holm corrected according to the topics described in the methods section.  
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2.2.4.5 Correlation of fNIRS patterns and clinical data   
Considering changes over time (post-iTBS - baseline), no significant correlations were 
discerned for the verum or sham group. 
 
2.2.5 Discussion 
In this randomised, sham-controlled iTBS study, we set out to investigate via fNIRS 
whether (a) we could confirm prefrontal hypoactivation in PD patients (as compared 
to healthy controls) during an emotional regulation task (Emotional Stroop), and if 
(b) this hypoactivation could be normalised over a course of 15 sessions of iTBS over 
the left dorsolateral PFC as an add-on treatment to state-of-the-art CBT. Additionally, 
we assessed the impact of iTBS on clinical symptoms and evaluated whether changes 
in functional activation (as assessed via fNIRS) correlated with clinical change. 
As expected, a significant left lateral prefrontal hypoactivation in response to panic-
related, as compared to neutral, words could be detected in both patient groups, but 
not in the control group prior to the beginning of treatment. The effect was restricted 
to the left PFC. Hence, we were able to confirm a left-lateralized reduced prefrontal 
response to fear-related, compared to neutral, stimuli in PD patients which did not 
occur in healthy controls. 
Over the course of the combined iTBS and CBT intervention, this baseline prefrontal 
hypoactivation of the left PFC disappeared for both the sham and the verum group, 
pointing to a general, beneficial effect of CBT which is in line with previous studies 
investigating the neurobiological effects of CBT (Clark and Beck, 2010). It further 
speaks in favour of the assumption that one mode of action of CBT is the 
modification of cognitive processes which are again related to prefrontal activation 
(Clark and Beck, 2010). Further, when comparing changes in CBSI concentration 
over the course of add-on iTBS, significant alterations were only found for the verum 
group, whereby prefrontal activation decreased for neutral words and increased for 
panic-related words. These results are in line with our assumption that iTBS can 
enhance prefrontal activity with respect to fear-relevant stimuli. Interestingly, these 
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treatment effects were not only found for the left hemisphere, where the stimulation 
occurred, but also for the right PFC. Previous studies (e.g., Ilmoniemi et al., 1997) 
have also reported that rTMS may cause activation changes not only in the 
ipsilateral, but also the contralateral hemispheres. In contrast, the sham and control 
group did not show significant activation changes over time. 
To rule out that the iTBS-effect for the verum group merely represented a more 
general measurement effect without task specificity, we tested the temporal fNIRS 
channels for similar alterations in CBSI concentration. However, no significant 
activation changes were revealed for this cortical non-ROI, supporting an 
interpretation in terms of iTBS-induced prefrontal activation changes to fear-related 
stimuli. Interestingly, this conclusion, in terms of a fear-specific modulation of 
prefrontal activation patterns via iTBS, is also supported by the results of our 
cognitive paradigm we assessed within the same study. Here we observed general 
prefrontal hypoactivation which was, however, not affected by iTBS application 
(Deppermann et al., 2014). 
While we found significant clinical improvement on all questionnaires, we could not 
find a general therapy-enhancing effect of iTBS in the verum group. Specifically, for 
the verum and sham groups, we found a significant improvement of clinical 
symptoms from the beginning of treatment interventions to the end of iTBS 
treatment. Also, during the complete time course of CBT, symptom severity 
measured on clinical total- and subscales further improved significantly. For the total 
scores of the clinical ratings, differences between the sham and verum group could 
not be found, neither after iTBS treatment nor at the end of CBT. However, the 
reduction of self-rated agoraphobic avoidance was more stable over time in the 
verum group. Notably, agoraphobic avoidance in the verum group decreased with 
some temporal delay after the last iTBS session. This might be due to the general 
effect of CBT including the exposure session. However, delayed onset of action has 
also been reported for rTMS for major depression (Schutter, 2009) and might thus be 
a characteristic of rTMS treatment. More studies with adequate follow-up 
assessments are needed to clarify this matter. The lack of a general therapy-
enhancing effect of iTBS add-on treatment might be a ceiling effect. Alternatively, 
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the timing of iTBS relative to CBT might have been suboptimal. We delivered iTBS 
during the first three weeks of CBT, which were dedicated to psychoeducation about 
PD. In contrast, the active parts of CBT (i.e., exposure sessions) took place after the 
administration of iTBS. iTBS might have a stronger clinical effect if administered at 
the same time as the emotional learning, considered central to CBT (Craske et al., 
2014), is actually taking place. 
Looking at correlations between CBSI concentrations and clinical data, we could not 
find an association between treatment efficacy and changes in prefrontal activation 
patterns. 
All participants committed more errors for panic-related than for neutral words, 
indicating that the Stroop paradigm did induce emotional interference as intended, in 
line with Dresler et al. (2012). The fact that all participants showed this effect may 
be due to the panic-related words (e.g. death) being associated with negative 
emotions not only in patients but also in the control group. In fact, an Emotional 
Stroop effect for negative words has been reported for healthy subjects (e.g. Bar-
Haim et al., 2007). Surprisingly, sham-stimulated patients generally committed the 
fewest errors, whereas no differences between the verum-stimulated patients and 
the control group could be found. This finding is hard to interpret, but it should be 
kept in mind that the behavioural data were only analysed for a smaller subsample, 
possibly causing some effects that are not representative for the whole sample. 
Generally, more errors were committed at the second measurement time 
accompanied with an increase in RTs pointing to a motivational decrease. The 
missing differences in RTs between controls and PD patients might also be due to 
the relatively small subsample. Another explanation, given by De Cort et al. (2008), 
might be that external stressors like the experimental set-up (which may also 
increase the general stress level in the control group) can explain a missing Stroop 
effect. 
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2.2.6 Limitations 
Some considerations and limitations of this study should be discussed. As in the 
majority of clinical rTMS studies, the insufficient blinding certainly represents a 
limitation. However, only patients who received verum iTBS showed an increase of 
panic-specific cortical activation not only in the left, but also in the right, PFC. This 
could indicate a more pronounced, broader cortical activation, specifically induced by 
verum iTBS. For future studies, sham coils evoking scalp muscle stimulations should 
be used (e.g., Mennemeier et al., 2010). It should further be considered that other 
factors, like state-dependent neural baseline activity, might also have influenced iTBS 
effects. 
For future iTBS studies, it might be interesting to investigate its potential therapeutic 
add-on effects by systematically manipulating the activation of fear-relevant 
networks preceding iTBS application, and the timing of iTBS relative to the phase and 
contents of concurrent CBT. In this context, an especially interesting attempt might 
be the application of iTBS in order to enhance extinction learning. In fact, Guhn et al. 
(2014) could show that activating rTMS over the medial PFC improved the extinction 
of a previously conditioned fear reaction in a group of healthy adults. Regarding 
clinical populations, not much research exist until now. Marin et al. (2014) discusses 
two studies (Osuch et al., 2009; Boggio et al., 2010) were rTMS was successfully 
applied for improved extinction processes in groups of patients suffering from post-
traumatic stress disorder. However, the authors also emphasise that further 
systematic studies are needed before establishing rTMS as an add-on tool in clinical 
applications. At last it might have been interesting to perform an additional fNIRS 
measurement after the completion of CBT and not just after the first weeks when 
additional iTBS application took place. This way it would have been possible to 
further analyse the duration of iTBS effects on the one hand but also the general 
effects of CBT on a neurobiological level in more detail. 
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2.2.7 Conclusion 
We were able to demonstrate prefrontal hypoactivity for panic-related stimuli in PD 
patients, which could be normalised by add-on iTBS. Clinical ratings significantly 
improved during iTBS/CBT. No significant differences were found between verum and 
sham iTBS, except for a more stable reduction of agoraphobic avoidance in the 
verum group. Thus, the therapeutic potential of a combination of iTBS and CBT 
requires further investigation in future studies that systematically manipulate the 
mental activity (e.g., fear-network activation) of patients during iTBS, as well as the 
timing of iTBS relative to CBT contents. 
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3. Study 2: Clinical and neurobiological effects of fNIRS-controlled 
transcranial magnetic stimulation (rTMS) in patients with spider phobia 
3.1 Manuscript 1: Psychophysiological effects of an rTMS modulated virtual 
reality challenge including participants with spider phobia 
 
The contents of this chapter are published in: 
Notzon, S.*, Deppermann, S*., Fallgatter, A., Diemer, J., Kroczek, A., Domschke, K., 
Zwanzger, P. & Ehlis, A.-C. (2015). Psychophysiological effects of an iTBS modulated 
virtual reality challenge including participants with spider phobia. Biological 
psychology, 112, 66-76. 
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3.1.1 Abstract 
Preliminary evidence suggests beneficial effects of transcranial magnetic stimulation 
(TMS) on anxiety. The objective of this study was to investigate the effects of 
intermittent theta burst stimulation (iTBS) as a form of TMS on acute anxiety 
provoked by a virtual reality (VR) scenario. 
Participants with spider phobia (n = 41) and healthy controls (n = 42) were exposed 
to a spider scenario in VR after one session of iTBS over the prefrontal cortex or 
sham treatment. 
Participants with spider phobia reacted with more anxiety compared to healthy 
controls. Their heart rate and skin conductance increased compared to baseline. 
Contrary to expectations, iTBS did not influence these reactions, but modulated heart 
rate variability (HRV). Sympathetic influence on HRV showed an increase in the 
active iTBS group only. This study does not support the idea of beneficial effects of a 
single session of iTBS on anxiety, although other protocols or repeated sessions 
might be effective. 
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3.1.2 Introduction 
Converging evidence from many studies suggests that raised activity of the amygdala 
plays a key role in the development of fear and anxiety. According to this model, 
pathological anxiety is the result of inadequate amygdala activation to non-
threatening stimuli. Since the prefrontal cortex (PFC) has an inhibitory effect on the 
amygdala, this hyperactivity is attributed to a dysfunction of the PFC which results in 
an insufficient suppression of the amygdala (Eden et al., 2015; Etkin & Wager, 2007; 
Hariri, Mattay, Tessitore, Fera, & Weinberger, 2003). For example, Nishimura et al. 
(2007) reported hypoactivation of the left PFC in patients with panic disorder. 
Regarding spider phobia, Johanson, Risberg, Tucker, & Gustafson (2006) found an 
increase in bilateral prefrontal cerebral blood flow in initially strongly anxious patients 
with spider phobia after successful cognitive psychotherapy. Within the PFC the 
dorsolateral prefrontal cortex (DLPFC) has been shown to play a role in the 
processing of information with emotional content (Dolcos, LaBar, & Cabeza, 2004; 
Meyer-Lindenberg et al., 2005). However, other regions within the PFC like the 
dorsomedial prefrontal cortex may play an equally or even more important role in the 
interaction with the amygdala regarding anxiety (Robinson, Charney, Overstreet, 
Vytal, & Grillon, 2012; Robinson et al., 2014). 
Such a model of a dysbalance regarding the interaction of PFC and amygdala 
constitutes the use of transcranial magnetic stimulation (TMS) to modulate cortical 
activity non-invasively and thus influences the function of the PFC (Diemer et al., 
2010; Pallanti & Bernardi, 2009). Despite a paucity of evidence at a neural network-
level for the capability of prefrontal cortical TMS to influence the activity of the 
amygdala, TMS has been investigated in a repetitive form (rTMS) as a potential 
therapeutic intervention in depression (Herwig et al., 2007; Padberg et al., 1999; 
Pallanti & Bernardi, 2009; Plewnia et al., 2014) and panic disorder (see section 2; 
Dresler et al., 2009; Zwanzger et al., 2009; Zwanzger et al., 2002) aiming at an 
increase of PFC function. Intermittent theta burst stimulation (iTBS) is a more 
intense, innovative form of TMS that comprises the repeated application of bursts of 
stimuli and facilitates excitation in cortical circuits (Huang et al., 2005). In addition to 
the above described model of prefrontal top-down control, the “valence hypothesis” 
is another neurobiological model which has often been used to explain the 
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pathogenesis of anxiety disorders and depression (Vennewald et al., 2013). 
Accordingly, approach related emotions are rather modulated in the left hemisphere, 
while avoidance related emotions are rather modulated in the right hemisphere. In 
line with this idea, the most widely studied forms of TMS in major depression and 
anxiety disorders are low frequency rTMS over the right DLPFC and high frequency 
rTMS over the left DLPFC (Lefaucheur et al., 2014). At least in the context of major 
depression, a review by Chen et al. (2013) came to the conclusion that both 
stimulation protocols are equally effective. Since other interventions (e.g., 
antidepressant medication) have been demonstrated to be effective in both 
psychiatric disorders, its successful use in the treatment of depression makes TMS a 
promising therapeutic option in anxiety disorders. As there is not enough evidence 
which suggests to favor one over the other stimulation technique (Lefaucheur et al., 
2014), we decided to investigate iTBS over the left DLPFC which is comparable to 
high frequency rTMS (Huang et al., 2005), since this suits the model of prefrontal 
top–down control as well as the “valence hypothesis”. However, it should be kept in 
mind that these hypotheses simplify both, the underlying neural network as well as 
the mode of action of TMS, which are not fully understood yet and are for sure more 
complex and involve more brain regions than just the PFC and amygdala. For 
example, Chervyakov, Chernyavsky, Sinitsyn, & Piradov (2015) reviewed the 
literature about putative and established mechanisms explaining the therapeutic 
effects of TMS. They point out that TMS does not just induce the transmission of 
electrical signals to neurons, but also affects neurotransmitters, gene expression, the 
activity of certain enzymes, cerebral blood flow and many other processes within the 
brain. 
The present study investigated the effect of iTBS on acute anxiety. As a model, 
specific spider phobia was chosen because the disorder is very common (Fredrikson, 
Annas, Fischer, & Wik, 1996) and anxiety can be triggered easily by presentation of 
spiders. For a standardized presentation we chose virtual reality (VR), a technology 
that permits a very realistic presentation of virtual spiders in three-dimensional 
scenarios by means of a head-mounted display. VR scenarios are appropriate not 
only to provoke subjective anxiety, but also psychophysiological changes. A review 
by Diemer et al. (2014) compared thirty-eight studies on psychophysiological effects 
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of VR in patients with anxiety disorders as well as healthy participants with and 
without increased trait anxiety. They found that challenging situations in VR are 
capable of altering skin conductance levels (SCL) in patients with anxiety disorders as 
well as in healthy controls. Results for heart rate (HR) are inconclusive. 
Since patients experience an increase of SCL and often also HR in a VR exposure 
scenario, it is important to further investigate whether these parameters decrease 
with habituation to the scenario, and how long this takes. Only few studies have so 
far addressed these questions. Patients with fear of flying, for example, have shown 
reductions in HR and SCL response to virtual flight environments after repeated 
exposures (Mühlberger et al., 2001). Heart rate variability (HRV) is another 
parameter of psychophysiological arousal that provides information about influences 
of the autonomous nervous system on the heart. Two important sub-measures of 
HRV are LF, the low frequency component, mediated by the sympathetic as well as 
parasympathetic nervous system, and HF, mediated mainly by the parasympathetic 
nervous system. High LF as well as low HF point to more sympathetic and less 
parasympathetic influence, while low LF and high HF are associated with less 
sympathetic and more parasympathetic influence (Berntson et al., 1997). HRV has 
rarely been studied in the context of TMS. To the best of our knowledge, there is 
only one study on the long term effect of rTMS over the prefrontal cortex that 
measured HRV. Udupa et al. observed a decrease in LF/HF ratio in 30 patients with 
major depression after 12 sessions of high-frequency (15 Hz) rTMS over the left 
prefrontal cortex (Udupa et al., 2007; Udupa et al., 2011). As for immediate effects, 
there have only been studies on regions other than the DLPFC, e.g., Yoshida et al. 
(2001) found significantly elevated LF as well as HF after low frequency (0.2 Hz) 
rTMS over the vertex. In contrast to them, Vernieri et al. (2014) found a decrease of 
LF/HF ratio after low frequency (1 Hz) rTMS over the primary motor cortex. 
Closely related to emotions like anxiety and parameters of psychophysiological 
arousal like HR, SCL and HRV is the feeling of presence in virtual reality. Presence is 
defined as the impression of really being there in a certain environment, even if it is 
virtual (Slater, 1999). Strong emotions and arousal have repeatedly been shown to 
be associated with an increased feeling of presence (Diemer, Alpers, Peperkorn, 
Shiban, & Mühlberger, 2015). 
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In the present bicentric study, iTBS was combined with a VR challenge to provoke 
anxiety in participants with spider phobia in a single-blind, sham-controlled parallel 
group design. The aim of the study was to investigate the effect of iTBS on acute 
anxiety in spider phobia and the psychophysiological changes that go along with it. 
The following hypotheses were tested. (1) Watching a virtual spider scene provokes 
anxiety and disgust as well as the activation of the sympathetic nervous system as 
indicated by an increase of HR and SCL and, regarding HRV, an increase of the LF 
component accompanied by a decrease of the HF component in participants with 
spider phobia. (2) These emotional as well as psychophysiological reactions are less 
pronounced in healthy control participants. (3) ITBS attenuates the increase of 
anxiety, disgust, HR, SCL as well as the increase of the LF component and the 
respective decrease of the HF component in participants with spider phobia 
stimulated actively, but not in the sham group. (4) Participants with spider phobia 
display a stronger feeling of presence during virtual reality compared to healthy 
control participants. 
 
 
3.1.3 Material and methods 
3.1.3.1 Participants 
Participants with spider phobia and healthy controls were recruited via local 
advertisements. They had to be between 18 and 65 years of age. Participants with 
spider phobia had to fulfill DSM-IV-TR (American Psychiatric Association, 1995) 
diagnostic criteria of specific phobia for spiders (but did not necessarily need to be 
extremely restricted in their daily routine by their fear). Healthy participants were 
required to have no fear of spiders at all. Participants further filled in the German 
version of the spider phobia questionnaire (SPQ; Klorman, Weerts, Hastings, 
Melamed, & Lang, 1974; Watts & Sharrock, 1984) for screening, and were only 
included if they obtained 16 or more (participants with phobia), or 7 or less (healthy 
participants), of 31 possible points. If participants failed to fill in the SPQ during 
screening, the SPQ filled in at the beginning of the study (t0) was used for the 
decision instead. Exclusion criteria for all participants were pregnancy, severe 
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somatic disorders and current or previous psychiatric disorders other than specific 
phobia, intake of psychiatric or psychotropic medication and TMS contraindications 
(e.g., ferromagnetic implants). Diagnosis and comorbidity were assessed with the 
relevant section of the SCID interview (specific phobia)(First et al., 1995) and the 
M.I.N.I. (Sheehan et al., 1998) by a licensed psychologist or a medical doctor 
experienced in psychiatry. The study was approved by the local ethics committees of 
the Universities of Muenster and Tuebingen. Procedures were in accordance with the 
latest version of the Declaration of Helsinki. Written informed consent was obtained 
from all participants after detailed study description. 
 
 
3.1.3.2 Design 
A single-blind, randomized, sham-controlled parallel-group trial was conducted to 
test the clinical and neurobiological effects of iTBS in 41 subjects with spider phobia 
and 42 healthy participants during a virtual reality challenge. Participants in both 
groups were randomized either to active iTBS or to sham stimulation, resulting in 
four groups, the phobic actively stimulated group, the phobic sham-stimulated group, 
the healthy control actively stimulated group and the healthy control sham-
stimulated group (see Figure 1). 
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Figure 1 
 
Study design. Abbreviations: t0 and t1: measurement time points 
 
Subjects visited the study center once. Before this visit, a telephone screening was 
conducted. In addition to the procedures reported here, in the beginning and in the 
end of the study a functional near-infrared spectroscopy (fNIRS) measurement was 
conducted during performance of an emotional Stroop task, the results of which are 
reported elsewhere. 
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3.1.3.3 Sample size calculation 
Sample size was calculated with G*Power, provided freely by the University of 
Duesseldorf (www.gpower.hhu.de). In an earlier study investigating an acute 
intervention for participants with spider phobia exposed to the same VR scenario an 
effect size of 2.6 (Cohen’s d) was observed (Diemer et al., 2013). Acting on the 
assumption of a somewhat lower d of 1.5, a sample size of at least 13 per group 
would have been necessary. We decided to have at least 19 in each group. 
 
 
3.1.3.4 Self-report measures 
Participants filled in the fear of spiders questionnaire (FSQ; Rinck et al., 2002; 
Szymanski & O'Donohue, 1995) and the spider phobia questionnaire (SPQ). 
The questionnaires were administered at baseline and immediately after the second 
fNIRS measurement. At the latter assessment, subjects were instructed to rate 
symptoms retrospectively for the most aversive moment during the VR challenge. As 
for trait measures, we employed the anxiety sensitivity index (ASI; Reiss, Peterson, 
Gursky, & McNally, 1986), and the questionnaire for the assessment of disgust 
sensitivity (disgust scale: DS; Haidt, McCauley, & Rozin, 1994; Schienle, Walter, 
Stark, & Vaitl, 2002) at baseline only. 
During VR, subjective units of discomfort scale (SUDS) for anxiety and disgust on a 
scale from 0 to 100, with 100 indicating maximum fear or maximum disgust, had to 
be reported orally 60 s and 180 s after the beginning of the respective scene 
(baseline scene and spider scene). 
At the end, participants additionally filled in the Igroup Presence Questionnaire (IPQ; 
Schubert, Friedmann, & Regenbrecht, 2001). It consists of three subscales: namely 
Spatial Presence, the perception of the virtual space as a real space, Involvement, 
the level of attention towards the virtual reality, and Experienced Realism, the 
judgment, if virtual reality resembles the real world. 
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3.1.3.5 Electrophysiological measures 
Electrodes for heart rate (HR) measurement (Red Dot®, 3 M) were positioned on the 
upper part of the body. Two electrodes (sintered Ag/AgCl electrodes) for skin 
conductance (electrodermal activity, EDA) measurement were placed on the thenar 
and hypothenar of the non-dominant hand. During VR, physiological measures (HR 
and EDA) were continuously monitored, using V-Amp 16 (BrainProducts, Gilching, 
Germany), and BrainVision Recorder Software (V-Amp Edition 1.10, Brain Products 
GmbH, Gilching, Germany). 
 
 
3.1.3.6 iTBS 
A single session of intermittent theta burst stimulation (iTBS) (described in greater 
detail by Huang et al., 2005) was conducted directly before the VR challenge. 
According to this protocol, a total of 600 pulses were applied in intermittent biphasic 
bursts at a frequency of 15 pulses per second via 2 s trains, starting every 10 s, 
resulting in a stimulation period of about three minutes. Stimulation site was F3 (left 
DLPFC) according to the international 10–20 system for electrode placement (Herwig 
et al., 2003). During verum stimulation, the coil was positioned tangentially to the 
scalp forming a 45° angle to the mid-sagittal line of the head with the handle 
pointing into a posterior direction. For sham stimulation, it was rotated by 90°, so 
the stimulation face was no longer in contact with the scalp. Although small effects 
on brain activity cannot be excluded by this method, it induces such effects to a 
lesser extent than other comparable methods and is therefore used routinely for 
sham stimulation (Lisanby, Gutman, Luber, Schroeder, & Sackeim, 2001). To take 
into account individual differences in cortical excitability, the participants’ resting 
motor threshold was determined and the stimulation was conducted at 80% of that 
threshold. 
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3.1.3.7 Virtual reality challenge 
The VR environment (created with Source Engine, Valve Corporation, Bellevue, 
Washington, USA) was presented monoscopically using a Z800 3D Visor head-
mounted display (800 × 600 pixels, eMagin, Bellevue, Washington, USA), thereby 
generating the impression of a 3D environment. Head movements were assessed 
using the Patriot electromagnetic tracking device (Polhemus Corporation, Colchester, 
Vermont, USA). The simulation was controlled by the CyberSession software built at 
the Psychological Department of the University of Wuerzburg 
(www.cybersession.info). The VR challenge consisted of two scenes, each of which 
lasted for 180 s. A laboratory room was used as a neutral practice scene to allow 
familiarization with the virtual environment. Afterwards, this scene was shown again 
for baseline measurements of HR and SCL. In the following spider scene, participants 
saw three giant spiders crawling around the same laboratory room (Diemer et al., 
2013). 
 
 
3.1.3.8. Preprocessing of electrophysiological data 
HR and SCL were preprocessed with BrainVision Analyzer Software 2.0 (Brain 
Products GmbH, Gilching, Germany). HR and SCL were analyzed after excluding 
speaking time for subjective ratings of anxiety and disgust. As a result, we analyzed 
two segments out of each scene (baseline scene and spider scene): the first 50 s (0–
50 s, beginning of the scene) and the interval between 90 and 150 s (end of the 
scene). Mean HR (beats per minute) and mean skin conductance levels (per minute; 
SCL; µS) during the scenes were calculated for these segments. For analysis of mean 
HR low pass filter (high cut off frequency at 30 Hz) and high pass filter (low cut off 
frequency at 1.5915 Hz) were used. No filters were used for the analysis of mean 
SCL (Diemer et al., 2013). Data were screened for artefacts by visual examination 
which led to exclusion of the data from all participants recruited at the site of 
Muenster for further analysis of SCL. For HR as well as SCL, a few participants had to 
be excluded due to recording errors or bad data quality (see chapter “missing 
values”). For HRV, the first two and a half minutes of baseline and the first two and a 
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half minutes of the spider scene were analyzed without excluding speaking time, 
since segments would have been too short for a meaningful analysis of HRV 
otherwise. For calculation of parameters of HRV, Kubios HRV analysis software 
(Tarvainen, Niskanen, Lipponen, Ranta-Aho, & Karjalainen, 2014) was used. The 
HRV parameters LF (mediated by the sympathetic and the parasympathetic nervous 
system) and HF (mediated mainly by the parasympathetic nervous system) were 
calculated by the software according to the frequency-domain method Welch’s 
periodogram, whereby a spectrum estimate is calculated for the ECG interbeat 
intervals (described in greater detail by Tarvainen et al., 2014). Normalized units of 
LF and HF were defined according to Burr (2007) as the ratio of each component and 
total power of the individual participant (HFnu = HF/(HF + LF); 
LFnu = LF/(HF + LF)). Normalized units for LF and HF were used since normalized 
units are adjusted for the often large interindividual differences (see cf. Malik et al., 
1996). 
 
 
3.1.3.9 Statistical analyses 
Statistical analyses were calculated with IBM SPSS Statistics 22. Participants were 
excluded from analysis of a questionnaire if they had left out more than two items. If 
participants had omitted one or two items, these were replaced by the mean of the 
respective (sub)scale. To sample characteristics, age and years of education, 
questionnaire data for t0 and t1, scores of ASI, DS and IPQ were compared directly 
via analysis of variance (ANOVA) with study group (participants with spider phobia 
vs. healthy controls) and treatment group (active iTBS vs. sham treatment) as 
between-subjects factors. X2-tests (gender, handedness and first language) were 
conducted in order to ensure that there was no significant difference between 
participants with spider phobia and healthy controls or the participants randomized 
to either sham or verum iTBS. 
The effectiveness of blinding regarding treatment condition was evaluated using 
binomial tests (test proportion: 0.5) for the subjectively perceived condition, 
separately in each group of participants. 
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Mixed-design analysis of variance (ANOVA) of the scores of SPQ and FSQ was 
conducted with study group and treatment group as between-subjects factors and 
time (t0 and t1) as within-subjects factor. To avoid α-error accumulation due to 
multiple testing, the significance level of α = 0.05 was adjusted using a Bonferroni 
correction procedure for this analysis resulting in a level of α = 0.025 (0.05/2). 
Mixed-design ANOVA was also conducted for SUDS, SCL and HR with study group 
and treatment group as between-subjects factors and scenario (baseline and spider 
scene) as well as duration (beginning of the scene and end of the scene) as within-
subjects factors. For the HRV sub-measures LF and HF, a mixed-design ANOVA was 
conducted in almost the same manner, but without the factor duration. If significant 
three-way-interactions occurred, post-hoc-ANOVAs were conducted for groups 
separately. Two-tailed t-tests were used to further explore main effects and two-
way-interactions. 
Since not all scores were distributed normally according to Kolmogorov–Smirnov 
tests, Mann–Whitney-U-test or Wilcoxon-test as non-parametric tests were 
conducted post-hoc for all analyses which included scores not distributed normally. If 
results of non-parametric tests deviated from results of ANOVAs, these deviations are 
reported. As an additional post-hoc test for sub-measures of HRV, differences 
between spider scene and baseline were calculated for LF and HF and a univariate 
ANOVA with treatment group as between-subjects factor was conducted for these 
differences. 
 
 
3.1.3.10 Missing values 
SPQ and FSQ at t0 were available for 81 participants. SPQ at t1 was available for 81, 
FSQ for 82 participants. There were a relatively high amount of missing values (12) 
for the question of whether participants felt they were in the sham or verum iTBS 
condition. It is not clear why participants may have overlooked this question. SUDS 
were available for 80 participants. Heart rate data were available for the beginning of 
the spider scene for 80 participants and for 79 participants for all other time points 
during the scenes. LF and HF were available for 78 participants at baseline and for 
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79 participants during the spider scene. For analysis of mean skin conductance level 
(SCL) participants from the site of Muenster had to be excluded due to a technical 
problem. Measurements were available for 55 participants whereof 23 were 
participants with spider phobia (verum 12, sham 11) and 32 were healthy controls 
(verum 14, sham 18). The IPQ was available for 80 participants. 
 
 
3.1.4 Results 
3.1.4.1 Sample characteristics 
There were no differences in sociodemographic data (age, handedness, gender, first 
language and years of education) between the four groups except for significantly 
more left-handed participants in the actively stimulated iTBS compared to the sham 
group (see Table 1). As expected, SPQ and FSQ at baseline revealed significantly 
higher scores in participants with spider phobia than in healthy controls (see Table 
2). 
Table 1 
Study group 
 
Total 
(n=83) 
 
Partici-pants 
with spider 
phobia 
(n=41) 
Healthy 
controls 
(n=42) 
 
iTBS 
(n=40) 
 
 
Sham 
(n=43) 
 
Healthy 
controls vs. 
patients 
iTBS vs. 
Sham 
Age Mean 
(SD) 26.46 (8.47) 27.51 (9.45) 25.43 (7.37) 25.85 (7.65) 27.02 (9.23) 
F(1,79)=1.2
5, 
p=0.267 
F(1,79)=0.5
0, 
p=0.481 
Gender 9 male, 74 
female 
4 male, 37 
female 
5 male, 37 
female 
4 male, 36 
female 
35 male, 38 
female 
x
1
2
=0.10, 
p=0.753 
 
x
1
2
= 0.057, 
p=0.812 
 
Handed-ness 12 left, 71 right 
6 left, 35 
right 
6 left, 36 
right 
9 left, 31 
right 
3 left, 40 
right 
x
1
2
= 
0.002, 
p=0.964 
 
x
1
2
 = 4.04, 
p= 0.044* 
 
First Lan-
guage 
74 German, 
5 bilingual, 4 
other 
35 German, 
4 bilingual, 2 
other 
39 German, 
1 bilingual, 2 
other 
34 German, 
3 bilingual, 3 
other 
40 German, 
2 bilingual, 1 
other 
x
2
2
=2.00, 
p=0.367 
 
x
2
2
=1.58, 
p=0.454 
 
Years of 
edu-cation 
Mean (SD)a 
11.32 (3.68) 11.00 (2.90) 11.66 (3.34) 11.30 (3.91) 11.34 (3.51) F(1,78)=0.57, p=0.451 
F(1,78)=0.0
1, p=0.948 
Table 1. Sociodemographic Data. a = available for 82 participants only; *significant on the level p<0.05; SD = standard 
deviation; z = two-sided significance according to Fisher’s exact test. 
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Table 2  
 
Table 2. a = available for 81 participants only; *significant on the level p<0.05; **significant on the level p<0.01; 
***significant on the level p<0.001; SD = standard deviation 
 
Participants with spider phobia were significantly more sensitive than healthy controls 
to anxiety (according to ASI) as well as disgust (according to DS, see Table 2). 
 
 
3.1.4.2 Effectiveness of blinding 
Participants were asked to guess whether they had been treated with active or sham 
iTBS. The guesses did not differ significantly from chance for any of the four groups 
(results of binomial tests: participants with spider phobia active iTBS p = 1.00; 
participants with spider phobia sham p = 1.00; healthy control participants active 
iTBS p = 0.18; healthy control participants sham p = 0.52). In the total group 37 
answers were available for participants who had been sham-stimulated of which 21 
guessed this correctly and 16 assumed that they had received active iTBS. Of the 34 
actively stimulated participants that answered the question, 14 believed to have been 
sham-stimulated, while 20 stated to have received active iTBS. 
Study group 
Total 
(n=83) 
Partici-pants 
with spider 
phobia 
(n=41) 
Healthy 
controls 
(n=42) 
iTBS 
(n=40) 
Sham 
(n=43) 
Healthy controls 
vs. patients 
iTBS vs. 
Sham 
SPQa (SD) 
12.13 
(10.08) 21.81 (3.38) 2.68 (2.62) 
12.31 
(10.39) 
11.96 
(9.91) 
F(1,77)= 
804.13, 
p<0.001*** 
F(1,77)= 
0.271, 
p=0.604 
FSQa (SD) 38.18 (37.46) 
74.42 
(13.95) 2.83 (4.82) 
39.54 
(38.49) 
36.92 
(36.91) 
F(1,77)= 
940.39, 
p<0.001*** 
F(1,77)< 
0.001, 
p=0.997 
ASI (SD) 14.98 (7.95) 17.68 (8.56) 12.33 (6.35) 14.70 (7.62) 
15.23 
(8.32) 
F(1,79)= 
10.35, 
p=0.002** 
F(1,79)=0.2
65, p=0.608 
DS (SD) 77.32 (22.34) 
82.19 
(23.00) 
72.67 
(20.87) 
74.46 
(23.36) 
79.98 
(21.29) 
F(1,79)= 4.19, 
p=0.044* 
F(1,79)= 
1.61, 
p=0.208 
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3.1.4.3 Changes of spider phobia questionnaires over time 
Level of significance was adjusted from p = 0.05 to p = 0.025 (Bonferroni 
correction), because two spider phobia questionnaires were included in the analysis. 
Mean values of the SPQ did not change significantly over time (F(1,77) = 3.25, 
p = 0.075). For the FSQ, there were a significant main effect of time 
(F(1,77) = 8.55, p = 0.005) and an interaction of time and study group 
(F(1,77) = 7.46, p = 0.008) due to a decrease of the score from t0 to t1 in the 
spider phobic group, but not in the control group (phobic group t(39) = 3.01, 
p < 0.005; control group t(40) = 0.29, p = 0.774). There was a main effect of study 
group for both questionnaires (SPQ: F(1,77) = 922.32, p < 0.001; FSQ: 
F(1,77) = 762.07, p < 0.001) due to higher mean values in the spider phobic group 
compared to the control group. No differences occurred between the sham and the 
active iTBS group. 
 
 
3.1.4.4 SUDS  
Fig. 2(a and b) gives an overview over changes of anxiety and disgust over time. 
Significantly more anxiety and disgust were perceived by participants during spider 
scene than during baseline (main effect of scenario: anxiety F(1,76) = 133.53, 
p < 0.001; disgust F(1,76) = 272.22, p < 0.001). Mean anxiety and disgust were 
significantly stronger in the beginning compared to the end of spider scene (main 
effect of duration: anxiety F(1,76) = 7.83, p = 0.007; disgust F(1,76) = 5.20, 
p = 0.025; interaction of scenario and duration: anxiety F(1,76) = 14.15, p < 0.001; 
disgust F(1,76) = 5.97, p = 0.017). Overall, significantly more anxiety and disgust 
were reported by participants with spider phobia than by healthy controls (main 
effect of study group: anxiety F(1,76) = 133.05, p < 0.001; disgust 
F(1,76) = 163.34, p < 0.001). In participants with spider phobia anxiety and disgust 
increased more strongly from baseline to spider scene than in healthy control 
participants (significant interaction of scenario and study group: anxiety 
F(1,76) = 85.48, p < 0.001; disgust F(1,76) = 130.28, p < 0.001). Anxiety 
decreased significantly more strongly from the beginning to the end of spider scene 
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in the phobic group compared to the healthy control group (three-way-interaction of 
duration × scenario × study group F(1,76) = 4.73, p = 0.033). There was no 
significant main or interaction effect of iTBS on SUDS. 
 
Figure 2  
 
 (a) Anxiety during virtual reality. 1 = Beginning of baseline; 2 = end of baseline; 3 = beginning of 
spider scene; 4 = end of spider scene; * significant on the level p < 0.05; ** significant on the level 
p < 0.01; *** significant on the level p < 0.001. (b) Disgust during virtual reality. 1 = Beginning of 
baseline; 2 = end of baseline; 3 = beginning of spider scene; 4 = end of spider scene; * significant on 
the level p < 0.05; ** significant on the level p < 0.01; *** significant on the level p < 0.001. 
 
 
3.1.4.5 Heart rate 
Fig. 3 gives an overview about changes of HR over time. The phobic group only 
displayed a significantly higher heart rate during spider scene compared to baseline 
(main effect of scenario: F(1,74) = 24.71, p < 0.001; significant interaction of 
scenario and study group: F(1,74) = 20.46, p < 0.001). A significantly higher heart 
rate at the beginning of the spider scene and baseline compared to the end of the 
respective scene was also observed in participants with spider phobia only (main 
effect of duration: F(1,74) = 10.41, p = 0.002; significant interaction of duration and 
study group: F(1,74) = 22.08, p < 0.001). This decrease from the beginning to the 
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end of the scene was significantly more pronounced in the spider scene (three-way 
interaction scenario × duration × study group: F(1,74) = 4.91, p = 0.030). There 
was no significant main or interaction effect of iTBS on HR. 
 
Figure 3 
 
 Heart rate during virtual reality. 1 = Beginning of baseline; 2 = end of baseline; 3 = beginning of 
spider scene; 4 = end of spider scene; * significant on the level p < 0.05; ** significant on the level 
p < 0.01; *** significant on the level p < 0.001 
 
 
3.1.4.6. Heart rate variability 
Mixed-design ANOVAs revealed a significant interaction of scenario and treatment 
group (verum vs. sham) for HF and LF, displayed as normalized units (HF 
F(1,73) = 4.17, p = 0.045; LF F(1,73) = 4.96, p = 0.029). This was due to a 
significant increase of LF and a decrease of HF, thus an increase of sympathetic 
influence, in the active iTBS group only during the spider scene. Since data were not 
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distributed normally according to Kolmogorov–Smirnov tests, Wilcoxon tests were 
conducted which were only marginally significant (LF z = 1.88, p = 0.06; HF 
z = 1.88, p = 0.06). 
Differences between spider scene and baseline were calculated. ANOVA revealed a 
significant main effect of treatment group (iTBS vs. sham) for both differences 
(LFdiffF(1,73) = 5.23, p = 0.025; HFdiffF(1,73) = 4.67, p = 0.034; see Fig. 4). LFdiff 
and HFdiff were distributed normally according to Kolmogorov–Smirnov in the iTBS 
group. No main or interaction effect occurred according to study group. 
 
Figure 4 
 
 
Parameters of heart rate variability LF and HF during virtual reality. * Significant on the level p < 0.05. 
Error bars represent one standard error of the mean. 
 
 
3.1.4.7 Skin conductance 
Fig. 5 gives an overview about changes of SCL over time. Mean SCL was significantly 
higher during the spider scene than during baseline (main effect of scenario: 
F(1,51) = 27.93, p < 0.001). This increase was more pronounced in the phobic 
group compared to the control group (interaction of scenario and study group: 
F(1,51) = 5.17, p = 0.027). There was a higher SCL at the beginning compared to 
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the end of both scenes (main effect of duration: F(1,51) = 15.92, p < 0.001). No 
main or interaction effects occurred according to iTBS. 
 
Figure 5 
 
 
                                                                                 
 
 
 
 
 
 
 
 
 
            
Skin conductance level during virtual reality. 1 = Beginning of baseline; 2 = end of baseline; 
3 = beginning of spider scene; 4 = end of spider scene; * significant on the level p < 0.05; ** 
significant on the level p < 0.01; *** significant on the level p < 0.001. 
  
3.1.4.8. Presence 
There was a main effect of study group on presence. The experience of presence, 
measured by the IPQ, was significantly stronger in the phobic group (F(1,76) = 9.25, 
p = 0.003). This was due to the subscales Involvement (F(1,76) = 8.29, p = 0.005) 
and Experienced Realism (F(1,76) = 10.18, p = 0.002), while the subscale Spatial 
Presence showed no significant difference between groups (F(1,76) = 1.34, 
p = 0.250). 
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3.1.5 Discussion 
In accordance with our first hypothesis, the virtual reality (VR) spider challenge led 
to subjective anxiety and disgust as well as elevated heart rate (HR) and skin 
conductance level (SCL) in participants with spider phobia. However, there was no 
general change of heart rate variability (HRV) in terms of the LF and HF component 
in the phobic group during the challenge. Surprisingly, regarding fearfulness towards 
spiders, as measured by the fear of spiders questionnaire (FSQ), the phobic group 
scored significantly lower judging their feelings during virtual reality compared to the 
beginning of the study. In line with our second hypothesis, anxiety, disgust and 
elevated SCL were provoked to a lesser extent in healthy participants. Although not 
explicitly intended, anxiety, disgust, HR and SCL decreased from the beginning to the 
end of the spider scene in the whole group of participants. Contrary to our third 
hypothesis, we found no general effect of active intermittent theta burst stimulation 
(iTBS) on subjective anxiety, HR, and SCL. Interestingly; however, active iTBS 
significantly increased sympathetic activity (increase of LF and decrease of HF) 
during the spider scene. In accordance with our forth hypothesis, the experience of 
presence during VR was significantly stronger in participants with spider phobia than 
in healthy controls according to the subscales Involvement and Experienced Realism 
of the IPQ. 
In more detail, increases of anxiety and disgust were observed as expected and were 
hence in line with earlier studies on VR challenges in patients with specific phobia 
(e.g., Diemer et al., 2013; Muhlberger, Petrusek, Herrmann, & Pauli, 2005). The 
same holds true for increases of HR and SCL. In this study, HR differentiated better 
than SCL between participants with spider phobia and healthy controls, a result that 
has not been shown in other studies (e.g., Diemer et al., 2013) and might be due to 
the smaller number of participants that could be included in the analysis of SCL. 
However, the property of HR to differentiate accurately between participants with 
phobia and healthy controls during a VR challenge has been demonstrated before 
(Mühlberger, Bülthoff, Wiedemann, & Pauli, 2007). The decrease of the FSQ score 
was surprising to us, since participants were asked to rate their feelings towards 
spiders at the time during VR they felt the worst. A possible explanation might be 
that participants confused their feelings during and after the session. The latter time 
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might have been characterized by relief. This view is supported by the fact that 
anxiety and disgust strongly increased during the spider scene compared to baseline, 
while only the FSQ filled in with some latency after the challenge displayed a 
decrease. In any case, informative value of this decrease is limited, since the 
questionnaire was developed for the assessment of fear of spiders in general and not 
for short-term changes. 
Healthy participants reporting no fear of spiders in general and no or minimal anxiety 
or disgust during the spider scene nevertheless display psychophysiological arousal. 
While this remains an unanswered phenomenon, one possible explanation is that the 
arousal is caused by interest in the new situation, increased attention or elation, and 
not by fear. 
There was a decrease of anxiety and disgust as well as HR and SCL from the 
beginning to the end of the spider scene that can be interpreted as habituation. This 
is noteworthy, since participants were only exposed once, the duration of the session 
was relatively short (three minutes) and they had received no specific instruction 
before the challenge. However, it cannot be excluded that this decrease was caused 
by the knowledge of the participants that the end of the session was near, rather 
than by a real habituation effect. 
The increase of LF and decrease of HF displayed by the actively stimulated iTBS 
group during the spider scene is contrary to our expectation and to the best of our 
knowledge the first evidence for a short term effect of iTBS on HRV changes 
provoked by acute anxiety and disgust. If iTBS over the left PFC had the potential to 
attenuate arousal or anxiety, we would have expected decreased sympathetic and 
increased parasympathetic activity. This view is supported by results of Udupa et al. 
who reported just the opposite of our short term effect, namely a decrease of LF and 
an increase of HF succeeding long term repeated high-frequency rTMS over the left 
DLPFC (Udupa et al., 2007; Udupa et al., 2011). However, participants in this study 
were not exposed to a stressful situation or a stimulus that provoked anxiety and no 
theta burst stimulation was used. Effects of iTBS may depend on other factors 
influencing HRV at the same time and acute effects may differ from, or be even 
contrary to, long term effects. Though highly speculative, the iTBS induced increase 
of LF and decrease of HF could also be interpreted as increased attention towards, or 
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increased salience of, the presented stimuli. The latter was observed by Shahbabaie 
et al. (2014) after transcranial direct current stimulation over the left DLPFC in 
combination with exposure to a challenging situation, though the context of their 
study was a different one. 
Still, since reports on short-term effects of rTMS are up to now rather ambiguous 
(Vernieri et al., 2014; Yoshida et al., 2001), our study adds another piece of evidence 
to the complex picture of neurostimulation. Based on this, further research is 
necessary to better identify possible mechanisms by which TMS influences HRV and 
which parameters determine the direction of this influence. 
The significantly stronger experience of presence in participants with spider phobia is 
in accordance with earlier studies correlating presence with strong emotions as well 
as arousal (Diemer et al., 2015). Our results regarding the subscales of the IPQ 
suggest that this connection is not related to the experience of the virtual room as a 
real space (Spatial Presence), but to other aspects of presence (Involvement and 
Experienced Realism). To our knowledge, this is the first study that used the IPQ 
subscales in specific phobia. The results are partially in accordance with Price,  
Mehta, Tone, & Anderson (2011) who found a correlation of peak anxiety with 
Experienced Realism, but not with Involvement and Spatial Presence in patients with 
social phobia exposed to a virtual reality scenario. 
Finally, some limitations and considerations need to be mentioned. Firstly, iTBS was 
only applied once, which might not be enough to attenuate anxiety. Future research 
should therefore try to evaluate the effectiveness of repeated iTBS applications in 
anxiety disorders. Blinding was successful, which can be considered a strength of the 
study. Still, some participants complained about awkward sensations or even pain 
during active iTBS which might have influenced the perception of the subsequent VR, 
e.g., in a way that recipients of active iTBS felt more tensed or stressed and 
therefore also perceived VR to be more stressful. Baseline measurements of HR, HRV 
and SCL were recorded after iTBS only, which was due to the complexity of our 
design, but still limits the interpretation of iTBS effects on these parameters. Future 
studies therefore should focus on comparison of HR, HRV and SCL before and after 
iTBS. Questionnaires for the assessment of VR were not handed out immediately 
afterwards. Rather, participants attended the second functional near-infrared 
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spectroscopy first. It cannot be excluded that their evaluation of VR was changed by 
this interruption or that it became less precise due to the time delay. 
 
 
3.1.6 Conclusion 
Summarizing our results, VR is an effective method to provoke anxiety as well as 
disgust and psychophysiological arousal in participants with spider phobia. Compared 
to earlier VR studies showing these effects (cf.  Freire, De Carvalho, Joffily, Zin, & 
Nardi, 2010; Mühlberger et al., 2007; Wiederhold, Jang, Kim, & Wiederhold, 2002), 
our study comprised a larger sample and investigated changes of anxiety, disgust, 
HR and SCL over time thereby detecting an early decrease of these parameters, 
interpreted as a habituation effect. We conclude that VR in participants with spider 
phobia is a good model of acute anxiety that allows a differentiated investigation of 
this phenomenon. 
To our knowledge this is the first study probing iTBS in a model of acute anxiety. A 
single session of iTBS had no effect on the subjective and psychophysiological 
reactions provoked by VR. It cannot be decided whether more sessions would have 
been effective, or whether this TMS protocol is in general not appropriate to 
influence strong, acute anxiety. Future studies should also focus on other target 
regions and TMS protocols. Low frequency rTMS of the right DLPFC displayed 
anxiolytic properties in preclinical and clinical studies (Lefaucheur et al., 2014; 
Zwanzger et al., 2009).  Different forms of TMS targeting the medial prefrontal 
cortex have shown promising results in posttraumatic stress disorder (Isserles et al., 
2013), obsessive compulsive disorder (Modirrousta et al., 2015)and in modulating 
the processing of conditioned fear (Guhn et al., 2014). 
ITBS led to a sympathetic reaction towards the spider scene according to HRV. 
Future studies should therefore further examine the influence of different TMS 
protocols and stimulation sites on HRV. 
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Regarding presence, this study confirmed the link between presence and arousal. It 
provides preliminary evidence that this link is based on involvement and experienced 
realism during VR and not so much on the experience of VR as a real space. 
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3.2 Manuscript 2: Functional co-activation within the PFC supports the 
maintenance of behavioural performance in fear-relevant situations – an 
iTBS modulated virtual reality challenge with spider phobic participants 
 
The contents of this chapter are published in: 
Deppermann, S.*, Notzon, S.*, Kroczek, A., Rosenbaum, D., Haeussinger, F. B., 
Diemer, J., Domschke K., Fallgatter A. J., Ehlis A.-C. & Zwanzger, P. (2016). 
Functional co-activation within the prefrontal cortex supports the maintenance of 
behavioural performance in fear-relevant situations before an iTBS modulated virtual 
reality challenge in participants with spider phobia. Behavioural brain research, 307, 
208-217. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Both authors contributed equally to this work 
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3.2.1 Abstract 
A number of studies/meta-analyses reported moderate antidepressant effects of 
activating repetitive transcranial magnetic stimulation (rTMS) over the prefrontal 
cortex (PFC). Regarding the treatment of anxiety, study outcomes are inconsistent, 
probably because of the heterogenity of anxiety disorders/study designs. To 
specifically evaluate the impact of rTMS on emotion regulation in fear-relevant 
situations we applied a sham-controlled activating protocol (intermittent Theta Burst 
Stimulation/iTBS) over the left PFC (F3) succeeded by a virtual reality (VR) challenge 
in n = 41 participants with spider phobia and n = 42 controls. Prior to/after iTBS and 
following VR prefrontal activation was assessed by functional near-infrared 
spectroscopy during an emotional Stroop paradigm. Performance (reaction 
times/error rates) was evaluated. Stimuli were rated regarding valence/arousal at 
both measurements. 
We found diminished activation in the left inferior frontal gyrus (IFG) of participants 
with spider phobia compared to controls, particularly elicited by emotionally-
irrelevant words. Simultaneously, a functional connectivity analysis showed increased 
co-activation between the left IFG and the contra-lateral hemisphere. Behavioural 
performance was unimpaired. After iTBS/VR no significant differences in cortical 
activation between the phobic and control group remained. However, verum iTBS did 
not cause an additional augmentation. We interpreted our results in terms of a 
prefrontal network which gets activated by emotionally-relevant stimuli and supports 
the maintenance of adequate behavioural reactions. The missing add-on effects of 
iTBS might be due to a ceiling effect of VR, thereby supporting its potential during 
exposure therapy. Concurrently, it implies that the efficient application of iTBS in the 
context of emotion regulation still needs to be studied further. 
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3.2.2 Introduction 
With a life time prevalence of up to six percent, spider phobia is the most common 
specific phobia of the animal type which mostly affects women (Fredrikson et al., 
1996). As in other anxiety disorders, an inadequate top-down regulation of 
subcortical structures such as the modulation of the amygdala by the prefrontal 
cortex (PFC) is assumed to be a core feature (Carlsson et al., 2004; Dilger et al., 
2003; Gorman et al., 2000; Johanson et al., 2006; Schienle, Schäfer, Hermann, 
Rohrmann, & Vaitl, 2007). While the amygdala is thought to be associated with 
vigilance and flight reaction (LeDoux, 2001; Öhman & Mineka, 2001) the PFC is 
involved in the regulation of emotion (Goldin et al., 2008; Thier, 2006). The 
dorsolateral prefrontal cortex (DLPFC) specifically, as a main neural correlate of 
executive function, plays an important role regarding goal-oriented inhibition of 
emotional responses (Buhle et al., 2014; Delgado, Nearing, LeDoux, & Phelps, 2008). 
While the inferior frontal gyrus (IFG) comprises a major part of Broca’s area, known 
for its role in language processing (Friederici, 2011), it could also be linked to 
emotion regulation (Goldin et al., 2008), as well as response suppression and 
attentional control, especially but not exclusively in the non-dominant hemisphere 
(Hampshire et al., 2010; Swick et al., 2008). 
Diverging prefrontal brain activation patterns have been observed in response to 
fear-inducing stimuli. While some studies found prefrontal hypoactivation (Carlsson 
et al., 2004; Johanson et al., 2006; Schienle et al., 2007) other findings showed 
enhanced activation (Paquette et al., 2003; Schienle et al., 2005; Straube et al., 
2004). An explanation for these controversial outcomes might be the different 
cognitive processes involved in the specific tasks applied. 
Within this framework, the “Valence hypothesis” is a neurobiological model which 
postulates hypo- as well as prefrontal hyperactivation depending on the context of 
the task. In accordance with this hypothesis, the left hemisphere plays a major role 
in the modulation of approach related emotions while the right hemisphere mainly 
modulates avoidance related emotions (Vennewald et al., 2013). 
Bringing together the valence hypothesis and the model of inadequate top-down 
regulation found in anxiety disorders, we decided to apply an activating repetitive 
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transcranial magnetic stimulation (rTMS) protocol on the left hemisphere in order to 
enhance prefrontal activation and associated cognitive control during a situation 
which induces avoidance related emotions. 
Intermittent theta burst stimulation iTBS (Huang et al., 2005), is a modern form of 
activating rTMS which is able to modulate cortical activation non-invasively by 
electro-magnetic induction. Compared to traditional rTMS, a longer-lasting effect is 
obtained with shorter stimulation. In this context, studies point to an enhancing 
effect of approximately an hour after a one-time application of an iTBS protocol 
(Grossheinrich et al., 2009). 
So far, a number of studies and meta-analyses have found moderate antidepressant 
effects using repeated rTMS (O’Reardon et al., 2007). In the context of anxiety 
disorders, far fewer studies exist and results are inconsistent (Machado et al., 2012). 
This might be due to the complexity of some of these study designs where many 
active factors may have led to confounding effects. For example, in a previous study 
conducted by our workgroup (see section 2.1), panic disorder patients received 
repeated iTBS application while taking part in cognitive behavioural group therapy. 
To simplify the interpretation of study outcomes it might, however, be easier to look 
at an assessable number of specific factors separately. 
Recently, virtual reality (VR) exposure hasbecome more established as an alternative 
to in-vivo exposition in the treatment of pathological fear. Its advantages include a 
better controllability of the therapeutic setting as well as a high compliance with 
patients (Powers & Emmelkamp, 2008). At the same time, studies have shown that 
VR is able to induce a significant increase in subjectively received fear as well as 
psychophysiological arousal (heart rate, skin conductance, Diemer et al., 2013; 
Diemer et al., 2014; Freire et al., 2010). 
Within the framework of psychiatric research, functional near-infrared spectroscopy 
(fNIRS) is an imaging method with particularly good acceptance among participants 
due to its uncomplicated and fast application compared to other imaging methods, 
e.g. functional magnetic resonance imaging (fMRI) (Ehlis et al., 2014). As an optical 
imaging method, fNIRS exploits the fact that near-infrared light can penetrate scalp 
and skull. Because the chromophores oxyhaemoglobin (O2Hb) and 
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deoxyhaemoglobin (HHb) have distinct absorption spectra in the near-infrared range, 
it is possible to deduce regional oxygenation patterns by measuring the relative 
amount of reflected light (Ferrari & Quaresima, 2012), with a spatial resolution of 
approximately 3 cm and a depth penetration of about 2.5 cm (Haeussinger et al., 
2011). 
Altogether, this study aimed at examining the impact of one-time iTBS application 
over the PFC prior to a fearful situation. To do so, a VR environment was used to 
confront participants suffering from spider phobia with virtual spiders after receiving 
sham-controlled iTBS. Before and after the iTBS/VR combination, prefrontal 
activation was assessed by fNIRS while the participants completed an emotional 
Stroop paradigm. 
The advantage of an emotional Stroop paradigm is that participants are not asked to 
willingly influence their emotions (potentially triggering more individual strategies 
and therefore more diverging results) but still need to ignore phobic or fearful 
content of the presented stimuli if they want to complete the task in an adequate 
manner. 
In this regard, a number of authors (Dresler et al., 2012; Tupak, Reif, et al., 2013) 
reported increased activation in the IFG and other prefrontal areas elicited by anxiety 
provoking words during an emotional-word Stroop paradigm in a sample of patients 
with panic disorder. On a behavioural level, the difficulty of focusing on the mere 
task without getting distracted by anxiety-provoking stimuli is further supported by 
the fact that diverging reaction times (RTs) in emotional Stroop tasks have been 
shown (Dresler et al., 2012; Kindt & Brosschot, 1997; Mathews & Klug, 1993). 
Specifically, in this paper we report the results concerning the following hypotheses: 
a.) Phobic participants require more cognitive control when trying to respond to 
phobia-related stimuli in an adequate manner and therefore display increased 
DLPFC/IFG activation patterns. 
b.) At the same time, we still expect decreased behavioural performance (RTs, error 
rates) to fear-related stimuli compared to healthy controls reflecting the difficulties in 
implicit emotion regulation during the confrontation with phobic words. 
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c.) ITBS followed by a VR challenge further promotes prefrontal activation elicited by 
emotional stimuli in participants with spider phobia and is associated with an 
improved behavioural outcome as well as a temporary adjustment of subjectively 
perceived valence and arousal ratings of the presented words. 
d.) In addition to a standard fNIRS analysis of cortical activation patterns, we also 
investigated the functional connectivity within the PFC in order to get a better 
understanding of the interplay of the different sub-regions during emotional control 
processes. 
 
 
3.2.3 Materials and methods 
3.2.3.1 Subjects 
Forty-one participants with spider phobia and 42 healthy controls were included in 
the study after written informed consent was obtained. All phobic participants 
fulfilled the DSM-IV criteria for specific spider phobia except that their day-to-day 
functioning did not have to be overly impeded by their fear of spiders. They further 
had to score on at least 16 of 31 possible items on the German version of the spider 
phobia questionnaire Watts and Sharrock, (Watts & Sharrock, 1984) while control 
subjects had to remain under 7 points at screening. 
Subjects were excluded if they suffered from any psychiatric disorder other than 
specific phobia, organic brain disorder, another severe somatic illness or 
hypertension at the time of screening. Furthermore, pregnancy and lactation had to 
be ruled out and all subjects had to be between 18 and 65 years of age. 
Phobic and control participants did not differ significantly according to age, gender, 
handedness, education and first language (see Table 1). The study was approved by 
the Ethics Committees of the Universities of Muenster and Tuebingen and all 
procedures were in accordance with the latest version of the Declaration of Helsinki. 
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Table 1 
Study group 
 
Total 
(n=83) 
 
Partici-pants 
with spider 
phobia 
(n=41) 
Healthy 
controls 
(n=42) 
 
iTBS 
(n=40) 
 
 
Sham 
(n=43) 
 
Healthy 
controls vs. 
patients 
iTBS vs. 
Sham 
Age Mean 
(SD) 26.46 (8.47) 27.51 (9.45) 25.43 (7.37) 25.85 (7.65) 27.02 (9.23) 
F(1,79)=1.2
5, 
p=0.267 
F(1,79)=0.5
0, 
p=0.481 
Gender 9 male, 74 
female 
4 male, 37 
female 
5 male, 37 
female 
4 male, 36 
female 
35 male, 38 
female 
x
1
2
=0.10, 
p=0.753 
 
x
1
2
= 0.057, 
p=0.812 
 
Handed-ness 12 left, 71 right 
6 left, 35 
right 
6 left, 36 
right 
9 left, 31 
right 
3 left, 40 
right 
x
1
2
= 
0.002, 
p=0.964 
 
x
1
2
 = 4.04, 
p= 0.044* 
 
First Lan-
guage 
74 German, 
5 bilingual, 4 
other 
35 German, 
4 bilingual, 2 
other 
39 German, 
1 bilingual, 2 
other 
34 German, 
3 bilingual, 3 
other 
40 German, 
2 bilingual, 1 
other 
x
2
2
=2.00, 
p=0.367 
 
x
2
2
=1.58, 
p=0.454 
 
Years of 
edu-cation 
Mean (SD)a 
11.32 (3.68) 11.00 (2.90) 11.66 (3.34) 11.30 (3.91) 11.34 (3.51) F(1,78)=0.57, p=0.451 
F(1,78)=0.0
1, p=0.948 
Table 1. Sociodemographic Data. a = available for 82 participants only; *significant at the level p<0.05; SD = standard 
deviation 
 
 
3.2.3.2 Design 
The bicentric study (Muenster and Tuebingen) was conducted in a single-blind 
randomized sham-controlled group design. Phobic participants and controls 
participated in an fNIRS measurement before receiving either verum or sham iTBS 
(t1) which was followed by a VR challenge. During the VR objective (heart rate, skin 
conductance) as well as subjective (ratings of anxiety and disgust) parameters of the 
individual’s fear reaction were collected (results are reported elsewhere) 
Subsequently, the fNIRS measurement was repeated (t2). A flow chart of the study 
is depicted in section 3.1.3.2. 
 
 
 
   
106 
 
3.2.3.3 Stimuli 
During the fNIRS measurements all participants completed an emotional-word Stroop 
paradigm. In this regard, participants had to indicate via button press whether the 
presented words were written in red, green or blue, independent of their emotional 
content (10 emotionally positive, 10 emotionally negative, 10 neutral and 10 phobia 
related words). Beforehand, all words were matched with respect to the number of 
letters and syllables as well as corpus-based word frequency. Additionally, a pilot 
study was conducted where the words were rated on a 5-point scale to ensure that 
valence and arousal were induced as intended according to the word category and 
did not differ between groups except for the phobic words. After completing the 
fNIRS measurements, all participants also rated the presented words accordingly. 
During the experiment the stimuli were presented in a randomized order on a black 
LCD screen whereby each stimulus was presented for 1500 ms and was preceded by 
a fixation cross, which lasted 500 ms. The inter-trial intervals were randomly jittered 
between 4000 and 8000 ms. 
 
 
3.2.3.4 fNIRS 
The ETG-4000 continuous Optical Topography System (Hitachi Medical Co., Japan) 
was used for all fNIRS measurements to record relative changes in O2Hb and HHb 
concentration. To do so, we oriented the probe set (3 × 11 optodes array consisting 
of 16 photo detectors and 17 light emitters resulting in 52 channels) with its central 
optode of the lowest row on FPz reaching out towards T3 and T4 according to the 
international 10–20 EEG system for electrode placement (Jasper, 1958a). The ETG-
4000 uses near-infrared light of two wavelengths which are modulated at a 
distinctive frequency for each channel (695 ± 20 nm and 830 ± 20 nm). The 
sampling rate was 10 Hz. After the photo detectors received the scattered light it 
was transferred to a set of lock-in amplifiers in order to separate it with respect to its 
modulation frequency and to analyse and transform it according to its wavelength. 
The calculated time course of O2Hb and HHb concentration changes was exported in 
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mmol × mm which implies that changes in O2Hb and HHb depend on the unknown 
path length of the near-infrared light in the tissue.  
 
 
3.2.3.5 iTBS 
Directly after the first fNIRS measurement (t0), a single (verum or sham) iTBS 
session (for further details on the stimulation protocol please refer to Ref. (Huang et 
al., 2005) was applied over the left PFC at F3 of the international 10–20 EEG system 
according to Herwig et al. (2003). In line with the findings on prefrontal hypo 
activation mentioned in the introduction as well as the “valence hypothesis” (e.g. 
[56] which assumes a hemispheric lateralisation whereby approach related emotions 
are modulated on the left and withdrawal related emotions on the right hemisphere, 
we chose the left PFC as our stimulation site. For the application, a figure-of-eight 
coil (MCF-B65, 2 × 75 mm diameter) was positioned tangentially to the scalp forming 
a 45° angle to the mid-sagittal line of the head with the handle pointing in a 
posterior direction. The sham stimulation was achieved by turning the coil at a 90° 
angle away from the scalp. The used stimulator was a MagOption/MagPro X100 
stimulator (MagVenture, Denmark) with the stimulation intensity set to 80% of the 
individual’s motor threshold. The iTBS was conducted directly prior to a spider-
related VR challenge. 
 
 
3.2.3.6 VR challenge 
For the presentation of the virtual spider environment a head mounted display (HMD, 
Z800 3D Visor, 800 × 600 pixels, eMagin, Bellevue, Washington, USA) was used. 
The head position was registered using the 6DOF (Polhemus Corporation, Colchester, 
Vermont, USA) electro-magnetic tracking system by means of a head set. 
Experimental control was achieved via the CyberSession software programmed at the 
Psychological Department of the University of Wuerzburg (www.cybersession.info) 
which has previously successfully been used to induce anxiety in VR challenges 
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(Diemer et al., 2013). During the course of the VR confrontation, all participants first 
entered a neutral scene where they were presented with a room without any spiders 
in order to optimise the HMD and get familiarised with the virtual environment. After 
all final adaptations were completed the neutral scene was again shown for 3 min 
directly followed by the fear-induction scene where 3 giant spiders, one of which 
seemed to move around the participants’ feet, appeared in the office for an 
additional 3 min. As the VR confrontation was not intended to serve any therapeutic 
purpose, but was merely used to induce fear after the iTBS intervention, the 
participants were not given any instruction. 
 
 
3.2.3.7 Data preperation 
During the fNIRS measurement, changes in the concentration of O2Hb as well as 
HHb were registered from baseline. Subsequently, the HHb signal was chosen for 
further analysis as it is assumed to be less susceptible to stress-induced skin blood 
flow changes in the forehead (Sato et al., 2013). It was hence pre-processed with 
Matlab (The MathWorks, Inc., U.S.A.) in order to adjust the signal parts which were 
not associated with the attended task. This procedure included the following steps: 
application of a band pass filter to remove frequencies below 0.01 Hz and above 
0.5 Hz, interpolation (<1% of all channels, as performed e.g. by Hagen et al.  (2014) 
of noisy channels by corresponding HHb values of the remaining channels according 
to a Gaussian distribution (circumjacent channels were considered more than distant 
ones) and rejection of trials that clearly displayed technical artefacts after careful 
visual inspection by an experienced fNIRS researcher. 
Finally, the data of each participant was segmented in an event-related manner for 
each channel, whereby a time frame of 0–16 s after stimulus onset was extracted 
and adjusted for linear drifts and baseline. Next, a general linear model was applied, 
wherein the data was modelled as Y = β*X + ε, with Y being the time × channel 
matrix comprising the fNIRS time series, β being the estimated parameter vector of 
beta-weights needed to model X, X being the design matrix containing the respective 
modelled effects, and ε describing the error term. The adopted function was a 
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standard model used in SPM 8 (http://www.fil.ion.ucl.ac.uk/spm/doc/) as a 
haemodynamic response function (HRF) in terms of a gamma curve. While 
traditionally used for the analysis of fMRI data (Friston et al., 1995), this approach 
could also be validated for the analysis of fNIRS data (Plichta, Heinzel, Ehlis, Pauli, & 
Fallgatter, 2007). Following careful inspection of the averaged event-related HRF, a 
peak time of 8 s after stimulus onset was taken as the basis for the modelled curve. 
In order to estimate the beta weights, the method of least squares was used. 
For the functional connectivity analysis, we refrained from the interpolation 
procedure in order to avoid spurious correlations between different brain regions. 
 
 
3.2.3.8 Regions of interest (ROI) 
In order to analyse oxygenation changes induced by the emotional stroop paradigm, 
different ROIs as well as a “non-ROI” were defined. To do so, first the regions lying 
under the probe set were mapped according to (Lancaster et al., 2000; Rorden & 
Brett, 2000; Singh et al., 2005; Tsuzuki et al., 2007). Based on the findings 
concerning regions that are particularly involved in cognitive control during the 
processing of emotional words (Dresler et al., 2012; Straube et al., 2004) the 
channels corresponding to the DLPFC (Brodmann area 9 and 46) as well as the 
bilateral IFG (Brodmann area 45) were defined as the main ROIs (see Fig. 1). 
Channels which repeatedly displayed muscle artefacts due to their spatial location 
close to the frontalis and temporoparietalis muscles were considered a non-ROI in 
order to exclude them from the Gaussian interpolation procedure. 
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Figure 1  
 
 
Probeset arrangement with numbers indicating channels within the ROIs. 
 
 
 
3.2.3.9 Statistical analyses 
For each ROI 4 × 2 × 2 × 2 repeated measurement analyses of variance (RM-
ANOVAs) were conducted for the corresponding β-weights whereby the within-
subject factors were time (t0 versus t1) and condition (neutral versus phobic versus 
positive versus negative words) and the between-subject factors were group 
(phobics versus controls) and stimulation (verum versus sham). A Bonferroni-Holm 
(BH) correction procedure was applied to adjust the lowest alpha levels to 
0.017 < p < 0.05 per hemisphere in order to avoid alpha error accumulation due to 
the multiple analyses caused by the three different ROIs. For significant main or 
interaction effects, paired and independent two-tailed t-tests were employed for 
further post-hoc analysis. 
In addition to the NIRS data, the complementing behavioural data, namely RTs and 
error rates, were analysed by means of corresponding repeated measurement 
ANOVAs. Regarding error rates, post-hoc testing was achieved by means of Mann-
Whitney-U or Wilcoxon tests, as the data were not distributed normally. 
Finally Pearson’s correlation coefficients were calculated only for ROIs that displayed 
significant task-related HHb changes and corresponding RTs. 
With respect to valence and arousal ratings RM-ANOVAs were performed once more, 
and post-hoc testing was achieved via paired and independent two-tailed t-tests in 
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the case of valence ratings and two-tailed Mann-Whitney-U and Wilcoxon tests in the 
case of arousal ratings to account for the deviation from normal distribution. 
Finally, to further clarify our findings, a functional connectivity analysis (for similar 
fNIRS-based analyses refer to Medvedev, Kainerstorfer, Borisov, & VanMeter (2011)) 
was performed with the left IFG as the seed region. To do so, cross-correlation 
coefficients with a 0 time lag between the averaged HHb event-related time course 
of the left IFG and all other ROIs were calculated for the first 12 s after stimulus 
onset for each condition and time in a subject-wise manner. Before computing mean 
correlation values for each group, Fisher’s z-transformation was applied to account 
for the fact that correlation coefficients are not interval scaled. In a final step a 
4 × 2 × 2 × 2 RM-ANOVA with the same within- and between-subject factors as 
before, as well as the corresponding post-hoc t-tests, were performed. The alpha 
level was set to p < 0.025 in order to take the testing between the two hemispheres 
into consideration. 
Due to motion artefacts during the fNIRS measurement which were too severe to be 
corrected (n = 9) as well as insufficient knowledge of the German language (n = 1) 
some of the subjects had to be excluded from the final analysis of the fNIRS data, 
resulting in a sample of n = 19 sham as well as n = 16 verum stimulated controls 
and n = 19 sham as well as n = 17 verum stimulated participants with spider phobia. 
Regarding behavioural data additional to the participant with insufficient German 
knowledge, one sham-stimulated participant in each group had to be excluded as the 
behavioural reactions were not recorded properly. In the end, with respect to the 
subjective ratings relating to the n = 71 fNIRS datasets, n = 1 sham-stimulated 
participant of the control group as well as n = 2 sham- and n = 2 verum-stimulated 
phobic participants were excluded from valence rating analysis. Regarding the 
arousal ratings n = 4 sham- as well as n = 1 verum-stimulated participants of the 
control group and n = 5 sham- as well as n = 4 verum-stimulated participants of the 
phobic group were dismissed from the analysis, respectively, due to systematic 
mistakes in rating (e.g. confounding the configuration of the rating scales, which 
differed between valence and arousal ratings, too many missing items). In this way, 
the final sample size differed slightly depending on the analysed variables. 
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3.2.4 Results 
3.2.4.1 Behavioural performance 
In order to verify whether implicit emotion regulation during the confrontation with 
fear-inducing stimuli is impaired in participants with spider phobia, RTs and error 
rates were investigated. Hereby we expected an increase in behavioural performance 
after the VR challenge, particularly in the verum-stimulated group (hypothesis 2 and 
3). 
In terms of RTs (for a complete overview of mean RTs please refer to Table 2 at the 
end of the section) the emotional-word Stroop task revealed a significant main effect 
for the factor condition (F3195 = 3.91, p < 0.001) whereby the reaction to negative 
words was generally slower than to all other conditions (RTs neutral: 
654+/−111 ms; RT positive: 653+/−111 ms; RTs phobic: 652 +/−118 ms; RTs 
negative: 664 +/−120 ms). There were no other significant main effects or 
interactions. 
Concerning error rates (for a complete overview of mean error rates please refer to 
Table 3 at the end of the section), there was a significant main effect of the factor 
time (F1,65 = 10.88, p = 0.002), indicating that more errors were committed at t1 
(errors t0: 0.71+/−0.67; errors t1: 0.9 +/−0.6). Moreover, there was a significant 
interaction of time*group*stimulation (F1,65 = 6.63, p = 0.012) which could be 
explained by an increase in committed errors from t0 to t1 especially in the group of 
sham-stimulated controls (z = −1.969, p = 0.04) and the group of verum-stimulated 
phobic participants (z = −2.163, p = 0.031). Pairwise group comparisons however, 
did not reveal any significant differences. All in all, we did not find an increase in 
behavioural performance after iTBS and neither an impaired performance in 
participants with spider phobia compared to healthy controls. 
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Table 2 
 
Table 2. Mean reaction times and standard deviation (in brackets) for all conditions and groups shown separately for t0 and t1.  
 
Table 3 
 participants with spider  phobia – 
verum iTBS  
n=  
Participants with spider phobia – sham 
iTBS  
n= 
Healthy controls – verum iTBS 
n=  
Healthy controls – sham iTBS 
 n= 
t0 neutral 
0.88 
(1.32) 
phobic 
0.47 
(0.72) 
negative 
0.88 
(0.99) 
positive 
0.76 
(0.97) 
neutral 
1.00 
(1.33) 
phobic 
0.78 
(1.48) 
negative 
0.67 
(1.24) 
positive 
0.78 
(1.00) 
neutral 
0.81 
(0.91) 
phobic 
0.88 
(0.72) 
negative 
0.81 
(0.91) 
positive 
0.81 
(0.91) 
neutral 
0,72 
(0.83) 
phobic 
0.50 
(0.71) 
negative 
0.50 
(0.62) 
positive 
0.39 
(0.85) 
t1 1.47 
(1.18) 
1.24 
(0.90) 
1.18 
(1.29) 
1.12 
(0.78) 
0.67 
(0.77) 
1.06 
(1.06) 
0.89 
(1.18) 
0.83 
(0.79) 
0.94 
(0.93) 
0.88 
(1.14) 
0.75 
(0.93) 
1.00 
(1.16) 
0.67 
(0.68) 
1.00 
(1.14) 
1.22 
(1.00) 
1.06 
(0.94) 
Table 3. Mean error rates and standard deviation (in brackets) for all conditions and groups shown separately for t0 and t1 
 
 
 
 participants with spider  phobia – verum iTBS  
n=  
Participants with spider phobia – sham iTBS  
n= 
  Healthy controls – verum iTBS 
n= 
Healthy controls – sham iTBS 
 n= 
t0 neutral 
647 (99) 
phobic 
654 
(99) 
negative 
657 
(97) 
positive 
654 
(107) 
neutral 
641 
(131) 
phobic 
651 
(139) 
negative 
669 
(161) 
positive 
659 
(145) 
neutral 
645 
(141) 
phobic 
633 
(146) 
negative 
650 
(144) 
positive 
637 
(132) 
neutral 
621 
(89) 
phobic 
641 
(110) 
negative 
662 
(122) 
positive 
627 
(95) 
t1 643 
(117) 
623 
(109) 
637 
(113) 
631 
(101) 
661 
(153) 
655 
(168) 
658 
(155) 
664 
(151) 
646 
(126) 
655 
(121) 
662 
(137) 
648 
(121) 
651 
(96) 
641 
(90) 
648 
(83) 
642 
(89) 
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3.2.4.2 Cortical activation 
In terms of cortical activation patterns, we hypothesised increased DLPFC/IFG 
activation in participants with spider phobia due to higher demands on cognitive 
control when responding to phobia-related stimuli. We further expected that VR in 
combination with the activating rTMS protocol would result in an additional increase 
in activation, in this context reflecting a higher recruitment of prefrontal resources for 
the execution of the task (hypothesis 1 and 3). 
With regard to the left IFG, there was a significant interaction of time*group 
(F1,67 = 7.73, p = 0.007 < 0.017, BH-corrected) which was accounted for by 
reduced activation in the phobic compared to the control group at t0 (t69 = −2.22, 
p = 0.03; see Fig. 2) but not at t1. When comparing changes in cortical oxygenation 
over time, a significant decrease could only be found in the control group 
(t34 = 2.54, p = 0.016). Even though the activation in the phobic group increased 
from t0 to t1 on a descriptive level, this difference was not significant. 
 
Figure 2 
                             
   
   
 
   
 
 
 
 
 
 
HHb concentration levels contrasted between control and  phobic participants at t0 by means of t-
values for each channel. Only significant values are presented. 
 
   
115 
 
Concluding, contrary to our hypothesis, we found reduced rather than increased PFC 
activation in participants with spider phobia compared to healthy controls. An 
explanation for this finding will be discussed. Moreover, in line with what we 
expected, there was an increase in activation after the VR iTBS combination at least 
on a descriptive level. Verum iTBS did not cause an additional effect, however. 
 
 
3.2.4.3 Correlation of behavioural performance and cortical activation 
Inherently, we expected an association between brain activation and behavioural 
performance in terms of significant correlations between RTs/Error rates and HHb 
concentration (hypothesis 1 and 2). 
However, a significant correlation could only be found between RTs and HHb 
concentration (β weights) in the left IFG in the phobic group for neutral words at 
t0(r = 0.355, p = 0.017; see Figure 3). 
Figure 3 
 
 
 
 
Scatterplot RTs and cortical HHb concentration in the left IFG at t0 for neutral word in the group of 
participants with spider phobia. 
 
To get a better idea of how to interpret this finding, we looked at the averaged 
haemodynamic response functions (HRF) for each condition and measurement time 
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in the phobic and the control group separately. Strikingly, on a descriptive level, 
mean HHb concentrations were especially high (inferring reduced activation) for 
neutral words in the phobic group at t0 as depicted in Figure 4. 
Figure 4 
 
 
Averaged HRF of HHb at t0 and t1 for each condition in the phobic and control group, separately. 
According to the model-based analysis there was a significant difference between the two groups at 
t0. 
 
 
3.2.4.4 Valence and arousal ratings 
With respect to the subjective ratings of the presented words, we generally intended 
to replicate our results from the pilot study in order to show that our experimental 
manipulation was successful (graduation of valence and arousal ratings according to 
the specific word category without a difference between groups except for the 
phobic words). Following VR, we further postulated a temporary assimilation 
between the group of participants with spider phobia and controls, regarding 
subjectively perceived valence and arousal ratings of the phobia-relevant words. This 
effect was assumed to be bigger in the verum-stimulated group (hypothesis 3). 
Concerning valence ratings of the presented words, a main effect for condition 
(F3186 = 1248.48, p < 0.001) was detected, indicating that the valence for negative 
words was rated < the one for phobic words < the one for neutral words < the one 
for positive words (all p < 0.001). Furthermore, there was an interaction of 
condition*group (F3186 = 37.40, p < 0.001) since, as expected, phobic participants 
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judged the phobic words as more negative than the control group (t55 = 11.54, 
p < 0.001). An interaction of condition*time (F1,26 = 7.74, p = 0.003) revealed that 
while ratings for neutral and phobic words were stable over time, ratings for the 
negative ( t65= −4.00, p < 0.001) and positive words ( t65= 2.18, p = 0.033) were 
more negative at t1. Finally, there was a significant interaction of 
condition*group*stimulation (F1,84 = 5.64, p = 0.009). This interaction was basically 
due to the fact that (as for the entire group) the only difference in valence rating 
between the phobic and control group was found for phobic words in the verum-
stimulated group (t18 = −9.30, p < 0.001), while in the sham group a significant 
difference arose not only for phobic words (t34 = −7.31, p < 0.001) but also for 
negative words (which were rated more negative in the control group 
(t25.82 = 2.14, p = 0.042). 
In line with the valence ratings, a main effect of condition (F2113 = 125.43, 
p < 0.001) was also detected for the arousal ratings whereby the arousal for 
emotionally positive and emotionally negative words did not differ significantly but 
was > the arousal for phobic words > the one for neutral words (all p < 0.001). 
Accordingly, there was also an interaction of condition*group (F2113 = 17.27, 
p < 0.001) whereby the pairwise group comparison revealed significantly higher 
arousal ratings for phobic words solely in the group of spider phobic participants 
(z = −4.677, p < 0.001). In addition, in the phobic group only, the difference in 
arousal ratings between the emotionally negative and positive control words and the 
phobic words was not significant. An interaction of time*stimulation (F1,53 = 5.67, 
p = 0.021) further indicated that the arousal ratings in the sham-stimulated group 
only decreased from t0 to t1 (z = −2.35, p = 0.019). Aside from that, there was 
again an interaction of condition*group*stimulation (F2113 = 5.337, p = 0.005) 
whereby, equivalent to the valence rating, the only significant difference between the 
phobic and control group occurred for phobic words in the verum group (z = −3.69, 
p < 0.001). In the sham-stimulated group, however, the group differences were not 
only significant for phobic words (z = −2.62, p = 0.009) but also for negative 
(z = −2.62, p = 0.017) and positive (z = −1.99, p = 0.046) words, for which – 
contrary to the phobic words – the arousal was lower for the emotional control words 
in the phobic group. 
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Finally, there was an interaction of condition*time*group (F2133 = 7.25, p < 0.001) 
that was mainly carried by different changes in arousal ratings for the control and 
phobic group. Whereas in the control group (z = −2.55, p = 0.01) as well as in the 
phobic group (z = −1.98, p = 0.048) the arousal for neutral words increased from t0 
to t1, the arousal for phobic words solely decreased in the phobic group (z = −3.99, 
p < 0.001). 
Hence, in summary, the evaluation of the subjective ratings confirmed a successful 
experimental manipulation in terms of significant group differences between 
participants with spider phobia and healthy controls regarding valence and arousal 
ratings of phobic words explicitly (replicating the results from our pilot study as 
expected). Furthermore, there was a significant decrease with respect to the rated 
arousal for phobic words from t0 to t1 only in the group of participants with spider 
phobia which was also in line with our assumption. But in contrast to hypothesis 3, 
this effect was not bigger in the verum-stimulated group. 
 
 
3.2.4.5 Functional conectivity of the left IFG 
Finally, we performed a functional connectivity analysis in order to get a better 
understanding of the interaction of different sub-regions within the PFC during 
emotional control processes (hypothesis 4). Functional co-activation was thereby 
defined as the cross-correlation of the mean HHb time course for each condition 
between the left IFG and all other ROIs (ipsilateral DLPFC9/46 as well as 
contralateral DLPFC9/46 and contralateral IFG). As a result, we found a significant 
interaction of condition*group (F3201 = 3.33, p = 0.021 < 0.025, BH-corrected) for 
the right DLPFC9. In this context, the functional connectivity was increased in the 
phobic compared to the control group for phobic words only (t69 = 1.96, p = 0.05). 
Moreover, the within-group comparisons indicated a significant difference in co-
activation patterns for the control group solely when contrasting emotionally negative 
and emotionally positive words, wherein the connectivity was decreased for negative 
words (t34 = 2.13, p = 0.041). On the other hand, in the group of phobic 
participants the co-activation between left IFG and right DLPFC9 was significantly 
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enhanced for phobic compared to neutral (t35 = 2.472, p = 0.018), as well as phobic 
compared to positive, words (t35 = 2.604, p = 0.012; see Figure 5). 
Figure 5 
 
Functional co-activation of the left IFG and all other ROIs for each condition in the control as well as 
the phobic group at t0. Higher numbers of Fisher’s z-score indicate increased functional connectivity. 
 
 
3.2.5 Discussion 
The aim of this study was to verify whether spider phobia is characterised by 
alterations in prefrontal brain activation patterns, as assessed by fNIRS when being 
confronted with fear-inducing stimuli, in terms of an emotional Stroop paradigm. In a 
second step, we applied a one-time sham-controlled iTBS protocol over the left PFC 
which was followed by a spider challenge in a virtual environment that served as a 
triggering situation to elicit anxiety. The participants were not given any therapeutic 
instructions, as we merely wanted to evaluate the neural (fNIRS) and behavioural 
(RTs, error rates, valence, arousal) impact of iTBS in combination with a fear-
relevant situation without further confounding effects of therapist-guided exposure. 
In addition to a standard fNIRS analysis of cortical activation patterns, we also 
conducted a functional connectivity analysis in order to get a better understanding of 
our results. 
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Contrary to our first question, we found reduced activation in the left IFG of 
participants with spider phobia as compared to healthy controls at t0. 
With respect to our second hypothesis, we did not find reduced performance in 
terms of slower RTs or increased errors rates in the group of phobic participants at 
either t0 or t1 compared to healthy controls. However, a significant correlation 
between the RTs for neutral words and activation in the left IFG could be detected 
solely for phobic participants at t0. At the same time, RTs were generally significantly 
reduced for negative words in the entire group of participants. Regarding the third 
question, we found that after the iTBS/VR combination, the difference in prefrontal 
activation disappeared. However, this adjustment was independent of the stimulation 
group (verum versus sham). The valence and arousal ratings generally confirm that 
the emotional categories of our Stroop paradigm were perceived as intended. In this 
context, the valence of negative words was overall judged as the most unfavourable 
followed by phobic words while neutral words were located in the middle of the 
Likert scale. Positive words were perceived as most favourable. Regarding arousal 
ratings, the arousal for emotionally negative and emotionally positive words was the 
highest in the entire group of participants, followed by phobic and then neutral 
words. Group differences between phobic and control participants were significant 
with respect to explicitly phobic words—as expected, spider phobic participants rated 
phobic words as more negative, thereby indicating a higher arousal. Furthermore, 
there was a significant effect of time in both groups, whereby the emotional control 
words were judged as more negative in the second rating session. Concerning both 
valence and arousal ratings, there were differences in ratings for the separate word 
categories between the sham- and verum-stimulated groups which differed between 
controls and phobic participants. However, as these differences between groups did 
not depend on the rating session (prior to, versus after, the iTBS application; i.e., 
they were already present at the baseline assessment) they are unlikely to represent 
real stimulation effects but rather suggest that group sizes should have probably 
been slightly bigger in order to achieve a better control of random assignment 
effects. Regarding these baseline differences between the sham- and verum-
stimulated group, it is very likely that the same effect also accounts for the decrease 
in arousal after iTBS in the sham-stimulated group only. Interestingly, however, 
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comparable to the alterations in neuronal activation, changes regarding the rating 
scales over time were independent of the stimulation, but pointed towards an 
adjustment of the phobic to the control group (decrease in arousal for phobic words 
exclusively in the phobic group). Moreover, there was a significant change in arousal 
over time, indicated by an increase for neutral words in phobic and control 
participants. On a behavioural level this increase in arousal was accompanied by an 
increase in errors at t1, which was independent of the word category, probably 
pointing to a decrease in motivation and/or concentration. 
With respect to our forth question, we observed a significant increase in co-activation 
of the left IFG and the contra-lateral DLPFC in the phobic compared to the control 
group. Strikingly, this increase was characterised by enhanced connectivity for 
exclusively phobic words in the phobic group as compared to the control group. 
Additionally, the coherent activation was significantly decreased for negative as 
compared to positive words in the control group, and significantly increased for 
phobic relative to neutral as well as positive words in the group of spider phobics. 
Overall, it is not surprising that the detected differences in cortical activation were 
only significant in the left IFG, as this region comprises Broca’s area and is hence 
most important for the processing of semantic stimuli as in the case of an emotional-
word Stroop paradigm. Furthermore, unlike in other studies (Dresler et al., 2012) 
that additionally reported activation differences in other prefrontal areas, the 
behavioural performance of participants with spider phobia was not at all impaired, 
strongly pointing to a compensating mechanism. In line with this assumption, we 
investigated the functional connectivity of the left IFG with the other ROIs (ipsilateral 
DLPFC9/46 as well as contralateral DLPFC9/46 and contralateral IFG), hypothesising 
that we should find increased co-activation in the group of participants with spider 
phobia, which could explain the preserved performance level regarding phobic 
words. In line with this hypothesis, we were able to confirm a significant 
augmentation of coherent activation of the right hemisphere for the group of 
participants with spider phobia in response to phobic words. Even though only 
significant for the right DLPFC Brodmann area 9, on a descriptive level, this increase 
in functional connectivity could also be observed for the other ROIs of the contra-
lateral hemisphere (compare Fig. 5) underlining the interpretation of a compensatory 
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effect. At first glance it seems counter-intuitive that healthy controls should display a 
relative decrease in connectivity for negative words when at the same time phobic 
participants are characterised by an increase in connectivity for phobic words. 
However, it should be considered that the context of the experiment certainly also 
plays an important role. While the phobic participants were prepared from the 
beginning to respond to fearful stimuli, the situation was in general neutral for the 
control group. Moreover, it also needs to be kept in mind that, although not 
intended, parts of the control group were defined by lower valence and higher 
arousal ratings for negative words. Finally, when looking at the entire group, the 
performance level could not be maintained for negative words. Again, valence ratings 
were generally the lowest accompanied with a high arousal which further validates 
the idea of a (in this case insufficient) supportive prefrontal network. 
In conclusion, it can be assumed that fearful situations elicit the recruitment of a 
prefrontal compensatory network in order to allow for the down-regulation of 
emotional reactions and hence adequate behavioural reactions. If the fear triggered 
by adverse stimuli reaches a certain level, however, this network breaks down, 
leading to decrease in performance. Within this context, the fact that the phobic 
participants did not necessarily need to experience constraints in their daily routine 
might also serve as an explanation why there were no differences regarding 
behavioural performance. At their level of anxiety, compensation via the recruitment 
of other prefrontal areas was probably still possible. If we had only included people 
which were truly limited by their fear of spiders in their everyday life, it is likely that 
the network would not have offset the perception of phobic stimuli any longer, 
resulting in a decrease in performance. 
Regarding the activation within the left IFG itself, we found a general decrease in 
activation in the phobic group compared to the control group. This was surprising at 
first, as other studies have reported enhanced activation to emotionally relevant 
stimuli in Broca’s area (Dresler et al., 2012; Straube et al., 2004). Interestingly, 
however, this effect was mainly carried by decreased activation to neutral words in 
the phobic group at t0. Even though there was no significant interaction with the 
factor condition, when looking at Fig. 4, it is striking that the HRF is especially 
reduced for this condition. Moreover, a direct correlation between behavioural 
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performance and activation in the left IFG was found exclusively for this word 
category at t0 for phobic participants. This observation suggests an interpretation in 
terms of the already discussed network hypothesis: presumably neutral words carry 
the least emotional relevance in a potential phobic situation and hence receive the 
least support by compensatory co-activation of other prefrontal areas, on the one 
hand leading to the generally lowest cortical activation, but on the other hand 
leading to a more direct relationship between this activation and the visible 
behavioural performance. Although this idea is of course rather speculative, it can 
account for all our findings, and seems therefore worthy of further investigation 
examining this hypothesis in more detail. 
On a final note, we could not confirm a modulatory effect of iTBS on either cortical 
activation, behavioural performance or perceived emotional content of the stimuli. A 
possible explanation for this finding might be the time delay between iTBS 
application and the second fNIRS measurement (t1). As mentioned in the 
introduction, past studies mainly found acute effects of iTBS which lasted up to 
approximately an hour (Grossheinrich et al., 2009). In the present study, however, 
the average time delay was over an hour, due to the VR challenge and associated 
preparations succeeding iTBS. Even though this certainly represents a major 
limitation of our study, the fact that we could not find any physiological changes in 
terms of alterations in heart rate or skin conductance and respectively perceived 
disgust and anxiety (these results of the same study sample have been reported in 
section 3.1) during the VR makes it unlikely that our null findings are only due to 
methodological reasons. Another explanation for the missing iTBS effect may be the 
state-dependency of rTMS which basically infers that, depending on the already 
ongoing brain activity, the effects of rTMS may significantly vary between subjects 
(Silvanto & Pascual-Leone, 2008). However, in this context a review article by 
Sandrini, Umiltà, & Rusconi (2011) suggests that an activating protocol may 
specifically affect neural populations which display the lowest activation prior to 
stimulation onset. Therefore, we should have expected at least a trend-wise 
enhancement of neural activation in the verum-stimulated group of participants with 
spider phobia for specifically neutral words. It would probably still be premature to 
deduce that iTBS can generally not serve as a supportive tool with respect to 
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emotion regulation in fearful situations from our results. Instead, future studies 
should try to eliminate even more confounding factors in order to get a better 
understanding of its possible mode of action. Although we attempted to exclude 
other active factors by not giving any therapeutical instruction prior to the VR 
challenge, our results point to a generally fear-reducing effect triggered by mere 
confrontation with the virtual spiders. This reasoning is supported by the adjustment 
of cortical activation patterns at t1 as well as the significant decrease in perceived 
arousal in the phobic group. Another minor factor which should still not be neglected 
when interpreting our findings is the apparent decrease in performance from t0 to t1 
in the entire group of participants as indicated by the increase in errors as well as the 
changes concerning word ratings (e.g. the enhanced arousal to neutral words at the 
second rating session). A probable explanation for this might be a decline of 
motivation and/or concentration in the context of the long duration of the study. 
Such restricting factors could have further interfered with potential iTBS effects, 
which might have been detectable otherwise. Finally, within the framework of a 
combination of rTMS and VR it must be kept in mind that the feeling of presence – 
defined as the impression of actually being in the particular environment (Slater, 
1999) – is significantly modulated by a prefrontal network including the DLPFC as a 
pivot point, whereby the relationship between prefrontal activation and the feeling of 
being there is a negative one (Jäncke, Cheetham, & Baumgartner, 2009). This 
correlation could not only be replicated in a multitude of studies investigating 
patients with post traumatic stress disorder during dissociation (Hopper, Frewen, Van 
der Kolk, & Lanius, 2007; Lanius et al., 2010; Lanius et al., 2002) but could 
furthermore be found in healthy control subjects during VR immersion (Baumgartner 
et al., 2008). Accordingly, in our study we may have induced two counteracting 
effects by the application of iTBS: on the one hand the activating verum stimulation 
might have led to more efficient emotion regulation in terms of better cognitive 
control, while on the other hand, by doing so, the feeling of presence in the virtual 
scenario could have been diminished, resulting in a fainter (learning) experience. 
This could explain the missing effects on our dependent variables at t1, including the 
ratings of the emotional stimuli. These antagonising stimulation effects represent a 
further limitation with respect to our study design. In line with the results of Beeli, 
   
125 
 
Casutt, Baumgartner, & Jäncke (2008) we could, however, not confirm a significant 
effect of verum iTBS on the perceived feeling of presence, but rather only on the 
activation of the vegetative nervous system (section 3.1). Nevertheless, despite a 
large number of studies, there is no conclusive evidence for a direct relationship 
between initial (physiological) fear activation and a positive outcome of exposure 
therapy (Craske et al., 2008). Future investigations should therefore try to unravel 
the impact of iTBS into its separate components and then further explore its 
influence on the effectiveness of exposure therapy. 
 
 
3.2.6 Conclusion 
The results of the present study showed a generally diminished activation (which was 
particularly pronounced for neutral words) in response to semantic stimuli in the left 
IFG during a phobia-relevant emotional Stroop paradigm in the phobic group 
compared to a healthy control group. This decrease in activation correlated positively 
with behavioural performance, in terms of RTs, solely for emotionally irrelevant 
words and was thereby associated with a particular distinctive activation decline. 
Interestingly, behavioural performance was generally not impaired, which could be 
explained in terms of a compensatory prefrontal network that supports the 
maintenance of adequate behavioural responses in fear-relevant situations. If the 
adverse emotional response triggered by the situation succeeds a certain threshold, 
however, this network breaks down, and performance decreases, as was the case in 
response to negative words in our study. Apart from these findings, we found an 
adjustment of the reported alterations in the left IFG in phobic participants compared 
to healthy controls after a confrontation with virtual spiders, which was accompanied 
by a significant decrease on arousal ratings of the phobic words. This effect was 
independent of preceding iTBS application, on the one hand supporting the potential 
of virtual scenarios as part of exposure therapy, on the other hand challenging the 
application of single iTBS sessions in the context of emotion regulation. 
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4. General discussion 
4.1 Summary and conclusion 
The present work has been dedicated to the investigation of iTBS as a qualified 
treatment option in the therapy of anxiety disorders. The theoretical background to 
this research question was the imbalance of the fear network, characterised by 
prefrontal hypoactivation and hyperactivation of e.g. the amygdala which has been 
repeatedly reported in the literature (see section 1.3.1).  Moreover, the ability of 
rTMS and, within this context iTBS, to distinctly modulate cortical activation patterns 
in a non-invasive manner has been demonstrated in multiple studies as well as 
clinical case reports before (see section 1.4.2.4).  Drawing the conclusion from these 
findings, we designed two studies, whereby each addressed a different possible 
application of iTBS in the treatment of anxiety disorders. Hence, the first study 
examined the effects of repeated (sham-controlled) iTBS administration as an add-on 
tool during the time course of standardized CBT (15 sessions conducted during the 
first three weeks) in a group of patients suffering from panic disorder with or without 
agoraphobia. The second study on the other side, focused on the one-time iTBS 
effect on anxiety symptoms (subjectively perceived fear as well as behavioural and 
psychophysiological symptoms) prior to a fear-inducing situation in a group of spider 
phobic subjects. In both studies, prefrontal activation was recorded before as well as 
after iTBS treatment by means of fNIRS and finally compared to the prefrontal 
activation patterns of a healthy control group.  
In general, both studies could (1) replicate alterations within the fear network in 
terms of divergent prefrontal activation patterns compared to healthy controls. (2) 
Further, these deviations in prefrontal activity could partly be normalised after iTBS 
application. (3) However, clinical effects, in terms of a subjectively improved 
symptom reduction after verum iTBS could not be demonstrated in either of the 
studies.  The following sections will discuss these results across both studies in more 
detail and finally draw conclusions for possible clinical applications. 
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4.2 Integration of finding (1) in terms of altered prefrontal activation in 
anxiety disorders into the current literature    
In line with the current literature, as stated in the introduction, both our studies 
could confirm alterations within the fear network in terms of altered prefrontal 
activation. In more detail, study 1 revealed bilateral prefrontal hypoactivation in 
patients with panic disorder compared to healthy controls during a cognitive task as 
well as left sided hypoactivation in response to panic-relevant stimuli during an 
emotional Stroop paradigm. Study 2 on the other hand, showed left-sided 
hypoactivation of the IFG in spider phobic participants elicited by emotionally 
irrelevant words during a Stroop paradigm. Even though at first sight, these results 
seem to be conflicting in terms of the elicited activational differences, they can be 
integrated when including further data as the functional connectivity analysis, or 
behavioural data into the interpretation. In this regard, it needs to be kept in mind, 
that the behavioural performance of patients suffering from panic disorder was 
impaired, whereas there was no decline in performance for the group of spider 
phobic participants. At the same time, the functional connectivity analysis that was 
conducted in study 2 pointed to a compensatory network whereby contralateral 
resources may be recruited in order to maintain adequate behavioural reactions as 
long as possible. Within the framework of this idea, it may be concluded that such 
additional resources might rather be distributed to the processing of emotionally 
relevant stimuli thereby explaining the relative hypoactivation towards emotionally 
irrelevant stimuli. In fact, this perspective may also serve as an explanatory approach 
for the diverging literature findings with respect to the valence hypothesis: whereby 
on the one hand, this model of a lateral asymmetry regarding the valence of 
affective processing could be replicated in many studies (see 1.3.2), on the other 
hand there have also been results which showed bilateral hypoactivation (Ball, 
Ramsawh, Campbell-Sills, Paulus, & Stein, 2013) in different groups of patients or 
even on the contrary, increased activation towards phobic stimuli (Schienle et al., 
2005; Straube, Mentzel, & Miltner, 2006). Surely, these diverging results may also be 
due to a number of different factors including the chosen presented affective stimuli 
or study populations, yet it may be worthwhile to investigate this point of view in a 
study which specifically manipulates the emotional content and associated 
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maintenance of behavioural response while assessing the functional connectivity 
across hemispheres. Besides the hypothesised prefrontal hypoactivation in response 
to emotional stimuli, we also found bilateral hypoactivation during a cognitive task 
(verbal fluency task) in our group of patients with panic disorder which replicates the 
results of Nishimura et al. (2007) and underlines the idea that the imbalance of the 
fear network found in affective disorders is not restricted to emotional processing, 
but rather represents a more general trait across situations (Sylvester et al., 2012). 
Even though it needs to be kept in mind that in our study the fNIRS recording 
situation itself may have presented a fear-relevant situation for patients with panic 
disorder, hence explaining the detected hypoactivation, the fact that these aberrant 
activational patterns were only found during the experimental and not during the 
control condition speaks against such an assumption. In fact, the findings may even 
be integrated into the above presented idea as an example of why the generally 
hypothesised left-sided hypoactivation in anxiety disorders may not be found 
depending on the experimental condition. In this case, our paradigm presented a 
task based on language production which would be expected to cause increased 
activation in the left hemisphere (Vigneau et al., 2006) which could indeed be shown 
when comparing hemispheric differences between the experimental and control 
condition. Thus, it would make sense that a language-based paradigm, which does 
not primarily aim at the processing of affective stimuli, may result in bilateral 
prefrontal hypoactivation by “hiding” the more pronounced left-sided deficit due to 
the activation elicited by language processing. All in all, together our studies could 
confirm that there are changes in prefrontal activation patterns which seem to be 
detectable for different anxiety disorders as well as across different experimental 
conditions (fear-specific versus general) and thus seem to present a rather general 
trait of anxiety disorders. Yet, the manner in which these alterations of the fear 
network present themselves probably depends on the specific situation whereby 
particularly the difficulty of the task and hence the recruitment of a compensatory 
network to hold up the performance level may play an important role. Last but not 
least, we could show that fNIRS is a valid tool to collect such data including sufficient 
information to conduct a functional connectivity analysis of the prefrontal cortex 
(Medvedev et al., 2011) despite prior findings which suggested that the data quality 
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over prefrontal areas is rather poor (as compared to other regions) due to the 
anatomical characteristics of the area (e.g. frontal sinuses (Haeussinger et al., 
2011)). In this regard, the present work can finally also confirm the usefulness of 
fNIRS to address further questions focusing on the interplay of different prefrontal 
areas rather than the isolated investigation of specific regions of interest, which may 
be more and more important in the future. 
 
 
4.3 Finding (2): the effects of iTBS on psychophysiology and prefrontal 
activation patterns 
Regarding iTBS application, we could not obtain consistent findings. While in study 1 
we found significant increases in bilateral prefrontal activation solely after the 
completion of 15 verum iTBS sessions in response to panic-relevant stimuli, there 
were no such changes during the cognitive paradigm. In fact, contrary to our 
expectation, a significant increase of brain activation in the left hemisphere was 
solely found in the sham-stimulated group. Study 2, on the other hand, could not 
confirm any effects on brain activation after the single iTBS session. However, 
significant changes in HRV (but neither HR per se nor EDA) after verum stimulation 
could be reported. First of all, looking at these opposing findings on brain activation 
(significant increase in neural activation after verum iTBS versus significant increase 
after sham iTBS versus no significant increase at all), an explanation that comes to 
mind straight away is that one session is simply not sufficient at least when 
regarding the missing effects after the one-time application in study 2. Yet, there are 
a number of prior studies that repeatedly showed a robust effect on brain activation 
after one session (Huang et al., 2005; Tupak, Dresler, et al., 2013). Surely, another 
reason why, in contrast to other studies, we could not find any acute effects of iTBS 
might further be given by our experimental set-up. Despite the fact that our VR 
challenge was supposed to only serve as a fear-inducing situation without any 
therapeutical guidance, the sole exposure to the phobic objects may still have 
already been enough to cause some kind of “habituation” effect and accordingly an 
adjustment in brain activation in both, verum and sham-stimulated group hence 
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resulting in a ceiling effect. Still, it makes sense to also take the results from study 1 
into consideration and try and integrate both findings. To begin with, in our first 
manuscript (see section 2.1) we discussed that the increase in brain activation after 
sham stimulation was probably due to either a more general arousal related effect or 
else regression to the mean since the patients in the sham-stimulated group actually 
showed reduced activation compared to the verum-stimulated group at the first 
measurement time. This is a valid conclusion, yet it does not explain why there was 
indeed a specific effect of verum iTBS on panic-related stimuli for the emotional 
Stroop paradigm. Moreover, one might ask why in study 2 we did not find an effect 
of verum iTBS in the group of healthy control subjects since in their case the 
exposure to virtual spiders should not have triggered a fear reaction and thus cannot 
be explained in terms of a ceiling effect due to an unintended therapeutic 
intervention. Taken together, an explanation which comprises all above depicted 
results can be given by the assumption that the impact of iTBS actually depends on 
the prior states of the underlying neuronal circuits which has already been shown 
previously (Silvanto & Pascual-Leone, 2008) and was therefore discussed separately 
in our manuscripts. However, in order to resume all our findings it is necessary to go 
into even more detail in order to draw a comprehensive conclusion for future 
possibilities of iTBS application. To do so, it may be interesting to go back in time 
and look at an earlier visual adaption experiment (Silvanto, Muggleton, Cowey, & 
Walsh, 2007) in which the authors manipulated the excitability state of specific 
neural populations by adaption (prolonged exposure to a sensory stimulus in order to 
influence the perception of a subsequent stimulus (Gibson & Radner, 1937)) to 
different optical stimuli before excitatory TMS application over the visual cortex which 
is known to induce phosphene sensations (O'Shea & Walsh, 2007). Summing it up, 
they found that TMS especially facilitates the perception of the stimulus properties 
represented by less active neural circuitries. Thus, this finding may be able to explain 
the missing iTBS effect for the cognitive paradigm of study 1 as well as for the 
emotional Stroop paradigm of study 2 regarding phobic subjects, just the same as 
healthy controls. In this regard, it can be assumed that in all cases the stimulated 
underlying neural populations were already rather excited (no prefrontal 
hypoactivation in healthy controls; additional recruitment of compensatory network 
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in spider phobics; specific activation of left-hemispheric prefrontal activation due to 
language-based cognitive paradigm, compare last section), so iTBS did not result in 
an additional effect. Moreover, it needs to be kept in mind that we observed a 
significant change in HRV in study 2 in the verum-stimulated group only. However, 
the change in HRV did not point to a decrease in activation of the sympathetic 
nervous system as we originally expected, but on the contrary suggested an 
increase. We interpreted this in terms of an increased attention towards the 
presented stimuli which can be seen as some kind of cognitive control mechanism 
which was possibly masked by compensatory activation on a neural level but still 
manifested itself on a psychophysiological level. However, in contrast to this, patients 
suffering from panic disorder already showed diminished prefrontal activation in 
response to panic-relevant stimuli at the baseline measurement. Hence, iTBS 
application met an under-activated neural brain state and could consequently induce 
an increase in prefrontal activation to panic-relevant stimuli, as we had hypothesised.  
A possibility to manipulate the neural pre-state in a standardised manner is to 
combine rTMS with tDSC. In fact, there are already a few sham-controlled studies 
using traditional rTMS (Lang et al., 2004) as well as TBS (Weigand et al., 2013) that 
investigated the integration of these two methods. So far, the conclusion which can 
be drawn from the results is that excitatory rTMS can induce the greatest activational 
increase when being preceded by an about ten minutes lasting cathodal tDCS 
application. When applied in this manner, verum rTMS is not only superior to sham 
stimulation but also exceeds the results of traditional rTMS treatment without prior 
tDCS application. Concluding from these findings, it may be indicated to first 
systematically manipulate the initial brain state before rTMS administration during 
prospective studies. 
On a similar account, contextual as well as time-related factors probably also play an 
important role for the impact of the stimulation protocol, especially when assessing 
the anxiolytic effects of rTMS or more specifically iTBS. In this context, it may be 
reasonable to differentiate between the repeated applications of brain stimulation 
techniques such as iTBS or tDCS during the time course of psychotherapy, as we did 
in study 1 and single applications in combination with exposure as we did in study 2. 
For example, when administered during psychotherapy, besides the choice of the 
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stimulation protocol, it may be essential during which parts of the therapeutic 
process the stimulation takes place. This is even more important to consider as the 
different  brainstimulation techniques do not only enhance or decrease neural 
activation on a short term basis, but are further able to trigger neuroplastic changes 
when applied repeatedly (see section 1.4.2.4). Thus, an important research question 
might be under which conditions a particular brainstimulation protocol should be 
applied before, after or even during (in case of sole tDCS) a therapy session. Within 
this framework, another concern could be whether there are specific therapeutic 
modules like the psychoeducational phase at the beginning, cognitive restructuring 
elements and emotional activation or resource-oriented working when the add-on 
effect might be of the most supportive use. Similarly, regarding the one-time use of 
brainstimulation techniques, more research is needed concerning the stimulation 
time as well as additional factors. Thus, in order to choose a fitting stimulation 
method, possible questions to pose might be: is it the main goal to enhance 
neuroplasticity for improved extinction learning? Should the patient achieve better 
cognitive control during a fear-inducing situation? Or may even the opposite effect in 
terms of an intensification of the fear-induction be desirable? Of course, the latter 
point might especially make sense when working with patients that tend to use 
cognitive avoidance as a rather automated strategy in order to evade fear activation.  
Regarding this matter of an intensified fear-induction effect, it seems worthwhile to 
get back to study 2 where we combined iTBS with the VR scenario. Even though a 
number of  studies (see section 1.4.2.3) including ours have shown that VR can 
trigger subjectively perceived fear as well as the corresponding physiological 
reaction, it cannot be assumed that all potential participants manage to equally 
immerse into the given VR scenario thereby experiencing an actual feeling of 
presence. At the same time, studies have found a significant negative correlation 
between DLPFC activation and the feeling of presence during VR immersion 
(Baumgartner et al., 2008) which is in accordance with the finding that patients 
suffering from posttraumatic stress disorder accompanied by derealisation or 
depersonalisation phenomena also show increased activation in prefrontal areas 
(Hopper et al., 2007; Lanius et al., 2010; Lanius et al., 2002). Thus, a possible 
application in terms of fear-induction during virtual VR therapy could be the down-
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regulation of prefrontal activation prior to a VR challenge in order to enhance the 
feeling of presence. Surely, such considerations are still highly speculative at this 
point but nevertheless deserve further attention in prospective studies.  
 
 
4.4 Further explanations for the missing clinical effects of prefrontal iTBS 
(finding 3)  
Whereas on a neurobiological level we could show some significant iTBS induced 
changes in prefrontal activation and HRV, on a clinical level no differences in terms of 
phobic symptom reduction between the sham- and verum-stimulated group were 
found in either of our studies. One reason might be that the temporal relationship 
between stimulation and clinical impact is not necessarily a linear one, so a delayed 
onset of action should not yet be excluded. This is even more the case when 
considering that for major depression a delayed onset effect of rTMS has been 
reported before in a meta-analysis (Schutter, 2009) and further that the 
hypothesised mode of action for long-term iTBS effects are changes within the 
neurotransmitter system as already discussed during the last section. However, up to 
date, studies that have investigated the long-term effects of rTMS and more 
specifically iTBS on anxiety symptoms are still missing. On a related account, very 
recently Reznikov, Binko, Nobrega, & Hamani (2016) investigated the application of 
deep brain stimulation in areas including the amygdala, the ventral striatum, the 
hippocampus and the PFC in animal models of post traumatic stress disorder in a 
review article and found improved fear extinction and accordingly fewer anxiety 
symptoms. Even though this is not directly comparable to the repeated use of rTMS 
in humans, the results are encouraging regarding future research in the field of long-
term application of brain stimulation methods as clinical treatment options. 
Equivalently to the inconsistent neurobiological changes, another explanation for the 
missing stimulation effect in both of our studies might simply be given by a ceiling 
effect of psychotherapy. Indeed, our therapeutic intervention in study 1 was rather 
effective as already after the first three sessions a significant reduction in clinical 
symptom severity could be shown independently of the stimulation group. Moreover, 
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all patients received an individual therapist-guided exposure session which has been 
shown to be one of the major mechanisms of action in the treatment of panic 
disorder/agoraphobia (see section 1.4.1). In line with this assumption, a study by 
Prasser et al. (2015) where the authors investigated the effect of prefrontal rTMS on 
depressive symptoms as an add-on to psychotherapy could not find any advantages 
of verum compared to sham stimulation. Surely, this still does not explain why we 
could not find any difference in anxiety symptoms during the VR challenge in study 2 
where we explicitly refrained from all kinds of additional therapeutic intervention and 
solely focused on the effects of iTBS on fear-induction. Yet, as presumed above, the 
mere exposure to the phobic objects might have already induced some kind of 
habituation effect which is in fact supported by the adaption of our physiological 
measures in terms of HR and EDA as well as subjectively perceived anxiety.  Indeed, 
even though we did not find an anxiolytic effect of iTBS, on the upside one might say 
our study underlines the potential of VR exposure in psychotherapy. Even though this 
dissertation did not focus on the application of VR, it shall be mentioned that it also 
presents an important field for future studies as it undoubtedly also comprises 
further valuable possibilities regarding the implementation of exposure therapy 
considering its capability of simulating situations which would otherwise be hard to 
realise. Examples might be the exposure to trauma-associated stimuli in patients 
suffering from PTSD or the confrontation with illegal substances in drug dependence. 
A clear advantage in this regard is the safety as well as controllability of the virtual 
situation which may also improve the commitment of some patients who might have 
otherwise avoided the confrontation with their feared stimuli (Garcia-Palacios, 
Botella, Hoffman, & Fabregat, 2007; Mitrousia & Giotakos, 2016).  
But to get back to the missing iTBS effect in study 2 another reason might simply be 
that we should have chosen another stimulation site rather than the DLPFC. In this 
regard, a very recently published study by Herrmann et al. (2016) found an 
improvement of therapy response in patients suffering from acrophobia after VR 
exposure when combining it with activating rTMS over the MPFC in the verum- 
compared to the sham-stimulated group. In more detail, the authors showed a 
greater reduction of subjectively reported phobic symptoms right after rTMS-
augmented VR exposure therapy but not at follow-up three months later. From this, 
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they concluded that activating rTMS over the MPFC directly influences extinction 
learning processes per se but not the recall of extinction. However, this finding might 
still be of therapeutical relevance as it suggests that rTMS may accelerate therapy 
response which in turn may improve the patients` commitment at the beginning of 
exposure therapy and thus raises hope in patients who might have otherwise given 
up when not being able to experience a sense of achievement at the start of therapy. 
Furthermore, the authors emphasise the importance of the timing of rTMS 
stimulation as animal studies (Milad, Vidal-Gonzalez, & Quirk, 2004) have shown that 
infralimbic stimulation only modulates extinction learning when applied during the 
training situation but not before. A possible explanation for this finding could be an 
increase in functional connectivity during stimulation. A hint for this assumption is for 
example given by Kroczek et al. (2016) who found that anodal tDCS during smoking 
cue exposure led to increased functional connectivity between prefrontal areas 
responsible for value reinforcement and cognitive control. However, similar to our 
study the authors could not find any differences in subjectively perceived symptom 
reduction.  
All in all, these studies suggest that the effects of neurostimulation and its associated 
processes are very sensitive to a number of factors like the timing or the site of 
stimulation. Moreover, they always have to be regarded in interaction with the prior 
brain state as well as the stimulation environment, including further therapeutical 
interventions the stimulated individual may receive. From this point of view, it is not 
enough to just choose the brain region that should be inhibited or enhanced in order 
to achieve an improvement of clinical symptoms when designing a study. On the 
contrary, even when investigating the combination of a brain stimulation technique 
and a well-controlled exposure situation a number of details need to be considered in 
order to potentially gain a real add-on effect. To take this reasoning a bit further, it 
might be necessary to even individually decide which patient profits from what kind 
of supportive neurostimulation protocol. Taking panic disorder as an example, some 
patients might mainly suffer from loss of cognitive control as soon as they are 
confronted with a fear-inducing stimulus, be it an internal one like sensing their own 
heart beat or an external one like being in a situation similar to one where a panic 
attack has occurred before. This group of patients may be so overwhelmed by their 
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feelings of anxiety that even though they are familiar with “the vicious circle of 
anxiety” on a cognitive level, including the knowledge of their individual triggers for 
panic attacks, especially at the beginning of psychotherapy, they cannot transpose 
this knowledge to an adequate plan of action. Consequently, in this group of patients 
it might make sense to apply, for instance, prefrontal activating rTMS and as add-on 
intervention in order to enhance cognitive control. However, there might also be a 
second group of patients that already executes “too much” control by using cognitive 
avoidance strategies thereby distracting themselves from any kind of fear-inducing 
sensations or thoughts. In this group of patients, it might on the contrary be more 
helpful to receive an rTMS treatment which helps them to give up cognitive control 
and expose themselves to their feeling of anxiety. Taken together, a further 
explanation for the missing clinical iTBS effect might be that there were different 
kinds of patients within our treatment group who nevertheless all received the same 
stimulation independent of whether they tended to use cognitive avoidance 
strategies or be overwhelmed by their fear during the confrontation with panic-
associated stimuli. On a similar account, regarding one-time stimulation prior to a 
specific situation, a recent study (Möbius et al., 2017) found that negative mood 
swings in response to sad movie clips were significantly more pronounced after 
active rTMS over the left DLPFC then after sham stimulation. The authors discuss 
their findings at odds with the current literature as they used an activating protocol 
and thus expected less negative mood swings in the active group, which should 
indeed be expected if the subjects tried to avoid negative feelings. However, 
considering that only healthy subjects without any affective disorders were included 
who were instructed to pay attention to the video clips, at least from a “cognitive 
point of view”, it makes sense that increased prefrontal activation may lead to an 
increased capacity to pay attention to the presented stimuli. And thus, as they were 
negative ones consequently also produced a more pronounced negative mood 
induction.  Likewise, Shahbabaie et al. (2014) found significant changes in craving 
intensity to addiction-related stimuli during anodal tDCS in combination with a cue-
induced craving task. Interestingly, at rest, meaning when no cues were presented, 
craving was reduced during active as compared the sham tDCS. However, during cue 
presentation this pattern reversed and active stimulation induced a significant 
   
137 
 
increase in craving which the authors interpreted in terms of tDSC-induced saliency 
of the presented stimuli. Thus, this study also underlines that the effects of 
neurostimulation are very sensitive to the specific setting and the results depend 
very much not just on the environment but also the internal cognitive state of the 
stimulated individual.  
In order to complete this dissertation, it can be concluded that in line with the 
current literature, we could show functional prefrontal alterations within the fear 
network in different anxiety disorders. These neuronal activation patterns could 
partly be influenced and normalised by means of iTBS which may be seen as an 
indicator for its potential as an add-on tool in psychotherapy. However, so far this 
potential has not yet been sufficiently exploited as can also be seen in the lack of 
clinical effects in our studies. 
In this regard, a major limitation of both our studies was probably that we did not 
take the state-dependency of iTBS into account. Further, individual factors, like 
possible biomarkes, which might predict the effectiveness of iTBS were not 
considered. Aside from that, we did not clearly define the temporal and contextual 
factors of iTBS stimulation. For example, in study 1 all participants received 15 
sessions of iTBS during the first three weeks of the psychoeducational phase of 
psychotherapy. However, we did not specify whether the stimulation took place 
before or after the therapeutical sessions as long as the individually chosen time of 
the day was held constant over all 15 sessions. However, it might make a crucial 
difference at what time in relation to the specific element of psychotherapy iTBS as 
an add-on is delivered. In the same matter, it might have also been interesting to 
vary the timeframe of iTBS application and the phase of psychotherapy, for instance 
not just applying it during psychoeducation but also during the session when 
exposure training was taking place. At last, it cannot be ruled out that especially in 
study 1 where the blinding of our participants was not sufficiently successful a 
placebo effect might have also influenced our results. In fact, even though in study 2 
the blinding was effective, the mere stimulation situation might have induced some 
kind of placebo effect. 
In this regard, in future studies it might be of advantage to include an additional 
control condition without any iTBS application in order to be able to clearly ascribe 
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possible iTBS effects to the actual stimulation protocol. Even more importantly 
though, a lot of further research is needed to clarify under which circumstances what 
kind of stimulation should be applied in order to receive the desired effects. When 
not taking such contextual and individual factors into account, it will probably be 
hard to achieve a consistent clinical add-on effect in terms of symptom reduction in 
the patients. Thus, future research needs to specifically evaluate these contextual as 
well as individual factors, including the prior brain state of the stimulated patients, 
their emotion regulation strategies or the time of iTBS application in order to achieve 
a supportive therapeutic effect of iTBS or more universally speaking, of different 
neurostimulation methods in general.  
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